000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki|ţp|N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1577|3065|lyfalmen|V0045|1516|00|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1577||1577|3065| 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|33003|43301|lyfsjukr|||00|2|0|24,0000|Icepharma hf|Roche|Epóetín||33003||33003|43301| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|49580|64105|lyfsjukr|||00|2|0|36,0000|Icepharma hf|Roche|Epóetín||49580||49580|64105| 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10456|15211|lyfalmen|V0457|9274|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10456||10456|15211| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|30475|40606|lyfalmen|V0475|27463|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30475||30475|40606| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|39633|52099|lyfalmen|V0540|42150|00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39633||39633|52099| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|21318|29113|lyfalmen|V0456|17447|00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21318||21318|29113| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|4965|7166|lyfsjukr|||00|1|0|0,0400|Vistor hf|Ferring|Atosíban||4965||4965|7166| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7511|14595|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||7511||7511|14595| 000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|13300|18574|lyfsjukr|||00|5|0|0,2300|Vistor hf|Ferring|Atosíban||13300||13300|18574| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|20004|27464|lyfalmen|||00|0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||20004||20004|27464| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|38827|51087|lyfalmen|||00|1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||38827||38827|51087| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|5279|8129|lyfalmen|||00|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5279||5279|8129| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||00|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3241|5341|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3241|5341| 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|27612|37012|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||27612||27612|37012| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|LTH|0|0|0|100|DKK|1786|3351|lyfalmen|||06|5|0|0,0000|Vistor hf|Laboratoires THEA|Ketotifen||1786||1786|3351| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4826|7509|lyfalmen|||23|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4826||4826|7509| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|3614|5851|lyfalmen|||00|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3614||3614|5851| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||00|8|0|0,0000|Vistor hf|Laboratoires THEA|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|LTH|0|0|0|100|DKK|5304|8163|lyfalmen|||00|24|0|0,0000|Vistor hf|Laboratoires THEA|Ketotifen||5304||5304|8163| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7029|10145|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Fitusambönd||7029||7029|10145| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|3042|5069|lyfalmen|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3042||3042|5069| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3745|6030|lyfalmen|||23|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3745||3745|6030| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|166477|210811|lyfsjukr|||00|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||166477||166477|210811| 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|22190|29731|lyfsjukr|||02|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||22190||22190|29731| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|5662|8172|lyfsjukr|||02|0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5662||5662|8172| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1445|2884|lyfalmen|V0037|2361|00|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1445||1445|2884| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6312|9542|lyfalmen|||00|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6312||6312|9542| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|20886|28571|lyfalmen|V0115|18549|00|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||20886||20886|28571| 001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2310|4067|lyfalmen|||43|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2310||2310|4067| 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|ţpakki||C09CA02|01.08.2001|31.12.2011|R|A|3|0|0|0|0|AHP|0|0|0|100|XEU|10482|15246|lyfalmen|||00|98|0|98,0000|Vistor hf|Abbott Healthcare Products B.V.|Eprosartan||10482||10482|15246| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|28312|37414|lyfsjukr|||02|2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||28312||28312|37414| 001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|2540|2869|lyfalmen|V0278|2595|00|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||1434||1434|2869| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6062|9200|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||6062||6062|9200| 001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4162|6601|lyfalmen|||10|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4162||4162|6601| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2115|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2115| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4267|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4267| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|21820|29267|lyfsjukr|||00|4104|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||21820||21820|29267| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|15000|21184|lyfalmen|V0034|18454|00|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||15000||15000|21184| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31794|41784|lyfsjukr|||00|6160|0|6,1600|Icepharma hf|Fresenius Kabi|Blöndur||31794||31794|41784| 001792|N02BA0109|Alka-Seltzer|freyđit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004|31.12.2011|L|A|3|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,1600|Icepharma hf|Bayer AB|Acetýlsalicýlsýra|||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|2406|3472|lyfsjukr|||02|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2406||2406|3472| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4157|6594|lyfalmen|V0444|6594|06|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4157||4157|6594| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|829|1872|lyfalmen|V0004|532|00|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||705||705|1872| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1946|3301|lyfalmen|V0291|3301|00|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3301| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|6936|10395|lyfalmen|V0294|10395|00|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10395| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|1|100|SEK|4250|6721|lyfalmen|||00|45|0|45,0000|Icepharma hf|Bioglan AB|Capsaicin||4250||4250|6721| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|3353|5494|lyfalmen|V0292|5494|00|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5494| 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8895|13075|lyfalmen|V0161|12867|43|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||8895||8895|13075| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4321|2130|lyfalmen|V0004|2130|00|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||894||894|2130| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5263|8107|lyfalmen|V0293|8107|00|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8107| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8578|4282|lyfalmen|V0011|3936|0|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2467||2467|4282| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1362|2491|lyfalmen|V0005|532|00|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1158||1158|2491| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6046|2130|lyfalmen|V0005|2130|00|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||894||894|2130| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5274|8122|lyfalmen|||00|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5274||5274|8122| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5294|3821|lyfalmen|V0011|3514|00|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2130||2130|3821| 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25686|34118|lyfsjukr|||00|5760|0|5,7600|Icepharma hf|Fresenius Kabi|Blöndur||25686||25686|34118| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13147|7664|lyfalmen|V0011|7029|00|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4939||4939|7664| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9642|3821|lyfalmen|V0012|3821|00|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2130||2130|3821| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|3105|5155|lyfalmen|||02|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín aspart||3105||3105|5155| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|17483|7664|lyfalmen|V0012|7642|00|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4939||4939|7664| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|DKK|17033|23736|lyfalmen|V0492|19298|00|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||17033||17033|23736| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|103884|132257|lyfsjukr|||00|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||103884||103884|132257| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|52872|68237|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||52872||52872|68237| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|26748|35451|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||26748||26748|35451| 002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BYP|0|0|0|100|SEK|3172|5247|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||||3172|5247| 002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BYP|0|0|0|100|SEK|3172|5247|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3172||3172|5247| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1645|3158|lyfalmen|V0362|3158|00|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||1645||1645|3158| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|215114|271851|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||215114||215114|271851| 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|SEK|3430|5983|vetorma|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3430||3430|5983| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1250|2617|lyfalmen|||07|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1250||1250|2617| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|30131|39697|lyfsjukr|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||30131||30131|39697| 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002|30.11.2011|R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|73605|94734|lyfalmen|||00|1|0|14,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||73605||73605|94734| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14077|15211|lyfalmen|V0089|4330|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10456||10456|15211| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|10405|15141|lyfalmen|V0515|12275|00|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10405||10405|15141| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|244758|309054|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||244758||244758|309054| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|17965|24905|lyfalmen|V0253|20307|00|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17965||17965|24905| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|34907|46168|lyfalmen|V0516|37405|00|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||34907||34907|46168| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|10207|14870|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||10207||10207|14870| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|15173|21402|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||15173||15173|21402| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BYP|0|0|0|100|SEK|188494|238442|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Pharma AG|Gadóbútról||188494||188494|238442| 003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9227|13529|lyfalmen|V0356|12365|0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9227||9227|13529| 003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|8552|12606|lyfalmen|||00|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8552||8552|12606| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|DKK|59138|76578|lyfalmen|||00|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||59138||59138|76578| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|4351|6859|lyfalmen|||00|28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4351||4351|6859| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|3217|5308|lyfalmen|||00|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3217||3217|5308| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|15035|21228|lyfalmen|||00|98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||15035||15035|21228| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|6582|9911|lyfalmen|||00|28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6582||6582|9911| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|22464|30552|lyfalmen|||00|98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||22464||22464|30552| 003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|872|2100|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||872||872|2100| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1017|1977|lyfalmen|V0151|1977|00|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|1977| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|587|1710|lyfalmen|||67|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||587||587|1710| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2389|4175|lyfalmen|V0322|4175|00|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4175| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|72703|93125|lyfsjukr|||00|60|0|6,0000|Vistor hf|Abbott Laboratories A/S|Lopinavír||72703||72703|93125| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2128|3818|lyfalmen|V0469|2319|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2128||2128|3818| 004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|21811|29255|lyfsjukr|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||21811||21811|29255| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7917|11737|lyfalmen|||00|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7917||7917|11737| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4140|6571|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4140||4140|6571| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|A|5|0|0|0|0|PER|0|1|0|100|DKK|592|1717|lyfalmen|||00|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||592||592|1717| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1060|2357|lyfalmen|||10|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1060||1060|2357| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PER|0|1|0|100|DKK|5475|8397|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5475||5475|8397| 004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|7649|11371|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7649||7649|11371| 004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|10744|15605|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10744||10744|15605| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|634|1775|lyfalmen|V0366|1057|00|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||634||634|1775| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|0|0|ORG|0|1|0|100|DKK|5929|9018|lyfalmen|||00|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||5929||5929|9018| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|21072|28328|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||21072||21072|28328| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1655|3171|lyfalmen|V0366|3171|00|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1655||1655|3171| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7146|10683|lyfalmen|||0|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7146||7146|10683| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|4633|7245|lyfalmen|V0458|7244|00|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4633||4633|7245| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4797|9384|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||4797||4797|9384| 004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3248|5350|lyfalmen|||00|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3248||3248|5350| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|635|1776|lyfalmen|||00|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||635||635|1776| 004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4332|6833|lyfalmen|V0226|2712|00|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4332||4332|6833| 004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6119|9278|lyfalmen|V0227|4161|00|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6119||6119|9278| 004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8144|12048|lyfalmen|V0228|5371|00|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8144||8144|12048| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2194|3909|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||2194||2194|3909| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3499|5694|lyfalmen|V0494|3185|00|90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríđ||3499||3499|5694| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4404|lyfalmen|V0318|4404|00|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4404| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|K|3|0|1|0|1|EMA|0|0|0|100|SEK|35689|46672|lyfsjukr|||00|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||35689||35689|46672| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1419|2848|lyfalmen|||20|25|0|25,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||1419||1419|2848| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dćla|einnotadćl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3239|5338|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||3239||3239|5338| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|2092|lyfalmen|V0071|2092|00|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2092| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|7346|lyfalmen|V0320|7346|00|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||4707||4707|7346| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1969|lyfalmen|V0062|1969|00|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|1969| 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4605|lyfalmen|V0317|4605|00|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4605| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|926|1850|lyfalmen|V0067|1850|00|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||689||689|1850| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1691| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|38123|49727|lyfsjukr|||00|5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||38123||38123|49727| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3340|lyfalmen|V0318|2466|00|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3340| 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|135800|172312|lyfsjukr|||00|19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||135800||135800|172312| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|K|3|0|1|0|1|EMA|0|0|0|100|SEK|178447|225833|lyfsjukr|||00|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||178447||178447|225833| 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10382|15109|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10382||10382|15109| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|6884|7378|lyfalmen|V0250|7106|0|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4730||4730|7378| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|8895|8602|lyfalmen|V0251|5885|10|100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||5625||5625|8602| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|649|1795|lyfalmen|||41|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||649||649|1795| 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|14866|13346|lyfalmen|V0282|13278|00|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||9093||9093|13346| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|5418|7820|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5418||5418|7820| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|374|1419|lyfalmen|V0352|695|41|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||374||374|1419| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|656|1805|lyfalmen|V0352|1216|41|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||656||656|1805| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1242|2606|lyfalmen|V0352|2606|41|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1242||1242|2606| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1777|3338|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1777||1777|3338| 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2314|4073|lyfalmen|||00|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2314|4073| 005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|8759|7007|lyfalmen|V0148|4217|00|90|0|90,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4459||4459|7007| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1108|2423|lyfalmen|||10|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||1108||1108|2423| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1276|2653|lyfalmen|||10|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1276||1276|2653| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1745|3294|lyfalmen|||10|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1745||1745|3294| 005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|27679|37097|lyfalmen|V0356|37095|00|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27679||27679|37097| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|50854|66181|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||50854||50854|66181| 005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3335|5469|lyfalmen|||00|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3335||3335|5469| 005330|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1126|2448|lyfalmen|||00|2|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1126||1126|2448| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.04.1996||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|61509|79553|lyfalmen|V0451|79060|00|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||61509||61509|79553| 005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1486|2940|lyfalmen|||24|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1486||1486|2940| 005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|29524|18213|lyfalmen|V0283|12431|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12632||12632|18213| 005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|37550|49485|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||37550||37550|49485| 005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1231|2591|lyfalmen|V0545|2590|23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1231||1231|2591| 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6259|9469|lyfalmen|||00|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6259||6259|9469| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6596|9930|lyfalmen|||0|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||6596|9930| 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4179|6624|lyfalmen|||00|0|0|0,0000|Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4179||4179|6624| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1598|3093|lyfalmen|||00|30|0|15,0000|Icepharma hf|Servier|Glíklazíđ||1598||1598|3093| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2785|4717|lyfalmen|V0020|3674|00|60|0|30,0000|Icepharma hf|Servier|Glíklazíđ||2785||2785|4717| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7394|11022|lyfalmen|V0020|11022|00|180|0|90,0000|Icepharma hf|Servier|Glíklazíđ||7394||7394|11022| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4063|6465|lyfalmen|V0020|5511|00|90|0|45,0000|Icepharma hf|Servier|Glíklazíđ||4063||4063|6465| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|1788|3353|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1788||1788|3353| 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|ţpakki||L01BB05|01.11.2002|31.12.2011|R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|71355|91433|lyfsjukr|||00|15|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||71355||71355|91433| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6645|9007|lyfalmen|V0324|3895|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5921||5921|9007| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|3151|4887|lyfalmen|V0035|3563|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2909||2909|4887| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|17928|31274|vetorma|||16|5|0|0,0000|Vistor hf|Merial (MSD)|||17928||17928|31274| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6263|9475|lyfalmen|V0325|3543|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6263||6263|9475| 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.11.2002|31.12.2011|R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|88255|112643|lyfsjukr|||00|20|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||88255||88255|112643| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|10567|14134|lyfalmen|V0325|6326|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9669||9669|14134| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5061|7411|lyfalmen|V0175|4065|00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4754||4754|7411| 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|2992|5000|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||2992||2992|5000| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3495|5688|lyfalmen|||59|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3495||3495|5688| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|881|2113|lyfalmen|||00|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||881||881|2113| 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|10259|14941|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||10259||10259|14941| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|16360|20682|lyfalmen|V0326|6326|00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14600||14600|20682| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3569|5790|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3569||3569|5790| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6465|8694|lyfalmen|V0246|4435|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5692||5692|8694| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9442|12424|lyfalmen|V0072|3524|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8419||8419|12424| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|12667|18256|lyfalmen|V0327|3543|00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12667||12667|18256| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4691|7324|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4691||4691|7324| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|12833|17648|lyfalmen|V0073|3524|00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12182||12182|17648| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|84157|107500|lyfsjukr|||00|2|0|0,7500|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||84157||84157|107500| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|5781|8815|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||5781||5781|8815| 006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|DKK|104373|132871|lyfsjukr|||00|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||104373||104373|132871| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|5608|8579|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||5608||5608|8579| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|156714|198559|lyfsjukr|||00|3|0|1,5000|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||156714||156714|198559| 006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|DKK|79709|101917|lyfsjukr|||00|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||79709||79709|101917| 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1434|2869|lyfalmen|||00|4|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||1434||1434|2869| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|A||0|0|0|0|REP|0|0|1|100|SEK|2551|4397|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2551||2551|4397| 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2726|4636|lyfalmen|||43|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2726||2726|4636| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|8815|17099|vetalmen|||00|50|0|0,0000|Vistor hf|Boehringer Ingelheim|||8815||8815|17099| 006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|13051|18738|lyfalmen|||00|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13051||13051|18738| 006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|6983|10460|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6983||6983|10460| 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|12371|17885|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12371||12371|17885| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|1,0000|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14643|20736|lyfalmen|||00|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14643||14643|20736| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4509|7075|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4509||4509|7075| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|704|1870|lyfalmen|||00|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||704||704|1870| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|25409|48962|vetalmen|||27|20|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||25409||25409|48962| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13632|19468|lyfalmen|V0117|19468|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13632||13632|19468| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2062|3728|lyfalmen|||00|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2062||2062|3728| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6799|10208|lyfalmen|||00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6799||6799|10208| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|20577|28184|lyfalmen|V0118|28184|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20577||20577|28184| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|5235|8069|lyfalmen|||00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5235||5235|8069| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8545|12596|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8545||8545|12596| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|25741|34664|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||25741||25741|34664| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|166816|211237|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||166816||166816|211237| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|318338|401397|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||318338||318338|401397| 007278|C08CA0302|Lomir Retard|forđahlk|2,5|mg|30|stk|1|ţpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2006|3651|lyfalmen|||10|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2006||2006|3651| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2982|4987|lyfalmen|V0377|4305|00|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||2982||2982|4987| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|98264|125204|lyfsjukr|||00|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||98264||98264|125204| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|280926|354445|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||280926||280926|354445| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PER|0|0|0|100|DKK|3230|5326|lyfalmen|V0374|4252|06|2|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3230||3230|5326| 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|8570|12369|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Clintec parenteral SA|||8570||8570|12369| 007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|118171|150187|lyfsjukr|||00|100|0|0,0000|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||118171||118171|150187| 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|23376|31219|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Sevóflúran||23376||23376|31219| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|100|DKK|1968|3433|vetorma|||16|7|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1968|3433| 007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6245|9450|lyfalmen|||00|30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6245||6245|9450| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3626|5868|lyfalmen|V0079|5868|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3626||3626|5868| 007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|4957|7688|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||4957||4957|7688| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|4493|6485|lyfsjukr|||00|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4493||4493|6485| 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21463|29295|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21463||21463|29295| 007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|9662|14124|lyfalmen|||00|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9662||9662|14124| 007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6412|9679|lyfalmen|||00|30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6412||6412|9679| 007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|21768|29678|lyfalmen|||00|100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||21768||21768|29678| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3028|lyfalmen|V0290|3028|00|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3028| 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4001|6381|lyfalmen|||00|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||4001||4001|6381| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0,0000|Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1328|2724|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Ólópatadín||1328||1328|2724| 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|179716|227426|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||179716||179716|227426| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|20494|27602|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|Nituroxíđ||20494||20494|27602| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LOL|0|0|1|100|IKR|729|1905|lyfalmen|||00|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1905| 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|44935|58276|lyfsjukr|||00|1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||44935||44935|58276| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|SEK|603|1732|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||603||603|1732| 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|23634|31543|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||23634||23634|31543| 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29322|38682|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||29322||29322|38682| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|5506|8439|lyfalmen|||00|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5506||5506|8439| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|55215|71177|lyfsjukr|||00|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||55215||55215|71177| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|110430|140472|lyfsjukr|||00|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||110430||110430|140472| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|88000|112323|lyfsjukr|||00|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||88000||88000|112323| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|130180|165258|lyfsjukr|||00|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||130180||130180|165258| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|152924|193802|lyfsjukr|||00|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||152924||152924|193802| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1524|2992|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1524||1524|2992| 008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|288|1301|lyfalmen|||20|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||288||288|1301| 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|36566|47773|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||36566||36566|47773| 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|28632|37816|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||28632||28632|37816| 008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|563|1678|lyfalmen|||33|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||563||563|1678| 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|33455|43869|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||33455||33455|43869| 008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|891|1974|lyfalmen|||00|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||780||780|1974| 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.1998|31.01.2012|R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2876|4842|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2876||2876|4842| 008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1271|2646|lyfalmen|||33|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1271||1271|2646| 008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2877|4843|lyfalmen|V0226|4843|00|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2877||2877|4843| 008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4768|7430|lyfalmen|V0227|7430|00|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4768||4768|7430| 008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|6434|9591|lyfalmen|V0228|9591|00|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6348||6348|9591| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|153609|194662|lyfsjukr|||02|2|0|0,0000|Vistor hf|Genzyme BV|Thýrótrópín||153609||153609|194662| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|818|2026|lyfalmen|V0153|2026|00|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||818||818|2026| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|711|1880|lyfalmen|V0154|1880|00|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||711||711|1880| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|0|0|0|100|USD|5120|8932|vetorma|||00|1000|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||5120||5120|8932| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|12685|24530|vetalmen|||00|50|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||12685||12685|24530| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|ţpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|4085|6495|lyfalmen|||00|100|0|100,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4085||4085|6495| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2889|4859|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2889||2889|4859| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|109134|138846|lyfsjukr|||00|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||109134||109134|138846| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|115124|146363|lyfsjukr|||00|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||115124||115124|146363| 008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|3077|5117|lyfalmen|||00|15|0|15,0000|Vistor hf|Meda AB|Pímekrólímus||3077||3077|5117| 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3626|5868|lyfalmen|V0094|5868|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3626||3626|5868| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|1936|3556|lyfalmen|||20|60|0|60,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1936||1936|3556| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6035|9163|lyfalmen|V0145|8586|00|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6035|9163| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|11889|17171|lyfalmen|V0145|17171|00|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11889|17171| 009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|5191|8008|lyfalmen|||00|30|0|30,0000|Vistor hf|Meda AB|Pímekrólímus||5191||5191|8008| 009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8755|12636|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8755||8755|12636| 009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8755|12636|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8755||8755|12636| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|IPI|0|0|1|100|DKK|14295|20300|lyfalmen|||03|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||14295||14295|20300| 009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8755|12636|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8755||8755|12636| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|52147|67327|lyfsjukr|||00|30|0|3,7500|Icepharma hf|Pfizer ApS|Voricónazól||52147||52147|67327| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1740| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5441|8350|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5441||5441|8350| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1141|2468|lyfalmen|||23|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1141||1141|2468| 009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1258|2628|lyfalmen|V0130|1627|23|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1258||1258|2628| 009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1455|2898|lyfalmen|V0131|2393|23|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1455||1455|2898| 009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1822|3400|lyfalmen|V0132|2658|23|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1822||1822|3400| 009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7243|10453|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7243||7243|10453| 009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7243|10453|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7243||7243|10453| 009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7243|10453|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7243||7243|10453| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|199062|251705|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||199062||199062|251705| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5270|8116|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5270||5270|8116| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|59567|76639|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||59567||59567|76639| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8700|12809|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||8700||8700|12809| 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8188|12108|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|Prílókaín í blöndum||8188||8188|12108| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8035|11899|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|Lídókaín í blöndum||8035||8035|11899| 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|9417|13789|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|Prílókaín í blöndum||9417||9417|13789| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8203|12129|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|Lídókaín í blöndum||8203||8203|12129| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8063|11937|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||8063||8063|11937| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|2172|3879|lyfalmen|V0329|2400|00|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2172||2172|3879| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|4135|6564|lyfalmen|V0330|2799|00|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4135||4135|6564| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|5910|8992|lyfalmen|||00|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5910||5910|8992| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|226477|286111|lyfsjukr|||00|60|0|30,0000|Icepharma hf|Roche Registration Limited|Valgancíklóvír||226477||226477|286111| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|DKK|7263|10482|lyfsjukr|||00|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7263||7263|10482| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|12836|18469|lyfalmen|V0331|5149|00|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12836||12836|18469| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|18099|25074|lyfalmen|V0332|8502|00|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||18099||18099|25074| 010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|A||0|0|E|0|LBK|0|0|0|100|DKK|14306|20313|lyfalmen|||00|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14306|20313| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|23192|31465|lyfalmen|||00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||23192||23192|31465| 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3706|5977|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3706||3706|5977| 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|7367|10985|lyfalmen|||51|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||7367||7367|10985| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|12547|18106|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12547||12547|18106| 010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|ELA|0|0|0|100|DKK|74037|129154|vetorma|||00|1000|0|0,0000|Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||74037||74037|129154| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|6815|10230|lyfalmen|||00|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6815||6815|10230| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|7222|10423|lyfsjukr|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||7222||7222|10423| 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9213|13297|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Amínósýrur||9213||9213|13297| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1186|2530|lyfalmen|||00|5|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||1186||1186|2530| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|5550|8499|lyfalmen|V0207|1442|00|4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5550||5550|8499| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5927|8554|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Kolvetni||5927||5927|8554| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|9115|13155|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Kolvetni||9115||9115|13155| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4032|5819|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||4032||4032|5819| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2311|3335|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||2311||2311|3335| 010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|A||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8778|12915|lyfalmen|V0377|12915|00|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8778||8778|12915| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|9103|13138|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||9103||9103|13138| 010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|A||0|0|E|0|RAT|0|0|0|100|XEU|2451|3699|lyfalmen|V0006|3283|00|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2041||2041|3699| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6535|9432|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Elektrólýtar||6535||6535|9432| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3967|5725|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||3967||3967|5725| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|14349|5744|lyfalmen|V0207|4326|00|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3536||3536|5744| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2135|3081|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2135||2135|3081| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACT|0|0|0|100|DKK|353640|445701|lyfsjukr|||00|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||353640||353640|445701| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACL|0|0|0|100|DKK|353640|445701|lyfsjukr|||00|56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||353640||353640|445701| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2740|lyfalmen|||10|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||1340||1340|2740| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4936|7230|lyfalmen|V0006|5862|10|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||4622||4622|7230| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|3182|4353|lyfalmen|V0006|3283|10|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4353| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|48689|62987|lyfsjukr|||03|10|0|0,0000|Icepharma hf|Baxter Medical AB|Bleómýcín||48689||48689|62987| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|3153|4551|lyfsjukr|||03|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3153||3153|4551| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2970|4970|lyfalmen|||00|28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2970||2970|4970| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20252|27776|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20252||20252|27776| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20016|27479|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20016||20016|27479| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||00|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34482|45634|lyfalmen|||00|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34482||34482|45634| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34248|45341|lyfalmen|||00|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34248||34248|45341| 011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|18988|26189|lyfalmen|||00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||18988||18988|26189| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|DKK|4524|7096|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4524||4524|7096| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|DKK|4700|7337|lyfalmen|||00|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4700||4700|7337| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|20351|26325|lyfalmen|V0327|6326|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||19096||19096|26325| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|DKK|1200|2549|lyfalmen|||00|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1200||1200|2549| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|769|1959|lyfalmen|||00|28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||769||769|1959| 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|7416|11052|lyfalmen|V0457|9274|00|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||7416||7416|11052| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|12207|17679|lyfalmen|||02|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12207||12207|17679| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|1064|2363|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1064||1064|2363| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|2934|3524|lyfalmen|V0069|3524|00|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1913||1913|3524| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9252|13564|lyfalmen|V0357|12398|00|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9252||9252|13564| 011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7143|10679|lyfalmen|||00|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7143||7143|10679| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6712|9687|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Baxter Medical AB|Mannitól||6712||6712|9687| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|2438|3519|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Pfizer ApS|Esketamín||2438||2438|3519| 011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9375|13732|lyfalmen|||00|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9375||9375|13732| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|1931|3841|vetalmen|||00|25|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||1931||1931|3841| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|4969|7172|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Pfizer ApS|Esketamín||4969||4969|7172| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1594|3088|lyfalmen|||00|64|0|28,8000|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1594||1594|3088| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|88569|113037|lyfsjukr|||00|168|0|33,6000|Icepharma hf|Roche Registration Limited|Ribavirin||88569||88569|113037| 011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|10329|15037|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AB|Pímekrólímus||10329||10329|15037| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1486|1977|lyfalmen|V0152|1977|00|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|1977| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4738|6605|lyfalmen|V0323|6605|00|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4165||4165|6605| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4406|6359|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4406||4406|6359| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|2549|3679|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||2549||2549|3679| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8012|11867|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8012|11867| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|DKK|40728|52996|lyfsjukr|||00|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||40728||40728|52996| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|13131|18839|lyfalmen|||00|90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||13131||13131|18839| 012260|R01AC0301|Lastin|nefúđi|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1460|2905|lyfalmen|||00|20|0|35,7143|Vistor hf|Meda AB|Azelastínum||1460||1460|2905|30.11.2011 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6014|9134|lyfalmen|||00|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6014||6014|9134| 012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|490|1578|lyfalmen|||00|30|0|15,0000|Vistor hf|Aventis Pharma |Glímepíríđ||490||490|1578| 012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|11944|17246|lyfalmen|||00|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||11944||11944|17246| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|DKK|448469|564711|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Díbótermín alfa||448469||448469|564711| 012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1890|lyfalmen|||08|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1890| 012921|G03AA1301|Evra|forđapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4674|7301|lyfalmen|||00|9|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4674||4674|7301| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6764|10160|lyfalmen|||00|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6764||6764|10160| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6187|9371|lyfalmen|||00|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6187||6187|9371| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6988|13591|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||6988||6988|13591| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9341|13685|lyfalmen|||00|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9341||9341|13685| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1759|3499|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1759||1759|3499| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|22210|29756|lyfsjukr|||00|2|0|0,0000|Ísaga ehf|AGA AB|Nituroxíđ||22210||22210|29756| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|7006|10111|lyfsjukr|||17|2|0|0,0000|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7006||7006|10111| 013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|29646|39088|lyfsjukr|||00|250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||29646||29646|39088| 013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|50179|64857|lyfsjukr|||00|500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||50179||50179|64857| 013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|A||0|0|E|0|ANO|0|0|0|100|XEU|3375|4628|lyfalmen|V0042|4628|00|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2720||2720|4628| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4589|8984|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4589||4589|8984| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|10709|20735|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||10709||10709|20735| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1123|2234|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1123||1123|2234| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|188350|238262|lyfsjukr|||00|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||188350||188350|238262| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|A||0|1|0|1|AZD|0|0|0|100|SEK|406696|452313|lyfsjukr|||00|30|0||Vistor hf|AstraZeneca A/S DK|||358909||358909|452313| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|31695|41660|lyfsjukr|||00|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||31695||31695|41660| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|125567|159469|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||125567||125567|159469| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|62785|80678|lyfsjukr|||00|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||62785||62785|80678| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|5438|8346|lyfalmen|||00|28|0||Vistor hf|M.S.D.|Ezetimíb||5438||5438|8346| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|DKK|18514|25594|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb||18514||18514|25594| 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003|30.11.2011|R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|151614|192158|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||151614||151614|192158| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1320|2713|lyfalmen|||00|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1320||1320|2713| 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0,0000|Actavis Group hf|Actavis Group hf|Blöndur|||||1438| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2523|4359|lyfalmen|||00|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2523||2523|4359| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1427|2859|lyfalmen|||00|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1427||1427|2859| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|407|1464|lyfalmen|||00|30|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||407||407|1464| 013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|37525|48976|lyfsjukr|||00|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||37525||37525|48976| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|4710|7350|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4710||4710|7350| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|968|2232|lyfalmen|||00|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||968|2232| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2569|lyfalmen|V0168|2569|00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2569| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6223|9420|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||6223||6223|9420| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2592|4453|lyfalmen|||51|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2592||2592|4453| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|4649|7267|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||4649||4649|7267| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|378776|477246|lyfsjukr|||00|30|0|0,0000|Vistor hf|Novartis Europharm Ltd|Imatiníb||378776||378776|477246| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2509|4340|lyfalmen|||71|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2509||2509|4340| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|9013|13008|lyfsjukr|||00|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9013||9013|13008| 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|18200|25200|lyfalmen|||00|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||18200||18200|25200| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|57304|74276|lyfalmen|||AC|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||57304||57304|74276| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|29876|39377|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||29876||29876|39377| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|0|0|AZD|0|0|0|100|SEK|27756|37193|lyfalmen|V0357|37193|00|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27756||27756|37193| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1542|3017|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1542||1542|3017| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||29|4|0|0,0000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|19845|26788|lyfsjukr|||00|3944|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||19845||19845|26788| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25979|34486|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||25979||25979|34486| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|flaska||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|4073|lyfalmen|||00|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||||2314|4073| 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2295|4565|vetalmen|||00|45|0|0,0000|Dýraheilsa ehf|Vetcare Ltd.|||||2295|4565| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|BOY|0|0|0|100|SEK|18390|25439|lyfalmen|||23|1|0|1825,0000|Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18390||18390|25439| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|82989|106034|lyfsjukr|||0|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||82989|106034| 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PAL|0|0|0|100|XEU|5705|11127|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5705||5705|11127| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|241827|305375|lyfsjukr|||00|60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||241827||241827|305375| 014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2305|4060|lyfalmen|||10|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2305||2305|4060| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|1335|2734|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1335||1335|2734| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|63206|81206|lyfsjukr|||00|2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||63206||63206|81206| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|101127|128797|lyfsjukr|||00|2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||101127||101127|128797| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|A||0|0|E|0|MYL|0|0|0|100|SEK|877|2107|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||877|2107| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|19367|26665|lyfalmen|||00|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||19367||19367|26665| 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|A||0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|58440|75702|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||58440||58440|75702| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|38900|51179|lyfalmen|||00|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||38900||38900|51179| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|767|1957|lyfalmen|||00|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||767||767|1957| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|XEU|3200|5285|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3200||3200|5285| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|8629|12711|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||8629||8629|12711| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|XEU|1107|2400|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1091||1091|2400| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LOL|0|0|1|100|IKR|2760|4683|lyfalmen|||00|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4683| 015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1094|2404|lyfalmen|V0129|1647|23|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1094||1094|2404| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2003|3530|lyfalmen|V0234|3530|00|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3530| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2861|4653|lyfalmen|V0233|4653|00|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4653| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|10281|14971|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||10281||10281|14971| 015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|346793|437108|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||346793||346793|437108| 015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|92176|117563|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||92176||92176|117563| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5331|8200|lyfalmen|||00|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5331||5331|8200| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13553|19368|lyfalmen|||00|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13553||13553|19368| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5331|8200|lyfalmen|||00|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5331||5331|8200| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14651|20746|lyfalmen|V0264|20745|00|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14651||14651|20746| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|70707|90620|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70707||70707|90620| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|70707|90620|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70707||70707|90620| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|61484|79045|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||61484||61484|79045| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5331|8200|lyfalmen|||00|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5331||5331|8200| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13410|19189|lyfalmen|||00|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13410||13410|19189| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|70707|90620|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70707||70707|90620| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|22673|30814|lyfalmen|||00|120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||22673||22673|30814| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|47226|61628|lyfalmen|||00|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||47226||47226|61628| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3198|5579|vetorma|||16|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3198||3198|5579| 015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4494|7840|vetorma|||16|12|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4494||4494|7840| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2853|4977|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2853||2853|4977| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3577|6240|vetorma|||16|3|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3577||3577|6240| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4558|7142|lyfalmen|V0200|5460|10|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4558||4558|7142| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4008|6992|vetorma|||16|8|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4008||4008|6992| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2011|3658|lyfalmen|||0|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||||2011|3658| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2259|3998|lyfalmen|||00|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||2259||2259|3998| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1568|3052|lyfalmen|||02|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1568||1568|3052| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3198|5579|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3198||3198|5579| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|A|3|0|0|0|0|GSK|0|1|0|100|GBP|2002|3646|lyfalmen|||00|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2002||2002|3646| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14784|20913|lyfalmen|V0117|19865|00|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14784||14784|20913| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1165|2501|lyfalmen|||02|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1165||1165|2501| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|22138|30143|lyfalmen|V0118|28759|00|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22138||22138|30143| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1235|2597|lyfalmen|||02|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1235||1235|2597| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|2528|4366|lyfalmen|V0236|3780|00|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2528||2528|4366| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|||24|stk|1|ţpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000|31.12.2011|L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen|||||| 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|7674|11405|lyfalmen|||00|28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||7674||7674|11405| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2668|4557|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2668||2668|4557| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6716|10095|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6716||6716|10095| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|MSE|0|0|0|100|SEK|5100|7884|lyfalmen|||00|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5100||5100|7884| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10185|14840|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10185||10185|14840| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1759|3314|lyfalmen|||00|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1759||1759|3314| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|14795|20927|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14795||14795|20927| 016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|8881|13056|lyfalmen|||10|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||8881||8881|13056| 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4073|6479|lyfalmen|||00|28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||4073||4073|6479| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PER|0|0|0|100|DKK|96640|123166|lyfsjukr|||00|70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||96640||96640|123166| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|4279|6176|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Cýtarabín||4279||4279|6176| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2625|4498|lyfalmen|||00|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2625||2625|4498| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|17652|24513|lyfalmen|||00|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17652||17652|24513| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7108| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34482|45634|lyfalmen|V0295|45633|00|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34482||34482|45634| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2296|lyfalmen|V0169|2296|00|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2296| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|185903|235191|lyfsjukr|||00|2|0|120,0000|Icepharma hf|Roche|Epóetín||185903||185903|235191| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|7869|11672|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7869||7869|11672| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3081|5122|lyfalmen|V0433|5122|10|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3081||3081|5122| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|5686|8686|lyfalmen|V0240|8686|10|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5686||5686|8686| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|61513|79558|lyfalmen|||00|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||61513||61513|79558| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|90640|116113|lyfalmen|||00|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||90640||90640|116113| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|29291|39120|lyfalmen|||00|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||29291||29291|39120| 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004|31.12.2011|R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|56993|73886|lyfalmen|||00|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||56993||56993|73886| 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004|31.12.2011|R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|19777|27180|lyfalmen|||00|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||19777||19777|27180| 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004|31.12.2011|R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|29637|39554|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||29637||29637|39554| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2022|3673|lyfalmen|||00|14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2022||2022|3673| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|A||0|0|0|0|PER|0|0|0|100|DKK|3575|5798|lyfalmen|V0007|5798|00|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3575|5798| 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4066|6469|lyfalmen|||00|28|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||4066||4066|6469|31.12.2011 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|7884|11692|lyfalmen|V0007|10146|00|98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7884||7884|11692| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|39935|52001|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||39935||39935|52001| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|14026|19962|lyfalmen|||00|98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||14026||14026|19962| 016979|N02AE0103|Norspan|forđapl|5|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3167|5240|lyfalmen|||00|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3167||3167|5240| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PAL|0|0|0|100|DKK|18918|36498|vetalmen|||16|60|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||18918||18918|36498| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25686|34118|lyfsjukr|||00|4824|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||25686||25686|34118| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|1541|3015|lyfalmen|||03|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1541||1541|3015| 017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1442|2880|lyfalmen|||10|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1442||1442|2880| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|265958|335660|lyfsjukr|||00|5|0|0,0000|Icepharma hf|SkyPharma PLC|Cýtarabín||265958||265958|335660| 017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7962|11799|lyfalmen|||10|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7962||7962|11799| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|178954|226470|lyfsjukr|||00|1|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||178954||178954|226470| 017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|40593|52827|lyfsjukr|||00|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||40593||40593|52827| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1374|2787|lyfalmen|V0046|2184|00|100|0|33,3333|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1374||1374|2787| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIB|0|0|0|100|XEU|128744|163456|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||128744||128744|163456| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|48243|62904|lyfalmen|||00|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||48243||48243|62904| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|149813|190375|lyfalmen|||00|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||149813||149813|190375| 017266|N02AE0103|Norspan|forđapl|10|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|5498|8428|lyfalmen|||00|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5498||5498|8428| 017326|N02AE0103|Norspan|forđapl|20|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|10468|15227|lyfalmen|||00|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10468||10468|15227| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2717|4624|lyfalmen|||00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2717||2717|4624| 017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|DKK|9096|13128|lyfsjukr|||00|3|0|1,2600|Vistor hf|M.S.D.|Aprepitant||9096||9096|13128| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|893|2129|lyfalmen|||00|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||893||893|2129| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|2994|5003|lyfalmen|||00|30|0|150,0000|Vistor hf|Recip AB|Prednisón||2994||2994|5003| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1459|2653|lyfalmen|V0168|2569|00|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1276||1276|2653| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|6752|13137|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||6752||6752|13137| 017763|N06DA0401|Reminyl|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|40376|53031|lyfalmen|V0350|31951|00|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||40376||40376|53031| 017773|N06DA0401|Reminyl|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|13155|18869|lyfalmen|V0348|11837|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||13155||13155|18869| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10509|15283|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10509||10509|15283| 017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|43398|56824|lyfalmen|||00|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||43398||43398|56824| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|9597|14036|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9597||9597|14036| 018268|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BYP|0|0|0|100|SEK|7143|10679|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7143||7143|10679| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2287|4036|lyfalmen|||00|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2287||2287|4036| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3357|5500|lyfalmen|||00|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3357||3357|5500| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|10836|15730|lyfalmen|||00|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10836||10836|15730| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|7542|11224|lyfalmen|||00|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7542||7542|11224| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3864|6193|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3864||3864|6193| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4220|6680|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4220||4220|6680| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|8962|13167|lyfalmen|||00|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8962||8962|13167| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2481|lyfalmen|V0243|2481|00|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1150||1150|2481| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2808|4749|lyfalmen|||00|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2808||2808|4749| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8315|12282|lyfalmen|||00|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8315||8315|12282| 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|13789|19188|lyfsjukr|||03|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13789||13789|19188| 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|ţpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|1471|2920|lyfalmen|V0070|2468|00|14|0|7,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1471||1471|2920| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|20387|27945|lyfalmen|||00|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||20387||20387|27945| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|2944|4935|lyfalmen|V0070|4935|00|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2944||2944|4935| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MKA|0|0|1|100|SEK|967|2230|lyfalmen|V0414|1915|00|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||967||967|2230| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5888|8962|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5888||5888|8962| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|16599|23191|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16599||16599|23191| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|34690|45895|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||34690||34690|45895| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TPL|0|0|0|100|NOK|121676|154586|lyfsjukr|||00|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||121676||121676|154586| 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|ţpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|2934|4921|lyfalmen|||00|30|0|60,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||2934||2934|4921| 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|ţpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|9480|13876|lyfalmen|||00|100|0|200,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||9480||9480|13876| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|60048|77243|lyfsjukr|||43|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||60048||60048|77243| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|600|1728|lyfalmen|||00|100|0|50,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||600||600|1728| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1301|2588|vetalmen|||27|100|0|0,0000|Icepharma hf|Kela Laboratoria NV|||1301||1301|2588| 018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|10213|14878|lyfalmen|V0221|11267|00|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10213||10213|14878| 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|ţpakki||N06DA03|01.04.2004|31.12.2011|R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14760|20883|lyfalmen|||00|56|0|37,3300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14760||14760|20883| 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|A||0|0|0|1|GEH|0|0|0|100|NOK|21175|28457|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21175||21175|28457| 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|ţpakki||N06DA03|01.04.2004|31.12.2011|R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14760|20883|lyfalmen|||00|56|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14760||14760|20883| 019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|7300|10893|lyfalmen|V0220|8893|00|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7300||7300|10893| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|23898|31874|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||23898||23898|31874| 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2004|31.12.2011|R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|6661|10019|lyfalmen|||00|28|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||6661||6661|10019| 019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4047|6443|lyfalmen|V0219|5546|00|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4047||4047|6443| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|33179|43522|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||33179||33179|43522| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|34020|44578|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||34020||34020|44578| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|41568|54050|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||41568||41568|54050| 019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9500|13903|lyfalmen|V0223|12978|00|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||9500||9500|13903| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|14075|20024|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14075||14075|20024| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|4827|7510|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||4827||4827|7510| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|52301|67520|lyfsjukr|||00|1|0|0,0000|Gróco ehf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||52301||52301|67520| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|THE|0|0|0|100|XEU|746691|938980|lyfsjukr|||00|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||746691||746691|938980| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|A||0|0|0|0|VET|0|0|0|100|DKK|21293|41058|vetalmen|||00|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||21293|41058| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6868|10302|lyfalmen|||00|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6868||6868|10302| 019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|52714|68039|lyfsjukr|||AC|4|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||52714||52714|68039| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6868|10302|lyfalmen|||00|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6868||6868|10302| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|603|1732|lyfalmen|||00|100|0|100,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||603||603|1732| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|3760|5427|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3760||3760|5427| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|630|1769|lyfalmen|||00|250|0|250,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||630||630|1769| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|16520|22615|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||16520||16520|22615| 019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|195751|247550|lyfsjukr|||AC|16|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||195751||195751|247550| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1112|2429|lyfalmen|V0159|2427|10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1112||1112|2429| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|199136|251798|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||199136||199136|251798| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12949|18610|lyfalmen|||00|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12949||12949|18610| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12949|18610|lyfalmen|||00|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12949||12949|18610| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|56018|72662|lyfalmen|||00|1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||56018||56018|72662| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12949|18610|lyfalmen|||00|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12949||12949|18610| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12949|18610|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12949||12949|18610| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12949|18610|lyfalmen|||00|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12949||12949|18610| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|790774|994304|lyfsjukr|||02|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||790774||790774|994304| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|397|1450|lyfalmen|||00|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||397||397|1450| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|68045|87279|lyfsjukr|||00|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||68045||68045|87279| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1666|3133|lyfalmen|V0160|3133|10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1627||1627|3133| 020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||43|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2929|4914|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2929||2929|4914| 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|26531|35656|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||26531||26531|35656| 020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2767|4692|lyfalmen|||04|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2767||2767|4692| 020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|581|1702|lyfalmen|V0333|1527|00|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||581||581|1702| 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6837|10260|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6837||6837|10260| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|53366|69334|lyfalmen|||02|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||53366||53366|69334| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6300|9525|lyfalmen|V0530|7874|00|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6300||6300|9525| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|14037|19976|lyfalmen|V0531|9649|00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||14037||14037|19976| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|24083|32584|lyfalmen|||02|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||24083||24083|32584| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|606|1736|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||606||606|1736| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|5727|8742|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5727||5727|8742| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1847|3434|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1847||1847|3434| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|16679|23292|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16679||16679|23292| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2232|3894|vetorma|||16|8|0|0,0000|Vistor hf|Merial SAS|||2232||2232|3894| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|157074|199010|lyfsjukr|||00|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||157074||157074|199010| 020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|A||0|0|0|0|VET|0|0|0|100|XEU|2610|4553|vetorma|||16|52|0||Dýraheilsa ehf|Vetcare Ltd.|||2610||2610|4553| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2031|3686|lyfalmen|V0174|3686|00|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2031||2031|3686| 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|A||0|0|0|0|SEV|0|0|0|100|DKK|3027|5048|lyfalmen|||00|30|0|37,5000|Icepharma hf|Servier|Perindópríl||3027||3027|5048| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2483|4304|lyfalmen|||00|60|0|60,0000|Icepharma hf|Galderma Nordic AB|Adapalen||2483||2483|4304| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|827|1884|lyfalmen|||00|12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1884| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2296|lyfalmen|||00|12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1015||1015|2296|31.01.2012 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|A|2|0|0|E|0|ACA|0|0|1|100|IKR|453|1318|lyfalmen|V0188|1318|00|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||300||300|1318| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1021|2304|lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Dexpantenól||1021||1021|2304| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|A|2|0|0|E|0|ACA|0|0|1|100|IKR|1187|2044|lyfalmen|V0189|2044|00|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||831||831|2044| 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|17284|24051|lyfalmen|||02|4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||17284||17284|24051| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|DKK|17231|23984|lyfalmen|V0490|11298|63|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||17231||17231|23984| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A||0|0|E|0|DAC|0|0|1|100|SEK|1671|3143|lyfalmen|V0443|3143|24|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1634||1634|3143| 021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|DKK|17505|24328|lyfalmen|V0491|19297|63|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||17505||17505|24328| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1589|2293|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||1589||1589|2293| 021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4417|6950|lyfalmen|||00|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4417||4417|6950| 021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|13520|19327|lyfalmen|||00|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13520||13520|19327| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14454|20499|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14454||14454|20499| 021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|7145|10681|lyfalmen|||00|30|0|9,0000|Vistor hf|Ferring AB, Svíţjóđ|Desmópressín||7145||7145|10681| 021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|A||0|0|B|0|FER|0|0|0|100|DKK|15182|21413|lyfalmen|||00|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15182||15182|21413| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|15893|21828|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||15893||15893|21828| 021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|22758|30921|lyfalmen|||00|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||22758||22758|30921| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|15893|21828|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||15893||15893|21828| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24464|33062|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||24464||24464|33062| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4505|7070|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4505||4505|7070| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|9139|13190|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||9139||9139|13190| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|4612|6656|lyfsjukr|||02|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4612||4612|6656| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19585|26939|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19585||19585|26939| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|3846|6169|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3846||3846|6169| 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.01.2010||R|A||0|0|0|0|DAC|0|0|0|100|SEK|5766|7720|lyfalmen|||00|28|0|37,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4980||4980|7720|30.11.2011 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|21695|29110|lyfsjukr|||00|2500|0|2,5000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||21695||21695|29110| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|5315|8178|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5315||5315|8178| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|18315|25345|lyfalmen|||00|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18315||18315|25345| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19585|26939|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19585||19585|26939| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|84335|107723|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||84335||84335|107723| 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|A||0|0|0|1|BAM|0|0|0|100|SEK|123592|156990|lyfsjukr|||00|1200|0|1,2000|Icepharma hf|Baxter Medical AB|Albúmín||123592||123592|156990| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|7238|10809|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||7238||7238|10809| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|8482|12510|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8482||8482|12510| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|DKK|26011|35003|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||26011||26011|35003| 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|K||0|0|*|0|SAA|0|0|0|100|NOK|5400|8294|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5400||5400|8294| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|9046|13282|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||9046||9046|13282| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|295141|372284|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||295141||295141|372284| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|325712|410651|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||325712||325712|410651| 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11352|19803|vetorma|||00|24|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||11352||11352|19803| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|24628|33268|lyfalmen|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||24628||24628|33268| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2282|3981|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2282||2282|3981| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|1305|2693|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1305||1305|2693| 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|ţpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1389|2423|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1389|2423| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|3855|2652|lyfalmen|V0056|2532|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1275||1275|2652| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|6777|3675|lyfalmen|V0057|3480|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2023||2023|3675| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2161|3770|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2161||2161|3770| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|632|1772|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||632||632|1772| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1895|3500|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1895||1895|3500| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|1399|2440|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||1399||1399|2440| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4708|7348|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4708||4708|7348| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A||0|0|B|0|ACA|0|1|0|100|IKR|2129|2921|lyfalmen|V0321|2921|00|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2921| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|1974|lyfalmen|V0321|1753|00|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|1974| 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|13656|19498|lyfalmen|V0091|5245|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||13656||13656|19498| 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|26103|35119|lyfalmen|||00|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||26103||26103|35119| 022802|L01XC0401|MabCampath|irţ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|226344|285944|lyfsjukr|||00|3|0|0,0000|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||226344||226344|285944| 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|13051|18738|lyfalmen|||00|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13051||13051|18738| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2813| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2755|lyfalmen|V0124|2755|67|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2755| 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4125|lyfalmen|V0125|4125|67|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4125| 022962|V01AA1104|Alutard SQ, hrossavćrur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24464|33062|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24464||24464|33062| 022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19585|26939|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19585||19585|26939| 023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5693|8695|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5693||5693|8695| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|84329|107715|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||84329||84329|107715| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|25890|34851|lyfalmen|||00|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||25890||25890|34851| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|40422|53089|lyfalmen|||00|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||40422||40422|53089| 023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|20470|28049|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20470||20470|28049| 023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5750|8773|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5750||5750|8773| 023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|20677|28309|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20677||20677|28309| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|4860|7106|lyfalmen|V0250|7106|00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||4531||4531|7106| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|3639|5885|lyfalmen|V0251|5885|00|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3639||3639|5885| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|18544|25632|lyfalmen|||00|34|0|0,0000|Vistor hf|Dentsply DeTrey GmbH|Blöndur||18544||18544|25632| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|7449|10751|lyfsjukr|||00|0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7449||7449|10751| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|28643|37829|lyfsjukr|||00|0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||28643||28643|37829| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|21690|29103|lyfsjukr|||00|0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||21690||21690|29103| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|51656|66711|lyfsjukr|||00|0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||51656||51656|66711| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|34905|45688|lyfsjukr|||00|0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||34905||34905|45688| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|8490|12253|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8490||8490|12253| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|104038|132450|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||104038||104038|132450| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|21225|28520|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||21225||21225|28520| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|14972|20672|lyfsjukr|||00|0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||14972||14972|20672| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|36913|48208|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||36913||36913|48208| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|73826|94534|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||73826||73826|94534| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|181309|229425|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||181309||181309|229425| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|147652|187186|lyfsjukr|||00|200|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||147652||147652|187186| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13704|19558|lyfalmen|||00|4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13704||13704|19558| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|136008|172573|lyfsjukr|||00|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||136008||136008|172573| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|26586|30779|lyfalmen|V0029|10885|00|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||22645||22645|30779| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3624|5865|lyfalmen|||00|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3624||3624|5865| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|57031|73456|lyfsjukr|||00|120|0|33,3300|Icepharma hf|Roche|Saquínavír||57031||57031|73456| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|IPI|0|0|0|100|DKK|77212|98784|lyfsjukr|||00|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||77212||77212|98784| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|2952|4946|lyfalmen|||00|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2952||2952|4946| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|DKK|77979|99746|lyfsjukr|||00|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||77979||77979|99746| 024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|2577|4433|lyfalmen|||00|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2577||2577|4433| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|19508|26842|lyfalmen|||00|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||19508||19508|26842| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1818|2624|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||1818||1818|2624| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|22822|30524|lyfsjukr|||00|3944|0|3,9400|Icepharma hf|Fresenius Kabi|Blöndur||22822||22822|30524| 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|14523|20586|lyfalmen|V0456|17447|00|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||||14523|20586| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|64342|83109|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||64342||64342|83109| 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24464|33062|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24464||24464|33062| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7701|11442|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7701||7701|11442| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|435|1502|lyfalmen|||00|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||435||435|1502| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7701|11442|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7701||7701|11442| 024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12976|18644|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12976||12976|18644| 024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006|31.12.2011|R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12998|18672|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12998||12998|18672| 024532|V04CL0007|Soluprick SQ ALK203 - Háliđagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006|31.12.2011|R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584| 024559|V04CL0008|Soluprick SQ ALK214 -Axhnođapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006|31.12.2011|R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13131|18839|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13131||13131|18839| 024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006|31.12.2011|R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5553|8504|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5553||5553|8504| 024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006|31.12.2011|R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|70550|90900|lyfalmen|||00|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||70550||70550|90900| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13131|18839|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13131||13131|18839| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1581|3070|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1581||1581|3070| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5553|8504|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5553||5553|8504| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7701|11442|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7701||7701|11442| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7701|11442|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7701||7701|11442| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1581|3070|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1581||1581|3070| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|640|1783|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||640||640|1783| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19585|26939|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19585||19585|26939| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1949|3573|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1949||1949|3573| 025180|R03BA0201|Pulmicort|innúđal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009|31.01.2012|R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2121|3809|lyfalmen|||0|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||2121||2121|3809| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19585|26939|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19585||19585|26939| 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|961|2222|lyfalmen|||08|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||961||961|2222| 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|DKK|13907|19813|lyfalmen|||00|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||13907||13907|19813| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|84676|108151|lyfsjukr|||00|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||84676||84676|108151| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|79091|101142|lyfsjukr|||00|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||79091||79091|101142| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|9705|18808|vetalmen|||00|20|0|0,0000|Vistor hf|Boehringer Ingelheim|||9705||9705|18808| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|16799|23442|lyfalmen|||00|30|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||16799||16799|23442| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|19939|27383|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||19939||19939|27383| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6378|9632|lyfalmen|||00|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6378||6378|9632| 025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|A||0|0|*|0|POF|0|0|0|100|DKK|2334|3874|lyfalmen|V0462|3545|00|90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||2169||2169|3874| 025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|A||0|0|*|0|POF|0|0|0|100|DKK|2540|4141|lyfalmen|V0471|3709|00|90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||2364||2364|4141| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|A||0|0|*|0|DAC|0|0|0|100|DKK|1909|3519|lyfalmen|V0369|2918|06|5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíđ||1909||1909|3519| 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|5314|8177|lyfalmen|V0205|1806|00|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5314||5314|8177| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|14242|20233|lyfalmen|V0205|5419|00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14242||14242|20233| 025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|A||0|0|*|0|POF|0|0|0|100|DKK|2730|4386|lyfalmen|V0472|3983|00|90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||2543||2543|4386| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|53963|70083|lyfalmen|||00|100|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||53963||53963|70083| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|7413|10699|lyfsjukr|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7413||7413|10699| 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24464|33062|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24464||24464|33062| 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|A||0|1|0|1|CEE|0|0|0|100|XEU|58211|74937|lyfsjukr|||00|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||58211|74937| 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|A||0|0|B|0|POF|0|0|0|100|XEU|13497|19298|lyfalmen|V0492|19298|00|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||13497||13497|19298| 025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|1010|2289|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1010||1010|2289| 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|A||0|0|B|0|POF|0|0|0|100|XEU|16370|19297|lyfalmen|V0491|19297|63|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||13496||13496|19297| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|4757|8298|vetorma|||16|1|0|0,0000|Vistor hf|Merial (MSD)|||4757||4757|8298| 025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|A||0|0|E|0|MYL|0|0|1|100|SEK|524|1624|lyfalmen|||00|25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||524||524|1624| 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|A||0|0|B|0|POF|0|0|0|100|XEU|13806|11529|lyfalmen|V0490|11298|63|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||7765||7765|11529| 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|2681|3448|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1857||1857|3448| 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|A||0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||10|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||| 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|A|5|0|0|E|0|POF|0|0|0|100|IKR|820|2029|lyfalmen|V0447|2029|10|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2029| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|9373|16351|vetorma|||16|2|0|0,0000|Vistor hf|Merial (MSD)|||9373||9373|16351| 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|23752|32168|lyfalmen|V0475|27463|00|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||23752||23752|32168| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19585|26939|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19585||19585|26939| 026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|43198|56096|lyfsjukr|||00|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||43198||43198|56096| 026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|216016|272983|lyfsjukr|||00|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||216016||216016|272983| 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|1841|3426|lyfalmen|||00|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1841|3426| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|6974|10447|lyfalmen|||00|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6974|10447| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|3636|5881|lyfalmen|||00|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3636|5881| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|14401|20433|lyfalmen|||00|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||14401|20433| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|21579|29441|lyfalmen|||00|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||21579|29441| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|28759|38452|lyfalmen|||00|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||28759|38452| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1457|2900|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1457||1457|2900| 026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|A||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|A||0|0|0|0|DAC|0|0|1|100|SEK|1679|3133|lyfalmen|V0160|3133|10|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1627||1627|3133| 026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|A||0|0|0|0|DAC|0|0|1|100|SEK|1156|2427|lyfalmen|V0159|2427|10|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1111||1111|2427| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|433|1500|lyfalmen|||00|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||433||433|1500| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2735|4649|lyfalmen|V0199|3504|10|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2735||2735|4649| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|A||0|0|*|0|ALA|0|0|0|100|USD|2495|4320|lyfalmen|||00|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2495||2495|4320| 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|7124|10653|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7124||7124|10653| 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|29878|32542|lyfalmen|V0341|32527|00|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||24050||24050|32542| 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|33531|34957|lyfalmen|V0342|34957|00|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||25974||25974|34957| 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1765|3322|lyfalmen|||00|14|0|1,7500|Vistor hf|Eisai Ltd|Zonisamíđ||1765||1765|3322| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7359|10974|lyfalmen|||00|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7359||7359|10974| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|9697|14172|lyfalmen|||00|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9697||9697|14172| 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|ţpakki||N03AX15|01.03.2007|31.01.2012|R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|12301|17797|lyfalmen|V0255||00|56|0|28,0000|Vistor hf|Eisai Ltd|Zonisamíđ||12301||12301|17797| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|851|2071|lyfalmen|V0153|2026|00|100|0|33,3300|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||851||851|2071| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|850|2070|lyfalmen|V0154|1880|00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||850||850|2070| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPE|0|0|0|100|DKK|101790|129629|lyfsjukr|||00|105|0|5,2500|Vistor hf|SP Europe|Posacónazól||101790||101790|129629| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|20769|28424|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20769||20769|28424| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|32292|42886|lyfalmen|||00|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||32292|42886| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|24004|32484|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24004||24004|32484| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|47582|62075|lyfalmen|||00|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||47582||47582|62075| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|59940|77584|lyfalmen|||00|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||59940|77584| 028045|G03AB0001|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB|01.11.2009||R|A||0|0|0|0|BAP|0|0|0|100|SEK|5081|7858|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5081||5081|7858| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|A|2|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|DKK|24584|33212|lyfalmen|V0386|33212|00|196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||24584||24584|33212| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3632|5178|lyfalmen|V0364|5101|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3122||3122|5178| 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3982|6355|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||3982|6355| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|19021|26231|lyfalmen|V0120|26231|00|196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||19021|26231| 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13843|19732|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||13843|19732| 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|ţpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3982|6355|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||3982|6355| 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|ţpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13843|19732|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||13843|19732| 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|ţpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4590|7186|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4590|7186| 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|ţpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15967|22398|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||15967|22398| 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|ţpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4590|7186|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4590|7186| 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|ţpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15967|22398|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||15967|22398| 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|57419|73943|lyfsjukr|||00|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||57419||57419|73943| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2557|4405|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2557||2557|4405| 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21463|29295|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21463||21463|29295| 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8213|12142|lyfalmen|||02|1|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Hundaćđi, dauđ veira||8213||8213|12142| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|1900|3506|lyfalmen|V0202|3506|00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1900||1900|3506| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2131|3822|lyfalmen|V0428|3342|10|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2131||2131|3822| 028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|5326|8193|lyfalmen|||10|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5326||5326|8193| 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2656|lyfalmen|||00|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2656| 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8158|lyfalmen|V0245|8158|00|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5300||5300|8158| 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|15077|lyfalmen|||00|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|15077| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|806|1180|lyfalmen|V0266|1180|00|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||199||199|1180| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|1|0|0|100|DKK|8054|15637|vetalmen|||27|10|0|0,0000|Icepharma hf|Orion Corporation (I)|||8054||8054|15637| 028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|A||0|0|B|0|POF|0|0|0|100|XEU|4639|7253|lyfalmen|||63|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4639||4639|7253| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|5242|3642|lyfalmen|V0267|3502|00|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1999||1999|3642| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|18902|12720|lyfalmen|V0269|11980|00|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||8635||8635|12720| 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|904|2144|lyfalmen|||02|24|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||904||904|2144| 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|1362|2771|lyfalmen|V0179|1807|10|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2771| 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|4998|7744|lyfalmen|V0179|7744|10|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7744| 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|577|1697|lyfalmen|V0180|839|10|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1697| 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|563|1678|lyfalmen|V0180|1678|10|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1678| 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|2031|3686|lyfalmen|V0180|3356|10|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3686| 029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1104|2418|lyfalmen|||24|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1104|2418| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|7688|11424|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Agómelatín||7688||7688|11424| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|21931|29883|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Agómelatín||21931||21931|29883| 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|ţpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|611|1743|lyfalmen|||00|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||611||611|1743| 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|258|1260|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||258|1260| 029307|A07EA0603|Entocort enema (D.A.C.)|endaţ.dr|0,02|mg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.01.2007||R|A||0|0|B|0|DAC|0|0|0|100|SEK|7762|11374|lyfalmen|V0385|11374|56|7|0|7,0000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||7651||7651|11374| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|7653|9272|lyfalmen|V0109|2229|00|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6115||6115|9272| 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|A||0|1|0|1|EIS|0|0|0|100|SEK|65330|83872|lyfsjukr|||00|2|0||Vistor hf|Eisai Ltd|Eribulin||65330||65330|83872| 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|22805|30503|lyfsjukr|||00|50|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22805||22805|30503| 029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|5897|8511|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5897||5897|8511| 029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|4530|6538|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group hf|Írinótekan||4530||4530|6538| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5162|7969|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5162|7969| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16210|22703|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16210|22703| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5162|7969|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5162|7969| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16210|22703|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16210|22703| 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|A||0|0|0|0|GAN|0|0|1|100|SEK|6567|9891|lyfalmen|||00|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6567||6567|9891| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|101700|129516|lyfsjukr|||00|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||101700||101700|129516| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|203399|257148|lyfsjukr|||00|1|0|16,6600|Vistor hf|Amgen Europe B.V.|||203399||203399|257148| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|4885|4294|lyfalmen|V0148|4217|00|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2476||2476|4294| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|23046|31282|lyfalmen|V0255|31282|00|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||23046||23046|31282| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||00|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|9361|13713|lyfalmen|V0277|13711|00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9361||9361|13713| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|2986|4992|lyfalmen|V0276|4991|00|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2986||2986|4992| 030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|16323|28475|vetorma|||00|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||16323|28475| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|998|2273|lyfalmen|V0051|2273|00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||998||998|2273| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1456|2899|lyfalmen|||00|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||1456||1456|2899| 031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|3|0|0|0|0|NEH|0|0|1|100|DKK|1249|2616|lyfalmen|||23|2|0|4,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín||1249||1249|2616| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3192|5274|lyfalmen|||17|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3192||3192|5274| 031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|66482|85317|lyfsjukr|||00|20|0||Vistor hf|Schering-Plough|Temozolomid||66482||66482|85317| 031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|80998|103535|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||80998||80998|103535| 031394|L01AX0301|Temodal|hylki|250|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|178576|225995|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||178576||178576|225995| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2137|3831|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2137||2137|3831| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6024|9148|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||6024||6024|9148| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|23593|31492|lyfsjukr|||00|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||23593||23593|31492| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|2039|3697|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2039||2039|3697| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|9772|14103|lyfsjukr|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||9772|14103| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|14283|19808|lyfsjukr|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||14283|19808| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|49419|63903|lyfsjukr|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||49419|63903| 032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|21414|29234|lyfalmen|||00|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21414||21414|29234| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|3850|6716|vetorma|||27|50|0|0,0000|Vistor hf|Merial (MSD)|||3850||3850|6716| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|15024|26209|vetorma|||27|200|0|0,0000|Vistor hf|Merial (MSD)|||15024||15024|26209| 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|21705|29122|lyfsjukr|||00|1|0|29,6300|Vistor hf|Ferring|Degarelix||||21705|29122| 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|43289|56210|lyfsjukr|||00|2|0|88,8900|Vistor hf|Ferring|Degarelix||||43289|56210| 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||L|A||0|0|0|0|NOB|1|0|0|100|XEU|1241|2165|vetorma|||16|7|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||||1241|2165| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|A||0|0|0|0|LHS|0|0|0|100|XEU|9290|18011|vetalmen|||27|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9290|18011| 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1283|2662|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||1283||1283|2662| 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|A||0|0|*|0|WIH|0|0|0|100|XEU|47262|58846|lyfalmen|V0185|58846|00|100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||45009||45009|58846| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|82002|104795|lyfsjukr|||43|60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||82002||82002|104795| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|106959|136116|lyfsjukr|||43|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||106959||106959|136116| 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2518|5008|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2518|5008| 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|757|1943|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||757||757|1943| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|23594|31493|lyfsjukr|||00|25|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||23594||23594|31493| 034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|K||0|0|0|0|IAG|0|0|0|100|SEK|15270|21523|lyfalmen|||02|0|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||15270||15270|21523| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8245|12186|lyfalmen|||0|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8245|12186| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8245|12186|lyfalmen|||0|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8245|12186| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1861|3453|lyfalmen|V0367|2636|00|6|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1861||1861|3453| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3191|5272|lyfalmen|V0367|5272|00|12|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3191||3191|5272| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|176484|223370|lyfsjukr|||00|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||176484||176484|223370| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|7581|10941|lyfsjukr|||02|25|0|0,0000|Vistor hf|LEO Pharma A/S|Prótamín||7581||7581|10941| 035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|2303|3324|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||2303||2303|3324| 035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|16250|22753|lyfalmen|||10|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16250||16250|22753| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3626|5868|lyfalmen|V0079|5868|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3626|5868| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3253|lyfalmen|V0244|3253|00|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1715||1715|3253| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|122285|155350|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Pegaptaníb||122285||122285|155350| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|10399|15133|lyfalmen|V0080|13149|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10399||10399|15133| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|A||0|0|0|0|GZE|0|0|0|100|XEU|31010|37531|lyfalmen|||00|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||28025||28025|37531| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|144707|183490|lyfsjukr|||00|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||144707||144707|183490| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|6046|9178|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6046||6046|9178| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2967|4966|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2967||2967|4966| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8642|12729|lyfalmen|V0081|11078|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8642||8642|12729| 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|A||0|1|0|1|ABL|0|0|0|100|DKK|6169|8903|lyfsjukr|||00|30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||6169||6169|8903| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|200108|253018|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||200108||200108|253018| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|399134|502796|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||399134||399134|502796| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|796590|1001603|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||796590||796590|1001603| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|827|2039|lyfalmen|||00|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||827||827|2039| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1454|2896|lyfalmen|||08|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1454||1454|2896| 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|GSC|0|0|0|100|IKR|||lyflausa|||00|30|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2870|4833|lyfalmen|||08|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2870||2870|4833| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|870|2097|lyfalmen|||00|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||870||870|2097| 037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12290|17783|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12290||12290|17783| 037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|22561|30673|lyfalmen|||00|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||22561||22561|30673| 037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|44122|57733|lyfalmen|||00|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||44122||44122|57733| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2556|4404|lyfalmen|V0434|4404|00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2556||2556|4404| 037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1169|2506|lyfalmen|||0|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1169||1169|2506| 037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2201| 037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3621| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8515|12555|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8515|12555| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1427|lyfalmen|||00|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1427| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2303|lyfalmen|V0321|1753|00|60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2303| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3084|lyfalmen|V0321|2921|00|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3084| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1058|2355|lyfalmen|||00|50|0|50,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1058||1058|2355| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2615|4485|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2615||2615|4485| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|177523|224674|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||177523||177523|224674| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|K||0|1|0|1|WTE|0|0|0|100|DKK|76729|98177|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||76729||76729|98177| 039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|41302|53717|lyfsjukr|||00|10|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||41302||41302|53717| 039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|69042|88530|lyfsjukr|||00|20|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||69042||69042|88530| 039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|A||0|0|0|0|SAA|0|0|0|100|NOK|4594|7192|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4594|7192| 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|A||0|0|0|0|SAA|0|0|0|100|NOK|22511|30611|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||22511|30611| 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|3358|5501|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3358||3358|5501| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|581|1702|lyfalmen|||00|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||581||581|1702| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|653|1801|lyfalmen|||00|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||653||653|1801| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1311|2701|lyfalmen|||00|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1311||1311|2701| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1890|3493|lyfalmen|||00|22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1890||1890|3493| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|483|697|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||483||483|697| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1630|2977|lyfalmen|V0110|2959|00|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1513||1513|2977| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|8599|10234|lyfalmen|V0182|10234|00|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||6818||6818|10234| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|660|953|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||660||660|953| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|1863|2604|lyfalmen|V0033|2604|00|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1240||1240|2604| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1344|1940|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1344||1344|1940| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1652| 040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|4539|2456|lyfalmen|V0112|2456|00|100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1132||1132|2456| 041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BYP|0|0|0|100|SEK|3357|5500|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3357||3357|5500| 041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|K||0|0|0|0|IPF|1|0|0|100|DKK|28409|49558|vetorma|||00|240|0||Icepharma hf|Pfizer Limited|GnRF hliđstćđa samtengd próteini||||28409|49558| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4449|7761|vetorma|||AA|100|0|0,0000|Icepharma hf|Intervet International B.V.|||4449||4449|7761| 041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006|30.11.2011|R|A|3|0|0|0|0|TMC|0|0|0|100|SEK|199819|253132|lyfalmen|||02|100|0|0,0000|TMC Pharma Services Ltd|TMC Pharma Services Ltd|Gadófosveset||199819||199819|253132| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MYL|0|1|0|100|SEK|1201|2550|lyfalmen|||00|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1201|2550| 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1544|3019|lyfalmen|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1544||1544|3019| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|12996|18192|lyfsjukr|||00|500|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||12996||12996|18192| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2569|3708|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2569||2569|3708| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3105|4481|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3105||3105|4481| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4396|6345|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4396||4396|6345| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4505|6502|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4505||4505|6502| 042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5740|8284|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||5740||5740|8284| 042368|A06AB0602|Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2304|4059|lyfalmen|||00|500|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2304|4059| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7083|10223|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Kolvetni||7083||7083|10223| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3839|5541|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3839||3839|5541| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2938|4240|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2938||2938|4240| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2245|3240|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2245||2245|3240| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2811|4057|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2811||2811|4057| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3688|5323|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3688||3688|5323| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2519|3636|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2519||2519|3636| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|1815|2619|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||1815||1815|2619| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6159|8889|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||6159||6159|8889| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2055|2966|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2055||2055|2966| 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dćla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|781|1976|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||781||781|1976| 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2910|4200|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2910||2910|4200| 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dćlur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|14930|21097|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||14930||14930|21097| 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|1358|2701|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1358||1358|2701| 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2024|4026|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2024||2024|4026| 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2713|5382|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2713||2713|5382| 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|5428|10595|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5428||5428|10595| 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|6241|12156|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6241||6241|12156| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2450|3536|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2450||2450|3536| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|A||1|0|0|0|MYL|0|0|0|100|SEK|537|1642|lyfalmen|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||537||537|1642| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3219|4646|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3219||3219|4646| 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|A||0|0|0|0|PSA|0|0|0|100|DKK|27925|37405|lyfalmen|V0516|37405|00|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||27925||27925|37405| 043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|4958|5946|lyfalmen|||24|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3683||3683|5946| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5952|8590|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||5952||5952|8590| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|571|1688|lyfalmen|||00|30|0|3,7500|Icepharma hf|Pfizer ApS|Tríazólam||571||571|1688| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1240|2604|lyfalmen|||10|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1240||1240|2604| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|CHF|13080|18454|lyfalmen|V0034|18454|00|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||12824||12824|18454| 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|385597|485807|lyfsjukr|||00|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||385597|485807| 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|544145|684784|lyfsjukr|||00|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||544145|684784| 044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|23417|31748|lyfalmen|||00|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||23417||23417|31748| 044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|89444|114612|lyfalmen|||00|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||89444||89444|114612| 044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|2710|4615|lyfalmen|||00|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2710||2710|4615| 044888|QN05CM9003|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|A||0|0|0|0|OCO|1|0|0|100|DKK|2111|4199|vetalmen|||16|3|0||Icepharma hf|Orion Corporation (I)|||2111||2111|4199| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dćlur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7464|11118|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7464||7464|11118| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2229|lyfalmen|V0109|2229|00|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||966||966|2229| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2024|lyfalmen|V0108|2024|00|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||816||816|2024| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|2891|4172|lyfsjukr|||00|10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2891||2891|4172| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|5782|8345|lyfsjukr|||00|10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5782||5782|8345| 045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|A||0|0|0|0|AGT|0|0|1|100|XEU|380|1427|lyfalmen|||04|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||380||380|1427| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|21400|41264|vetalmen|||27|10|0|0,0000|Icepharma hf|Pfizer vet.|||21400||21400|41264| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1039|2329|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1039||1039|2329| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|3979|6350|lyfalmen|V0382|6350|02|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3979||3979|6350| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|684|1843|lyfalmen|V0021|1843|00|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||684||684|1843| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|1124|2445|lyfalmen|V0022|2445|00|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1124||1124|2445| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|1413|2840|lyfalmen|V0023|2840|00|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1413||1413|2840| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|6627|9973|lyfalmen|V0383|9973|02|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6627||6627|9973| 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|A||0|0|E|0|POF|0|0|0|100|GBP|5093|7874|lyfalmen|V0530|7874|00|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||5093||5093|7874| 046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|A||0|0|E|0|POF|0|0|0|100|GBP|6390|9649|lyfalmen|V0531|9649|00|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||6390||6390|9649| 046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|10530|14576|lyfalmen|V0283|12431|00|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||9992||9992|14576| 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|A||0|0|E|0|POF|0|0|0|100|DKK|10938|5419|lyfalmen|V0205|5419|00|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||3298||3298|5419| 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|3398|3437|lyfalmen|V0279|3366|00|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1849||1849|3437| 047042|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|74379|95228|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||74379||74379|95228| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1030|2316|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1030||1030|2316| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||00|50|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|148737|188547|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||148737||148737|188547| 047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|25917|34885|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||25917||25917|34885| 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|12740|13915|lyfalmen|V0420|13915|00|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||9509||9509|13915| 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|24126|27930|lyfalmen|V0421|27930|00|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||20375||20375|27930| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5349|7720|lyfsjukr|||02|250|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||5349||5349|7720| 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|8854|12779|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8854||8854|12779| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8444|12187|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||8444||8444|12187| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|2729|4641|lyfalmen|V0324|3895|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2729||2729|4641| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|2535|3563|lyfalmen|V0035|3563|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1941||1941|3563| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|7867|7394|lyfalmen|V0325|6326|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4742||4742|7394| 048133|N06AB1004|Esopram|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|2991|4065|lyfalmen|V0175|4065|00|28|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2308||2308|4065| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|7729|7394|lyfalmen|V0326|6326|00|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4742||4742|7394| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|3964|4435|lyfalmen|V0246|4435|00|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2579||2579|4435| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|15456|7394|lyfalmen|V0327|6326|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4742||4742|7394| 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1185|2528|lyfalmen|||00|100|0|0,0000|Vistor hf|Meda AB|Klídín og geđlyf||1185||1185|2528| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14077|20026|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||14077||14077|20026| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4172|6614|lyfalmen|||00|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4172||4172|6614| 048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1816|3392|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1816||1816|3392| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|62420|77264|lyfalmen|V0187|53169|00|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||59685||59685|77264| 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|A||0|1|0|1|GZE|0|0|0|100|XEU|997676|1253966|lyfsjukr|||00|1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||997676||997676|1253966| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GSH|0|0|1|100|DKK|488|1575|lyfalmen|V0230|1482|00|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||488||488|1575| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|2471|4288|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2471||2471|4288| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|17558|24395|lyfalmen|||00|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||17558||17558|24395| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2427|4227|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2427||2427|4227| 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|6677|10041|lyfalmen|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB|Amorolfín||6677||6677|10041| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2024|lyfalmen|V0108|2024|00|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||816||816|2024| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2229|lyfalmen|V0109|2229|00|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||966||966|2229| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1827|3019|lyfalmen|V0110|3019|00|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1544||1544|3019| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4928|lyfalmen|V0123|4454|00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4928| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1208|2545|lyfalmen|V0496|2545|00|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1197||1197|2545| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|1595|3089|lyfalmen|||00|30|0|30,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||1595||1595|3089| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|2490|3595|lyfalmen|||00|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1965||1965|3595| 049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1345| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|62420|80697|lyfalmen|V0470|71022|00|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||62420||62420|80697| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BAP|0|0|0|100|SEK|572786|720729|lyfsjukr|||00|112|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||572786||572786|720729| 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|72679|93095|lyfsjukr|||00|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||72679|93095| 050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|7604|8699|lyfalmen|V0012|4280|00|56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||5696||5696|8699| 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3352|5493|lyfalmen|||00|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3352||3352|5493| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|13132|18840|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13132||13132|18840| 050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5574|5138|lyfalmen|V0042|4628|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3093||3093|5138| 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|4937|7629|lyfalmen|V0002|7629|00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4914||4914|7629| 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A||0|0|0|0|AGT|0|0|0|100|IKR|4744|7230|lyfalmen|V0006|5862|00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4622||4622|7230| 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|A||0|0|0|0|AGT|0|0|0|100|IKR|11336|8129|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||5279||5279|8129| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1721|3262|lyfalmen|||10|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1721||1721|3262| 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007|31.12.2011|L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|D.A.C. ehf|D.A.C. ehf|Ketóprófen|||||| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A||0|0|B|0|DAC|0|0|0|100|DKK|6982|8562|lyfalmen|||00|60|0||D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||5596||5596|8562| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1778|3340|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1778||1778|3340| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1441|2739|lyfalmen|V0363|2706|00|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1339||1339|2739| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3919|6023|lyfalmen|V0365|5930|00|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3740||3740|6023| 051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|0|0|1|UCB|0|0|0|100|DKK|30722|40439|lyfsjukr|||00|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||30722||30722|40439| 051686|N05AE0402|Zeldox (DAC)|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2011||R|A|4|0|0|*|0|DAC|0|1|0|100|DKK|27435|36790|lyfalmen|||00|56|0|56,0000|D.A.C. ehf|D.A.C. ehf|Ziprasidon||27435||27435|36790|31.01.2012 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1642|2532|lyfalmen|V0056|2532|00|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||1188||1188|2532| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|2779|3480|lyfalmen|V0057|3480|00|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1881||1881|3480| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|216|1203|lyfalmen|V0047|1203|00|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||216||216|1203| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|509|1604|lyfalmen|V0305|961|00|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||509||509|1604| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|347665|438202|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||347665||347665|438202| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|361|1401|lyfalmen|V0439|1401|00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||361|1401| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|1157|2490|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1157||1157|2490| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|742|1922|lyfalmen|V0305|1922|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||742||742|1922| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|726272|913354|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||726272||726272|913354| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|643707|809735|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||643707||643707|809735| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|3814|6125|lyfalmen|||00|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3814||3814|6125| 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|10780|15654|lyfalmen|||00|9|0|90,0000|Vistor hf|Allergan|Tímólól í blöndum||10780||10780|15654|31.12.2011 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37600|49071|lyfsjukr|||00|8212|0|8,2000|Icepharma hf|Fresenius Kabi|Blöndur||37600||37600|49071| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30567|40244|lyfsjukr|||00|7698|0|7,7100|Icepharma hf|Fresenius Kabi|Blöndur||30567||30567|40244| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32269|42380|lyfsjukr|||00|7680|0|7,6800|Icepharma hf|Fresenius Kabi|Blöndur||32269||32269|42380| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26998|35765|lyfsjukr|||00|7200|0|7,2000|Icepharma hf|Fresenius Kabi|Blöndur||26998||26998|35765| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36307|47448|lyfsjukr|||00|7880|0|7,9000|Icepharma hf|Fresenius Kabi|Blöndur||36307||36307|47448| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33714|44194|lyfsjukr|||00|7616|0|7,6000|Icepharma hf|Fresenius Kabi|Blöndur||33714||33714|44194| 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|K||0|0|*|0|NAS|0|0|0|100|DKK|15694|22055|lyfalmen|||00|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||15694||15694|22055| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2408|4201|lyfalmen|V0313|4026|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2408||2408|4201| 053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2264|4004|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2264||2264|4004| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|63219|81222|lyfsjukr|||00|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||63219||63219|81222| 053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5555|8506|lyfalmen|||10|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5555||5555|8506| 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6208|9400|lyfalmen|||02|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||6208||6208|9400| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|39202|51558|lyfalmen|V0453|43781|00|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||39202||39202|51558| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|32906|43656|lyfalmen|V0454|39450|00|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||32906||32906|43656| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|641|1784|lyfalmen|V0060|1682|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||641||641|1784| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|15863|22267|lyfalmen|||00|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||15863||15863|22267| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|A||0|0|0|0|OTS|0|1|0|100|DKK|1573|3059|lyfalmen|||00|1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1573||1573|3059| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|1172|2511|lyfalmen|||20|30|0|30,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1172||1172|2511| 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|7923|11529|lyfalmen|V0490|11529|63|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||7765||7765|11529| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2646|4527|lyfalmen|||02|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2646||2646|4527| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|65631|84249|lyfsjukr|||00|56|0|22,4000|Icepharma hf|Roche Registration Limited|Ribavirin||65631||65631|84249| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1106|2420|lyfalmen|||00|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1106||1106|2420| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|A|3|0|0|0|0|ACA|0|1|0|100|XEU|1725|3267|lyfalmen|V0061|3267|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1725||1725|3267| 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|A||1|0|0|0|REB|0|0|0|100|DKK|4877|9537|vetalmen|||27|10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríđ||||4877|9537| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|7897|13776|vetorma|||16|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7897||7897|13776| 055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|A||0|0|0|0|ALA|0|0|1|100|USD|1775|3335|lyfalmen|||00|5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1775|3335| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|790|1988|lyfalmen|||10|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||790||790|1988| 055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|9460|13848|lyfalmen|||10|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9460||9460|13848| 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4350|6858|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Pýrazínamíđ||4350||4350|6858| 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|2208|3775|lyfalmen|V0467|3775|00|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2096||2096|3775| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4539|2456|lyfalmen|V0112|2456|00|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2456| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6185|3174|lyfalmen|V0113|3174|00|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3174| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|5976|lyfalmen|V0114|5976|00|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|5976| 056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|18531|25616|lyfalmen|V0459|24660|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||18531||18531|25616| 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|A|5|0|0|0|0|CES|1|0|0|100|XEU|27638|48213|vetorma|||00|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||27638||27638|48213| 056514|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.11.2009|30.11.2011|R|K||0|1|0|1|SOI|0|0|0|100|DKK|86538|110488|lyfsjukr|||00|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||86538||86538|110488| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1285|2665|lyfalmen|||10|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1285||1285|2665| 056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3811|6121|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3811|6121| 056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3811|6121|lyfalmen|||00|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3811|6121| 056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|238386|301057|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||238386||238386|301057| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|59567|76639|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||59567||59567|76639| 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3626|5868|lyfalmen|V0094|5868|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||3626|5868| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11537|16689|lyfalmen|V0095|14491|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||11537|16689| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|12061|17019|lyfsjukr|||02|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||12061||12061|17019| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|6935|10009|lyfsjukr|||02|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||6935||6935|10009| 057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|K||0|0|0|1|BAA|0|0|0|100|SEK|246342|311042|lyfsjukr|||00|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||246342||246342|311042| 057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|23579|31951|lyfalmen|V0350|31951|00|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||23579||23579|31951| 057422|B05XA3102|Tracel|irţ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5018|7242|lyfsjukr|||00|200|0|0,2000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5018||5018|7242| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|3824|5519|lyfsjukr|||02|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3824||3824|5519| 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|A||0|1|0|1|JAS|0|0|0|100|SEK|552314|695037|lyfsjukr|||00|120|0||Vistor hf|Janssen-Cilag AB|Abírateron||552314||552314|695037| 057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|25423|33788|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||25423||25423|33788| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|20695|28332|lyfalmen|||0|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||20695|28332| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|437|1505|lyfalmen|||02|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||437||437|1505| 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|A||0|1|0|1|GGL|0|0|0|100|GBP|130877|166133|lyfsjukr|||00|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||130877||130877|166133| 058283|QI01AD040|Avipro Thymovac|frţlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|166050|289666|vetorma|||00|5000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||166050|289666| 058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|252247|440032|vetorma|||00|10000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||252247|440032| 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|17830|24736|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17830||17830|24736| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1040|2330|lyfalmen|||00|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1040||1040|2330| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|102914|131040|lyfsjukr|||00|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||102914||102914|131040| 058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1255|2624|lyfalmen|||43|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1255||1255|2624| 058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2339|4107|lyfalmen|||43|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2339||2339|4107| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dćla|einnota dćla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4392|6915|lyfalmen|||51|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4392||4392|6915| 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|A||0|0|0|0|AGT|0|0|0|100|IKR|2540|4382|lyfalmen|V0006|3283|0|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2540||2540|4382| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1531|3002|lyfalmen|||00|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1531||1531|3002| 059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.08.2011|31.12.2011|R|A||0|0|E|0|LVR|0|0|1|100|IKR|2207|3926|lyfalmen|||07|5|1||Lyfjaver ehf|Lyfjaver ehf|Klóramfeníkól||2207||2207|3926| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|101623|129896|lyfalmen|||02|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||101623||101623|129896| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|33531|44441|lyfalmen|||51|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||33531||33531|44441| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|92940|118522|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||92940||92940|118522| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|A||0|0|E|0|BPC|0|0|0|100|SEK|41206|47327|lyfalmen|||00|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||35831||35831|47327| 059870|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.11.2010||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|56357|73087|lyfalmen|||00|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||56357||56357|73087| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|386541|487468|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||386541||386541|487468| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|193287|244935|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||193287||193287|244935| 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|96648|123653|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||96648||96648|123653| 060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|5783|8818|lyfalmen|||10|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5783||5783|8818| 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1973| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2818|5584|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||2818|5584| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1477|2938|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||1477|2938| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|8723|16922|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Animal Health|||||8723|16922| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|A||0|0|E|0|DAC|0|0|0|100|DKK|7165|10709|lyfalmen|V0133|10709|00|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7165||7165|10709| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|50|0|0,0000|Icepharma hf|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7166|10710|lyfalmen|V0133|10709|00|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7166||7166|10710| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|1746|3046|vetorma|||16|26|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||1746|3046| 061715|L01XE0901|Torisel|irţ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|DKK|164013|207719|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Temsirolímus||164013||164013|207719| 061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|4553|6571|lyfsjukr|||00|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4553||4553|6571| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|16259|22288|lyfsjukr|||00|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||16259||16259|22288| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|22891|30611|lyfsjukr|||00|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||22891||22891|30611| 062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|471|1552|lyfalmen|||10|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||471||471|1552| 062265|M01AB0505|Voltaren|eţ-stíll|50|mg|10|stk|1|pakki||M01AB05|01.11.2010||R|A||0|0|E|0|NOH|0|0|1|100|DKK|366|1408|lyfalmen|||04|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||366||366|1408| 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|A||0|1|*|0|AGP|0|0|0|100|XEU|61041|54365|lyfalmen|V0187|53169|00|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||41439||41439|54365| 062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|1691|3221|lyfalmen|||00|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1691||1691|3221| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|6824|9849|lyfsjukr|||02|20|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||6824||6824|9849| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|465|671|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||465||465|671| 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|950|2207|lyfalmen|||10|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||950||950|2207| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|1892|3496|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1892||1892|3496| 062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|18463|32208|vetorma|||16|1000|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||18463||18463|32208| 062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|40698|52958|lyfsjukr|||00|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||40698||40698|52958| 062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|49689|64242|lyfsjukr|||00|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||49689||49689|64242| 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|16622|23220|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||16622||16622|23220| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|4317|6813|lyfalmen|||00|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4317||4317|6813| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2925| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|2596|4456|lyfalmen|V0123|4454|00|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2594||2594|4456| 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1655|3171|lyfalmen|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1655||1655|3171|31.01.2012 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|4632|7244|lyfalmen|V0458|7244|00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||4632||4632|7244| 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|7978|11514|lyfsjukr|||17|2|0|0,0000|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7978||7978|11514| 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2594|4525|vetorma|||16|12|0|0,0000|Vistor hf|Fort Dodge Veterinär GmbH|||2594||2594|4525| 063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|997|2271|lyfalmen|||10|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||997||997|2271| 063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2090|3766|lyfalmen|||10|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2090||2090|3766| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|1110373|1395401|lyfsjukr|||00|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1110373|1395401| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|444149|559289|lyfsjukr|||00|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||444149|559289| 064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|2194|3909|lyfalmen|||10|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2194||2194|3909| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|4441493|5575956|lyfsjukr|||00|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4441493|5575956| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|2220747|2788920|lyfsjukr|||00|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2220747|2788920| 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|843|2061|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||843||843|2061| 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|A||0|0|0|1|OCT|0|0|0|100|DKK|60018|77205|lyfsjukr|||00|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||60018||60018|77205| 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2002|3646|lyfalmen|||38|25|0|0,0000|Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||2002||2002|3646| 065314|G01AF0201|Canesten|sk-stíll|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||25|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|15411|21223|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15411||15411|21223| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|2567|3724|lyfalmen|V0376|2160|06|2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2059||2059|3724| 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.06.2011||R|A||0|1|*|0|LVR|0|0|0|100|SEK|61507|79060|lyfalmen|V0451|79060|00|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||61116||61116|79060| 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|7693|10970|lyfalmen|V0376|6480|06|8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7356||7356|10970| 065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|101|IKR|||lyflausa|||23|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065778|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.12.2009||R|K||0|1|0|1|WTE|0|0|0|100|DKK|148737|188547|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||148737||148737|188547| 065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|4779|6897|lyfsjukr|||02|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4779||4779|6897| 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|A||0|0|0|0|DOR|1|0|0|100|DKK|4188|8214|vetalmen|||00|100|0||Icepharma hf|Dopharma Reserch B.V|||4188||4188|8214| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6851|10279|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6851||6851|10279| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|33748|44236|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||33748||33748|44236| 066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|A||0|0|0|0|GOG|0|0|1|100|DKK|869|2096|lyfalmen|||23|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||869||869|2096| 066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||02|120|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1524|2992|lyfalmen|V0036|2992|70|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1524||1524|2992| 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|A||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|A||0|1|0|1|AGP|0|0|0|100|XEU|15649|21522|lyfsjukr|||00|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15649||15649|21522| 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|8855|12780|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8855||8855|12780| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1475|2925|lyfalmen|||00|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1475||1475|2925| 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|K||0|0|*|0|APC|0|0|0|100|DKK|1901|2522|lyfalmen|V0376|2160|06|2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1180||1180|2522| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1567|2771|lyfalmen|V0179|1807|10|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1362||1362|2771| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|5748|7744|lyfalmen|V0179|7744|10|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||4998||4998|7744| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|664|1697|lyfalmen|V0180|839|10|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1697| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|612|1678|lyfalmen|V0180|1678|10|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1678| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2031|3686|lyfalmen|V0180|3356|10|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2031||2031|3686| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|14199|16616|lyfalmen|V0419|16362|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||11483||11483|16616| 068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6244|12162|vetalmen|||27|50|0|0,0000|Icepharma hf|Vétoquinol AG|||6244||6244|12162| 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|A||0|1|0|1|GTS|0|0|0|100|GBP|79837|102078|lyfsjukr|||00|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||79837||79837|102078| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|1806|3378|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1806||1806|3378| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|5980|9088|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||5980||5980|9088| 068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|2572|3712|lyfsjukr|||00|400|0|0,4000|Actavis Group hf|Braun|Natríumklóríđ||2572||2572|3712| 068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|3201|4620|lyfsjukr|||00|400|0|0,4000|Actavis Group hf|Braun|Kalíumklóríđ||3201||3201|4620| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3297|lyfalmen|V0123|2227|00|14|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3297| 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|17190|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|17190| 069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|440|1359|lyfalmen|V0448|1359|00|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||330||330|1359| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|18619|25726|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18619|25726| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|26930|36157|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||26930|36157| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|34876|46129|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||34876|46129| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|46693|60482|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||46693||46693|60482| 070359|L01DB0701|Novantrone|irţ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987|31.12.2011|R|A|3|0|1|0|1|MEB|0|0|0|100|USD|30586|40268|lyfsjukr|||00|10|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||30586||30586|40268| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen|||27|100|0|0,0000|Vistor hf|Pharmaxim AB|||10511||10511|20355| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|12655|18241|lyfalmen|||00|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12655||12655|18241| 071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PAB|0|0|0|100|SEK|6359|12383|vetalmen|||16|1250|0|0,0000|Vistor hf|Pharmaxim AB|||6359||6359|12383| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|XEU|713|1883|lyfalmen|||00|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||713||713|1883| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|67147|86152|lyfsjukr|||00|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||67147||67147|86152| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|335735|423230|lyfsjukr|||00|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||335735||335735|423230| 071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|8728|12847|lyfalmen|||00|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||8728|12847| 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|11120|12047|lyfalmen|V0144|12047|00|12|0|24,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||8143||8143|12047| 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|A||0|1|0|1|GZE|0|0|0|100|SEK|90456|115405|lyfsjukr|||00|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||90456|115405| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|A||0|0|E|0|PSA|0|0|0|100|XEU|3224|3401|lyfalmen|V0009|3389|00|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||1823||1823|3401| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|7196|13990|vetalmen|||27|5|0|0,0000|Vistor hf|Orion-Farmos|||7196||7196|13990| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|A||0|0|E|0|PSA|0|0|0|100|XEU|10139|10885|lyfalmen|V0029|10885|00|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||7294||7294|10885| 072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19585|26939|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19585||19585|26939| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|658|950|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Súfentaníl||658||658|950| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|151873|192483|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||151873||151873|192483| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|16896|23564|lyfalmen|||00|1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16896||16896|23564| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|16896|23564|lyfalmen|||00|2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16896||16896|23564| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1080|2385|lyfalmen|||00|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1080||1080|2385| 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008|31.12.2011|R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|3207|5294|lyfalmen|||10|100|0|16,6700|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3207||3207|5294| 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|A||0|0|E|0|GSK|0|0|0|100|GBP|3834|6152|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3834||3834|6152| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1682|3208|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1682||1682|3208| 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|52328|58846|lyfalmen|V0185|58846|00|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||45009||45009|58846| 073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|732|1557|lyfalmen|V0066|1557|0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||475||475|1557| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|312|1334|lyfalmen|V0047|1203|00|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||312||312|1334| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|769|1959|lyfalmen|V0305|961|00|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||769||769|1959| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|982|2251|lyfalmen|V0305|1922|00|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||982||982|2251| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|528|1630|lyfalmen|V0439|1401|00|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||528||528|1630| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1436|2872|lyfalmen|||00|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1436||1436|2872| 073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|3806|6639|vetorma|||16|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3806||3806|6639| 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|1363|2772|lyfalmen|||10|50|0|8,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||1363||1363|2772| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|4756|7413|lyfalmen|V0142|7413|00|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4756||4756|7413| 074038|N02AB0304|Durogesic (D.A.C.)|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2009|30.11.2011|R|A||1|0|E|0|DAC|0|0|0|100|SEK|2569|4422|lyfalmen|||00|5|0|3,6000|D.A.C. ehf|D.A.C. ehf|Fentanýl||2569||2569|4422| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|3677|5937|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3677||3677|5937| 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|10709|15557|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||10709||10709|15557| 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4692|7326|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4692||4692|7326| 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|13811|19692|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||13811||13811|19692| 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4692|7326|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4692||4692|7326| 074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|A||0|0|E|0|DAC|0|0|1|100|GBP|410|1464|lyfalmen|V0391|1464|00|28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||407||407|1464| 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|15502|21814|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15502||15502|21814| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|17643|24024|lyfsjukr|||00|50|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||17643||17643|24024| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|491|1579|lyfalmen|||00|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||491||491|1579| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|702|1868|lyfalmen|||00|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||702||702|1868| 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|A||0|0|0|0|AGT|0|0|0|100|DKK|1103|2416|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1103||1103|2416| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|21206|36993|vetorma|||58|25|0|0,0000|Vistor hf|Scan Vet Animal Health AS|||21206||21206|36993| 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|420|1482|lyfalmen|V0510|1475|00|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||420||420|1482| 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|767|1957|lyfalmen|V0512|1941|00|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||767||767|1957| 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|A|3|0|0|B|0|AEG|0|0|0|100|GBP|971|2236|lyfalmen|||00|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||971||971|2236| 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|A|5|0|0|B|0|AEG|0|0|0|100|GBP|518|1616|lyfalmen|||00|100|0|100,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||518||518|1616| 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1569|2409|lyfalmen|||00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1098||1098|2409| 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|A||0|0|*|0|AEG|0|0|0|100|GBP|2595|4413|lyfalmen|||10|100|0|33,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||2563||2563|4413| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5007|7757|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5007||5007|7757| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|15021|21211|lyfalmen|||00|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15021||15021|21211| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1791|3357|lyfalmen|||69|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1791||1791|3357| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5007|7757|lyfalmen|||00|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5007||5007|7757| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1971|2706|lyfalmen|V0363|2706|00|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1315||1315|2706| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|15021|21211|lyfalmen|||00|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15021||15021|21211| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|XEU|1911|3522|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1911||1911|3522| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|3092|5137|lyfalmen|||00|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3092||3092|5137| 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|A||0|0|0|0|NBV|0|0|0|100|XEU|2663|4550|lyfalmen|||00|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2663|4550| 075288|N05AX1203|Abilify (Lyfjaver)|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|DKK|34481|45633|lyfalmen|V0295|45633|00|56|0|18,6670|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||34481||34481|45633| 075299|M01AH0103|Celebra (Lyfjaver)|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|7057|10561|lyfalmen|V0429|10561|00|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||7057||7057|10561| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|13600|19427|lyfalmen|V0196|19427|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13600||13600|19427| 075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|A||0|0|E|0|LVR|0|0|0|100|DKK|18284|25306|lyfalmen|||00|84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||||18284|25306| 075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075391|N05AL0502|Solian (Lyfjaver)|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|19102|26332|lyfalmen|V0289|26332|00|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríđ||19102||19102|26332| 075402|N05AL0502|Solian (Lyfjaver)|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|6349|9592|lyfalmen|V0288|9592|00|90|0|11,2500|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríđ||6349||6349|9592| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|A||0|0|E|0|POF|0|0|0|100|XEU|4194|5486|lyfalmen|V0445|5486|00|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||3347||3347|5486| 075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|31221|41065|lyfsjukr|||00|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||31221||31221|41065| 075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2011|R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270| 075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|117182|148946|lyfsjukr|||00|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||117182||117182|148946| 075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|100213|127650|lyfsjukr|||00|1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||100213||100213|127650| 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|A|5|0|0|0|0|DEC|0|0|0|100|DKK|980|1949|vetalmen|||16|20|0||Vistor hf|Dechra Veterinary Products A/S|||980||980|1949| 075787|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas||QS02CA01|01.12.1982|31.01.2012|R|A|3|0|0|0|0|DEC|0|0|0|100|DKK|2132|4241|vetalmen|||13|25|0|0,0000|Vistor hf|Dechra Veterinary Products A/S|||2132||2132|4241| 075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|5969|8615|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||5969||5969|8615| 075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|5969|8615|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||5969||5969|8615| 075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|5989|8644|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||5989||5989|8644| 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|A||0|0|0|0|AUK|0|0|0|100|GBP|449|1522|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||449||449|1522| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|A||0|0|0|0|AEA|0|0|1|100|XEU|460|1537|lyfalmen|||00|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||460||460|1537| 075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|913|1846|lyfalmen|V0449|1846|00|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||686||686|1846| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|DKK|6711|10088|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6711||6711|10088| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|DKK|22855|31042|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||22855||22855|31042| 076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2LIV|V03AN01|01.12.2009||L|A||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|445|1516|lyfalmen|V0045|1516|00|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1516| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|1986|3028|lyfalmen|V0290|3028|00|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3028| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|1946|3301|lyfalmen|V0291|3301|00|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3301| 076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|903|2143|lyfalmen|||00|100|0|6,6667|Vistor hf|Schering-Plough|Perfenazín||903||903|2143| 076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1263|2635|lyfalmen|||00|100|0|13,3333|Vistor hf|Schering-Plough|Perfenazín||||1263|2635| 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1799|3368|lyfalmen|||00|100|0|26,6667|Vistor hf|Schering-Plough|Perfenazín||||1799|3368| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7288|12714|vetorma|||27|100|0|0,0000|Vistor hf|Merial (MSD)|||7288||7288|12714| 076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|K||0|0|0|0|GLB|0|0|0|100|GBP|7167|10603|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7088||7088|10603| 076871|G01AF0202|Canesten (D.A.C.)|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|235|1229|lyfalmen|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||235||235|1229| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|693|1855|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||693||693|1855| 077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.07.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|10138|11256|lyfalmen|V0029|10885|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||7565||7565|11256| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|803|2006|lyfalmen|||02|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||803||803|2006| 078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Ekónazól|||||| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||29|4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||| 078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||| 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|11524|15271|lyfalmen|V0419|15271|10|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||10500||10500|15271| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|536|1641|lyfalmen|||00|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||536||536|1641| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|816|2024|lyfalmen|||00|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||816||816|2024| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|124639|158304|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||124639||124639|158304| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|9100|6127|lyfalmen|V0069|3524|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3816||3816|6127| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2798|4038|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíđ||2798||2798|4038| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4741|6842|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíđ||4741||4741|6842| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|8818|12727|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíđ||8818||8818|12727| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3729|6008|lyfalmen|||00|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3729||3729|6008| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|18838|26001|lyfalmen|||02|10|0|154,5714|Vistor hf|Schering-Plough|Perfenazín||18838||18838|26001| 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|A||0|0|B|0|ACA|0|1|0|100|XEU|3491|5683|lyfalmen|V0315|5683|00|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3491||3491|5683| 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2115|3052|lyfsjukr|||03|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2115||2115|3052| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1445|lyfalmen|V0176|1445|00|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1445| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1780|lyfalmen|V0418|1780|00|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1780| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1792|lyfalmen|V0177|1792|00|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1792| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2505|lyfalmen|V0411|2505|00|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2505| 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|A||0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||27|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745| 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|A||0|0|0|0|ANI|1|0|0|100|XEU|4087|8020|vetalmen|||27|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4087|8020| 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||05|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|A||0|0|0|0|BAN|1|0|0|100|DKK|10422|18181|vetorma|||00|24|0||Icepharma hf|Bayer Animal Health GmbH|||10422||10422|18181| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2294|4045|lyfalmen|||00|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2294||2294|4045| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|6027|9152|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6027||6027|9152| 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2703|3791|lyfalmen|V0143|2578|00|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2108||2108|3791| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|3130|5189|lyfalmen|||00|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3130||3130|5189| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|34782|60675|vetorma|||27|500|0|0,0000|Vistor hf|Merial (MSD)|||34782||34782|60675| 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|7639|10027|lyfalmen|V0143|7735|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||6667||6667|10027| 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2984|4138|lyfalmen|V0144|4016|00|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2362||2362|4138| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|15269|21045|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Ídarúbicín||15269||15269|21045| 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|11121|12047|lyfalmen|V0144|12047|00|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||8143||8143|12047| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|30101|39659|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Ídarúbicín||30101||30101|39659| 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|6135|9300|lyfalmen|||00|4|0|8,0000|D.A.C. ehf|D.A.C. ehf|Tadalafíl||6135||6135|9300|30.11.2011 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|A||0|0|0|0|PSA|0|0|0|100|DKK|8310|12275|lyfalmen|V0515|12275|00|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||8310||8310|12275| 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|4704|7342|lyfalmen|||00|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4704||4704|7342| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1863|2689|lyfsjukr|||02|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1863||1863|2689| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|19938|27382|lyfalmen|V0456|17447|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||19938||19938|27382| 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5870|8937|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5870||5870|8937| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8818|12970|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8818||8818|12970| 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|38659|38270|lyfalmen|V0184|38270|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||28614||28614|38270| 082040|D07XC0101|Diprosalic|áburđur|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2289|4039|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2289||2289|4039| 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3225|4836|lyfalmen|||23|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2872||2872|4836| 082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5715|8725|lyfalmen|||23|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5715||5715|8725| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|936|2188|lyfalmen|||00|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||936||936|2188| 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|A||0|0|0|0|GGL|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|GlaxoSmithKline ehf|Glaxo Group Limited|Paracetamól|||||| 082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4765|7426|lyfalmen|||00|20|0|1,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4765||4765|7426| 082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|5633|8613|lyfalmen|||00|20|0|3,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5633||5633|8613| 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|A||0|0|0|0|AGP|0|0|0|100|XEU|9145|13417|lyfalmen|V0080|13417|00|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||9145||9145|13417| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13374|19144|lyfalmen|||00|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13374||13374|19144| 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|19072|26295|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19072||19072|26295| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13967|19888|lyfalmen|V0344|13909|00|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13967||13967|19888| 083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|7444|11090|lyfalmen|||00|20|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7444||7444|11090| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|78054|99840|lyfsjukr|||00|450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||78054||78054|99840| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30309|40397|lyfalmen|V0346|29885|00|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30309||30309|40397| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8402|12126|lyfsjukr|||02|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8402||8402|12126| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|273|1281|lyfalmen|||02|10|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||273||273|1281| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|527|1628|lyfalmen|||02|20|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||527||527|1628| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|62220|79969|lyfsjukr|||00|0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||62220||62220|79969| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|81112|103678|lyfsjukr|||00|0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||81112||81112|103678| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|100347|127818|lyfsjukr|||00|0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||100347||100347|127818| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|20740|27911|lyfsjukr|||00|0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||20740||20740|27911| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|32393|42536|lyfsjukr|||00|0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||32393||32393|42536| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|41479|53939|lyfsjukr|||00|0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||41479||41479|53939| 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|12846|18004|lyfsjukr|||00|0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12846|18004| 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|48968|63337|lyfsjukr|||00|0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||48968|63337| 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|150818|191159|lyfsjukr|||00|1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||150818|191159| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|951|2208|lyfalmen|||00|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||951||951|2208| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|11279|16336|lyfalmen|||00|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11279||11279|16336| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|36707|48427|lyfalmen|||00|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||36707||36707|48427| 085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|15724|22093|lyfalmen|||10|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||15724||15724|22093| 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|K|1|0|1|*|0|GAN|0|0|0|100|NOK|43578|57050|lyfalmen|||00|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||43578||43578|57050| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|2660|4546|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||2660||2660|4546| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30309|40397|lyfalmen|V0345|29885|00|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30309||30309|40397| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|794|1994|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||794||794|1994| 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|20626|28245|lyfalmen|V0412|23619|00|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||20626||20626|28245| 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|35760|47238|lyfalmen|V0412|47238|00|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||35760||35760|47238| 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|A||0|1|0|1|ELD|0|0|0|100|XEU|95432|121650|lyfsjukr|||00|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||95432||95432|121650| 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|K|3|0|0|0|0|AEU|0|0|0|100|DKK|40491|53176|lyfalmen|||00|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||40491||40491|53176| 085829|S01EB0104|Pilokarpin|augndr|2|%|0,5|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2270|4013|lyfalmen|||00|10|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Pílókarpín||2270||2270|4013| 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|A||0|0|*|0|API|0|0|0|100|SEK|2975|4977|lyfalmen|V0465|4311|00|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2975||2975|4977| 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|A||0|0|*|0|API|0|0|0|100|SEK|8791|12933|lyfalmen|V0465|12933|00|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||8791||8791|12933| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4094|5101|lyfalmen|V0364|5101|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3066||3066|5101| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5544|5930|lyfalmen|V0365|5930|00|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3672||3672|5930| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8358|12063|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8358||8358|12063| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|14529|20116|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14529||14529|20116| 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|30650|40825|lyfalmen|||00|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||30650||30650|40825| 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|61301|79292|lyfalmen|||00|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||61301||61301|79292| 086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|54390|70142|lyfsjukr|||00|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |||54390||54390|70142| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|A||0|0|0|1|ROA|0|0|0|100|DKK|51010|65900|lyfsjukr|||00|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||51010||51010|65900| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3026|5047|lyfalmen|||00|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3026||3026|5047| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|163303|206828|lyfsjukr|||00|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||163303||163303|206828| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|293|1308|lyfalmen|V0312|420|00|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||293||293|1308| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|258|1260|lyfalmen|V0312|1260|00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||258||258|1260| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2170|3876|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2170||2170|3876| 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||01|500|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||3515| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|MEC|0|0|0|100|SEK|885|2118|lyfalmen|||00|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||885||885|2118| 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|3545|3234|lyfalmen|V0009|3163|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1701||1701|3234| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|10867|13915|lyfalmen|V0420|13915|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||9509||9509|13915| 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|A||0|0|0|0|CHP|0|0|0|100|XEU|31861|55580|vetorma|||00|104|0||Icepharma hf|Chanelle Pharmaceuticals|||31861||31861|55580| 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||| 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|A||0|0|0|0|CES|1|0|0|100|SEK|28285|49342|vetorma|||00|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28285||28285|49342| 088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1358|2765|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1358||1358|2765| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1542|3017|lyfalmen|||14|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1542||1542|3017| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|5952|9049|lyfalmen|||14|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5952||5952|9049| 088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|397|1450|lyfalmen|||04|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||397||397|1450| 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9929|14490|lyfalmen|||00|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9929||9929|14490| 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|ţpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|170853|216303|lyfsjukr|||00|70|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|||||170853|216303| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|23056|27930|lyfalmen|V0421|27930|00|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||20375||20375|27930| 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|6464|6480|lyfalmen|V0376|6480|06|8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4074||4074|6480| 088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|A||0|0|0|0|PER|0|0|0|100|DKK|1775|3335|lyfalmen|||23|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1775||1775|3335| 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|120|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||5602| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|163303|206828|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||163303||163303|206828| 089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|A||0|0|E|0|MYD|0|0|0|100|SEK|4044|6439|lyfalmen|||00|100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4044||4044|6439| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2356|4130|lyfalmen|||00|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2356||2356|4130| 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|A||0|0|0|0|PAD|0|0|1|100|DKK|1611|3111|lyfalmen|||00|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1611||1611|3111| 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007|30.11.2011|R|K|3|0|1|0|1|MKA|0|0|0|100|SEK|35323|46213|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||35323||35323|46213| 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|A||0|0|0|0|PAD|0|0|1|100|DKK|3200|5285|lyfalmen|||00|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3200||3200|5285| 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007|31.12.2011|R|K|3|0|1|0|1|MKA|0|0|0|100|SEK|177797|225018|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||177797||177797|225018| 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|A||0|0|0|1|NOM|0|0|0|100|DKK|5890|8501|lyfsjukr|||03|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5890||5890|8501| 090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1786|3351|lyfalmen|||24|16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1786||1786|3351| 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|884|2117|lyfalmen|||00|60|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||884||884|2117| 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|A||0|1|0|1|ACK|0|0|0|100|USD|16713|22857|lyfsjukr|||00|60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||16713|22857| 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|A||1|0|0|0|NOH|0|0|0|100|DKK|3403|5562|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3403||3403|5562| 091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|K||0|1|0|1|APC|0|0|0|100|XEU|1815|2619|lyfsjukr|||00|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1815|2619| 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|K||0|1|0|1|APC|0|0|0|100|XEU|7424|10715|lyfsjukr|||00|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7424|10715| 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|A||0|0|E|0|CCA|0|0|1|100|DKK|4015|6400|lyfalmen|||00|30|0||Vistor hf|CCS Clean Chemical Sweden AB|Dexametasón||4015||4015|6400| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1265|2519|lyfalmen|V0021|1843|00|90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1178||1178|2519| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2187|3457|lyfalmen|V0022|2445|00|90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1864||1864|3457| 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|631|1771|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||631||631|1771| 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|3912|6259|lyfalmen|||00|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3912|6259| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|1|0|0|100|DKK|9271|17974|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||9271||9271|17974| 092241|J01AA0209|Doxycyclin Actavis Disper|töflur|100|mg|8|stk|1|ţpakki|0|J01AA02|01.02.2012||R|A||0|0|0|0|AGT|0|0|1|100|XEU|451|1524|lyfalmen|||00|8|0|8,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||451||451|1524| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7951|10743|lyfalmen|V0009|3163|00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7190||7190|10743| 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|A||0|0|E|0|NON|0|0|0|100|DKK|2297|4050|lyfalmen|||05|18|0|7,2000|Vistor hf|Novo-Nordisk|Estradíól||2297||2297|4050| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A||0|0|*|0|DAC|0|1|0|100|DKK|9360|13711|lyfalmen|V0277|13711|00|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9360||9360|13711| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|24232|32771|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||24232||24232|32771| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|438|1507|lyfalmen|||10|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||438||438|1507| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|569|1686|lyfalmen|||10|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||569||569|1686| 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3383|4260|lyfalmen|V0203|4260|00|12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||2451||2451|4260| 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|1159|2493|lyfalmen|||00|28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1159|2493| 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|2660|4546|lyfalmen|||00|28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2660|4546| 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|5171|7981|lyfalmen|||00|28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||5171|7981| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6922|10376|lyfalmen|||00|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6922||6922|10376| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|26719|46610|vetorma|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||26719||26719|46610| 093708|L01DB0701|Novantrone|irţ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987|31.12.2011|R|A|3|0|1|0|1|MEB|0|0|0|100|USD|15422|21237|lyfsjukr|||00|5|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||15422||15422|21237| 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|61507|79409|lyfalmen|V0451|79060|00|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||61394||61394|79409| 093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|A||0|0|B|0|DAC|0|0|0|100|XEU|1197|2545|lyfalmen|V0496|2545|00|100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1197||1197|2545| 093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16294|22808|lyfalmen|||10|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||16294||16294|22808| 093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|22799|30972|lyfalmen|V0183|30972|00|1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||22799||22799|30972| 093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|45983|60068|lyfalmen|||10|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||45983||45983|60068| 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|K||0|1|0|1|JCI|0|0|0|100|SEK|553976|697122|lyfsjukr|||AC|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||553976||553976|697122| 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|K||0|1|0|1|JCI|0|0|0|100|SEK|596603|750619|lyfsjukr|||AC|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||596603||596603|750619| 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|||84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2704|4606|lyfalmen|||23|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2704||2704|4606|31.12.2011 094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|5147|7948|lyfalmen|V0236|7561|00|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5147||5147|7948| 094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|7627|11341|lyfalmen|V0236|11341|00|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7627||7627|11341| 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1800|3581|vetalmen|||00|15|0|0,0000|Vistor hf|Boehringer Ingelheim|||1800||1800|3581| 094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13115|18819|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13115||13115|18819| 094296|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|18786|25936|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18786||18786|25936| 094305|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|84529|108443|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||84529||84529|108443| 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|81479|104139|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||81479||81479|104139| 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|A||0|0|0|0|APE|0|0|1|100|XEU|47766|62306|lyfalmen|||00|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||47766|62306| 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|6517|11369|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6517||6517|11369| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3065|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráđ lyf|||1577||1577|3065| 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|5096|4792|lyfalmen|||00|8|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2840||2840|4792|31.01.2012 095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|5847|8906|lyfalmen|||00|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5847||5847|8906| 095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17990|24937|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17990||17990|24937| 095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17990|24937|lyfalmen|||00|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17990||17990|24937| 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|1934|3553|lyfalmen|||00|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1934||1934|3553| 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|3028|5050|lyfalmen|||00|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3028||3028|5050| 095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17990|24937|lyfalmen|||00|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17990||17990|24937| 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|A||0|0|0|1|POF|0|0|0|100|XEU|2538|3663|lyfsjukr|||00|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2538|3663| 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|A||0|0|0|1|POF|0|0|0|100|XEU|3512|5069|lyfsjukr|||00|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3512|5069| 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|A||0|0|E|0|AGP|0|0|1|100|XEU|1073|1437|lyfalmen|V0225|1437|00|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||387||387|1437| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3670|7220|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3670||3670|7220| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4842|9470|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4842||4842|9470| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|8818|17104|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8818||8818|17104| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2395|3457|lyfsjukr|||02|60|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||2395||2395|3457| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|12913|18088|lyfsjukr|||17|10|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12913||12913|18088| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|100949|128573|lyfsjukr|||17|100|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||100949||100949|128573| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|2052|3714|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2052||2052|3714| 096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16237|22737|lyfalmen|||00|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16237||16237|22737| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|691187|869322|lyfsjukr|||0|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||691187||691187|869322| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|732695|921415|lyfsjukr|||0|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||732695||732695|921415| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|770616|969006|lyfsjukr|||0|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||770616||770616|969006| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|845724|1063266|lyfsjukr|||0|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||845724||845724|1063266| 096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16237|22737|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16237||16237|22737| 096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1326|2721|lyfalmen|||00|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1326||1326|2721| 096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|32475|43116|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||32475||32475|43116| 096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|A||0|1|E|0|SNO|0|0|0|100|NOK|18584|25682|lyfalmen|||00|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||18584||18584|25682| 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|IPI|0|0|0|100|DKK|89544|114260|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||89544||89544|114260| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|27415|36288|lyfsjukr|||00|10000|0|10,0000|Actavis Group hf|Braun|Hýdróxyetýl sterkja||27415||27415|36288| 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|A||0|0|0|0|AUW|1|0|0|100|XEU|8143|15808|vetalmen|||27|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8143|15808| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2211|3913|lyfalmen|V0461|3913|00|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2197||2197|3913| 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1112|2429|lyfalmen|||00|120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1112||1112|2429| 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|23026|30780|lyfsjukr|||00|20|1|0,0000|Distica|Distica - óskráđ lyf|||23026||23026|30780| 097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|A||0|0|0|0|PER|0|1|0|100|DKK|21258|29038|lyfalmen|V0335|5997|00|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||21258|29038| 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|2446|4253|lyfalmen|||00|100|1|40,0000|Icepharma hf|Pfizer ApS|Lórazepam||2446||2446|4253| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3138|4281|lyfalmen|V0023|2840|00|90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríđ||2466||2466|4281| 097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4653|lyfalmen|V0233|4653|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4653| 097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3530|lyfalmen|V0234|3530|00|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3530| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1106|2400|lyfalmen|V0329|2400|00|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1091||1091|2400| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|6617|3524|lyfalmen|V0072|3524|00|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1913||1913|3524| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|8479|3524|lyfalmen|V0073|3524|00|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1913||1913|3524| 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|604|1734|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||604||604|1734| 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|604|1734|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||604||604|1734| 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|A||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Icepharma hf|Bioglan AB|Klórhexidín|||||| 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|ţpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|3144|5208|lyfalmen|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||3144||3144|5208|31.01.2012 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|10337|15048|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||10337||10337|15048|30.11.2011 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2530|lyfalmen|||06|5|1|25,0000|Distica|Distica - óskráđ lyf|||1186||1186|2530| 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|18775|25445|lyfsjukr|||02|25|0||Actavis Group hf|Braun|Flúmazeníl||18775||18775|25445| 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|17649|24509|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17649||17649|24509| 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|98388|125359|lyfsjukr|||00|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||98388||98388|125359| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|6090|9238|lyfalmen|V0284|9238|00|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||6090||6090|9238| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|13983|19809|lyfalmen|V0285|19809|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||13904||13904|19809| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|22858|30726|lyfalmen|V0286|30725|00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||22603||22603|30726| 099705|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|2954|3950|lyfalmen|V0247|3950|00|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2224||2224|3950| 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|4084|6037|lyfalmen|V0248|6037|00|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3750||3750|6037| 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|8296|10130|lyfalmen|V0249|10130|00|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6742||6742|10130| 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|709|1877|lyfalmen|V0414|1877|00|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||709||709|1877| 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13222|18953|lyfalmen|||00|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13222|18953| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13222|18953|lyfalmen|||00|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13222|18953| 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|A||0|0|B|0|ACA|0|1|0|100|XEU|1908|3517|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1908||1908|3517| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|12637|13322|lyfalmen|||0|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9075||9075|13322| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|17480|24297|lyfalmen|||0|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||17480||17480|24297| 101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|1999|3642|lyfalmen|||00|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||1999||1999|3642| 101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|6451|9732|lyfalmen|||00|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6451||6451|9732| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|0|0|AGP|0|1|0|100|XEU|1383|2799|lyfalmen|V0330|2799|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1383||1383|2799| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|3101|5149|lyfalmen|V0331|5149|00|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3101||3101|5149| 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|3889|4341|lyfalmen|V0088|4341|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||2510||2510|4341| 101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|A||0|0|0|0|AGP|0|1|0|100|XEU|5552|8502|lyfalmen|V0332|8502|00|96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5552||5552|8502| 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|4511|4418|lyfalmen|V0089|4418|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||2566||2566|4418| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|5175|7987|lyfalmen|V0227|7430|00|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5175||5175|7987| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|SEK|17373|33531|vetalmen|||0|250|0|0,0000|Vistor hf|Boehringer Ingelheim|||||17373|33531| 101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|A||0|0|E|0|APR|0|0|0|100|DKK|3225|5319|lyfalmen|||10|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3225|5319| 102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3749|6036|lyfalmen|V0041|3693|43|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3749||3749|6036| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|1879|2712|lyfsjukr|||02|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||1879||1879|2712| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|3054|4408|lyfsjukr|||00|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||3054||3054|4408| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|3494|4271|lyfalmen|V0088|4254|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||2459||2459|4271| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|4421|4348|lyfalmen|V0089|4330|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||2515||2515|4348| 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|XEU|2984|3524|lyfalmen|V0069|3524|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1913||1913|3524| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2562|2604|lyfalmen|V0033|2604|00|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||1240||1240|2604| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|10135|9791|lyfalmen|V0182|9747|00|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||6494||6494|9791| 103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|4442|6119|lyfalmen|V0334|6119|00|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3810||3810|6119| 103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|7129|6119|lyfalmen|V0335|6119|00|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3810||3810|6119| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1844| 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|13608|18961|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||13608||13608|18961| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3167|5240|lyfalmen|||23|2|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3167||3167|5240| 104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2178|3887|lyfalmen|||00|21|0|21,0000|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2178||2178|3887| 104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8350|12330|lyfalmen|||04|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8350||8350|12330| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|4689|7322|lyfalmen|V0017|7322|56|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4689||4689|7322| 104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5307|8167|lyfalmen|||10|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5307||5307|8167| 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|129672|164621|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||129672|164621| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4320|5929|lyfalmen|V0004|2130|00|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3671||3671|5929| 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|13146|16194|lyfalmen|V0011|7029|00|100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||11175||11175|16194| 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A||0|0|0|0|DAC|0|0|0|100|SEK|17482|19144|lyfalmen|V0012|7642|00|100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13374||13374|19144| 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1230|2590|lyfalmen|V0545|2590|23|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1230||1230|2590| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3982|6355|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||3982||3982|6355| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13843|19732|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13843||13843|19732| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4590|7186|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4590||4590|7186| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15967|22398|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15967||15967|22398| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2437|4241|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2437||2437|4241| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2881|4848|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2881||2881|4848| 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|A||0|0|0|0|RRL|0|0|0|100|DKK|1858|3449|lyfalmen|||00|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1858||1858|3449| 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|A||0|0|0|0|RRL|0|0|0|100|DKK|3716|5991|lyfalmen|||00|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3716||3716|5991| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|2689|4586|lyfalmen|||63|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2689||2689|4586| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|18831|25515|lyfsjukr|||00|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||18831||18831|25515| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10414|14952|lyfsjukr|||00|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10414||10414|14952| 107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|2041|2872|lyfalmen|V0278|2595|00|28|0|7,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||1436||1436|2872| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|1585|3076|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1585||1585|3076| 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|1552|2707|vetorma|||16|6|0|0,0000|Dýraheilsa/Icevet ehf|Icevet ehf|||||1552|2707| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|931|2181|lyfalmen|||00|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||931||931|2181| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2851|4807|lyfalmen|||63|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2851||2851|4807| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|3325|5456|lyfalmen|||00|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3325||3325|5456| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|9868|14406|lyfalmen|||00|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9868||9868|14406| 108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|13853|13278|lyfalmen|V0282|13278|00|56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||9043||9043|13278| 108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1178|2519|lyfalmen|||24|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1178||1178|2519| 108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1635|3144|lyfalmen|V0443|3143|24|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1635||1635|3144| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24464|33062|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||24464||24464|33062| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19585|26939|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19585||19585|26939| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7603|11308|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7603||7603|11308| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|420|1482|lyfalmen|V0230|1482|00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||420||420|1482| 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|401|1456|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||401||401|1456|31.01.2012 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|521|1620|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||521||521|1620| 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3LIV|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1551|3029|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1551||1551|3029| 110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|3967|6334|lyfalmen|||10|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3967||3967|6334| 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|5909|7290|lyfalmen|V0373|7290|06|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4666||4666|7290| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GSH|0|0|1|100|DKK|755|1940|lyfalmen|||00|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||755||755|1940| 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|21919|29868|lyfalmen|||00|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||21919||21919|29868| 112615|C01DA0201|Discotrine|forđapl|15|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|4299|6788|lyfalmen|||23|30|0|90,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||4299||4299|6788| 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|8267|4330|lyfalmen|V0203|4260|00|12|0|84,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2502||2502|4330| 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|8574|12636|lyfalmen|V0024|11448|00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8574||8574|12636| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|25485|34343|lyfalmen|V0024|34343|00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25485||25485|34343| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|8685|12788|lyfalmen|V0025|11572|00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8685||8685|12788| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3757|6047|lyfalmen|||00|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3757||3757|6047| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|25782|34716|lyfalmen|V0025|34716|00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25782||25782|34716| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6438|9714|lyfalmen|||00|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6438||6438|9714| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|671568|844700|lyfsjukr|||00|112|0|0,0000|Vistor hf|Novartis Europharm Ltd|Nilotiníb||671568||671568|844700| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|721|1894|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||721||721|1894| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|915|2159|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||915||915|2159| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1397|2818|lyfalmen|||00|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1397||1397|2818| 114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|967|2230|lyfalmen|||23|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||967||967|2230| 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|A||0|1|0|1|WIL|0|0|0|100|XEU|52833|68188|lyfsjukr|||00|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||52833||52833|68188| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|DKK|4164|6604|lyfalmen|||00|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4164||4164|6604| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|2375|4156|lyfalmen|V0373|2430|06|5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2375||2375|4156| 114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2227|3954|lyfalmen|||23|4|0|3,5000|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2227||2227|3954| 114664|D10AD5301|Epiduo|hlaup|||30|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|A||0|0|0|0|GAN|0|0|0|100|SEK|3190|5271|lyfalmen|||00|30|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||3190||3190|5271| 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|A||0|0|0|0|GAN|0|0|0|100|SEK|6246|9452|lyfalmen|||00|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6246||6246|9452| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1919|3532|lyfalmen|||0|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1919||1919|3532| 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr|||00|10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1574|3061|lyfalmen|||00|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1574||1574|3061| 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|ţpakki|hart|B01AE07|01.01.2009|30.11.2011|R|A|3|0|0|E|0|BII|0|0|0|100|DKK|10636|15457|lyfalmen|||0|30|0|10,2300|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10636||10636|15457| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11513|16657|lyfalmen|||0|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11513||11513|16657| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1919|3532|lyfalmen|||0|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1919||1919|3532| 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|ţpakki|hart|B01AE07|01.01.2009|30.11.2011|R|A|3|0|0|E|0|BII|0|0|0|100|DKK|10636|15457|lyfalmen|||0|30|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10636||10636|15457| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11513|16657|lyfalmen|||0|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11513||11513|16657| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|1911|3522|lyfalmen|V0369|2918|06|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1911||1911|3522| 115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3740|6023|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3740||3740|6023| 115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3757|5422|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3757||3757|5422| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1964|2835|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1964||1964|2835| 116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10,0000|Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||| 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2618|4489|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||2618||2618|4489| 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3009|5024|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||3009||3009|5024| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|763|1951|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||763||763|1951| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|380|1427|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||380||380|1427| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|925|2173|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||925||925|2173| 116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|17846|24756|lyfalmen|||00|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17846||17846|24756| 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|A||0|0|0|0|AGP|0|0|0|100|XEU|7600|11304|lyfalmen|V0081|11304|00|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||7600||7600|11304| 116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6081|9226|lyfalmen|||00|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6081||6081|9226| 116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6530|9840|lyfalmen|||00|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6530||6530|9840| 116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|19279|26555|lyfalmen|||00|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||19279||19279|26555| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|K||0|0|0|0|WLV|0|0|0|100|DKK|8318|12286|lyfalmen|||00|0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8318||8318|12286| 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|10535|20401|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||10535||10535|20401| 117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|3232|5329|lyfalmen|||10|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3232||3232|5329| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4569|7158|lyfalmen|V0435|7052|00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4569||4569|7158| 117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|14851|20997|lyfalmen|||00|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||14851|20997| 117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26248|35301|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26248|35301| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|1619|3122|lyfalmen|||10|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1619||1619|3122| 117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4539|7116|lyfalmen|||00|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4539|7116| 117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|45386|59319|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||45386|59319| 117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|52496|68242|lyfalmen|||00|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||52496|68242| 117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|K|1,6|0|1|0|1|JCI|0|0|0|100|SEK|66792|85706|lyfsjukr|||00|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||66792||66792|85706| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|9796|17089|vetorma|||00|250|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||9796||9796|17089| 117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2328|4092|lyfalmen|||61|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2328||2328|4092| 117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|5564|8519|lyfalmen|||61|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5564||5564|8519| 117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|8332|12305|lyfalmen|||61|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8332||8332|12305| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7359|14303|vetalmen|||00|1200|0|0,0000|Icepharma hf|Kela Laboratoria NV|||7359||7359|14303| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|12907|24956|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||12907||12907|24956| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4020|2869|lyfalmen|V0278|2595|00|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1434||1434|2869| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5714|3616|lyfalmen|V0279|3366|00|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1980||1980|3616| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|22160|13886|lyfalmen|V0282|13278|00|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||9488||9488|13886| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|16929|15312|lyfalmen|V0283|12431|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||10530||10530|15312| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|2237|3967|lyfalmen|||65|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2237||2237|3967| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||00|4|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118315|M01AB0505|Voltaren|eţ-stíll|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|379|1426|lyfalmen|||04|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||379||379|1426| 118323|M01AB0505|Voltaren|eţ-stíll|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|3467|5650|lyfalmen|||04|50|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3467||3467|5650| 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|942|2196|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||942||942|2196| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17421|11811|lyfalmen|V0280|11323|00|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||7971||7971|11811| 118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|7591|11291|lyfalmen|V0015|10536|00|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7591||7591|11291| 118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|23306|31608|lyfalmen|V0015|31608|00|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||23306||23306|31608| 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|2985|4991|lyfalmen|V0276|4991|00|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||2985||2985|4991| 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|9360|13711|lyfalmen|V0277|13711|00|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9360||9360|13711| 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|A||0|0|B|0|AEG|0|0|0|100|XEU|492|1580|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||492||492|1580| 119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|77971|99736|lyfsjukr|||00|5|0|0,0000|Vistor hf|Amgen Europe B.V.|Panitúmúmab||77971||77971|99736| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|448644|564931|lyfsjukr|||00|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||448644||448644|564931| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|448644|564931|lyfsjukr|||00|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||448644||448644|564931| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|SAL|0|0|0|100|USD|992|2264|lyfalmen|||06|10|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||992||992|2264| 120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|48444|62680|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Lilly ICOS Limited|Pemetrexed||48444||48444|62680| 120341|N06DA0402|Reminyl (Lyfjaver)|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.05.2008|31.12.2011|R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|12834|18466|lyfalmen|||00|28|0|14,0000|Lyfjaver ehf|Lyfjaver ehf|Galantamín||12834||12834|18466| 120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012||L|A||0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa|||00|24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen|||||| 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008||R|A||0|0|0|0|LVR|0|0|0|100|DKK|17964|24904|lyfalmen|V0253|20307|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||17964||17964|24904| 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5649|8635|lyfalmen|||00|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5649||5649|8635| 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|9559|13796|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíđ||9559||9559|13796| 121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|452|1526|lyfalmen|||24|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||452||452|1526| 121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|8391|7893|lyfalmen|||00|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||5107||5107|7893|31.01.2012 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|411|1465|lyfalmen|V0391|1464|00|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||408||408|1465| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|1776|3337|lyfalmen|V0314|2218|00|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1776||1776|3337| 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|274|1282|lyfalmen|||00|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||274||274|1282| 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|K||0|0|0|0|BIV|0|0|0|100|DKK|9593|16735|vetorma|||00|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9593||9593|16735| 123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|556|1668|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||556||556|1668| 123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|867|2093|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||867||867|2093| 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|A||0|0|0|0|ICE|0|0|0|100|USD|27225|47493|vetorma|||00|100|0||Icepharma hf|Icepharma hf|||27225||27225|47493| 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.11.2005|31.01.2012|R|A|3|0|0|0|0|PCO|0|0|1|100|DKK|2447|4255|lyfalmen|||00|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2447||2447|4255| 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|247|1245|lyfalmen|||00|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||247|1245| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|45683|59692|lyfalmen|||00|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||45683||45683|59692| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|1833|3646|vetalmen|||00|42|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals|||||1833|3646| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|A||0|0|0|0|SBM|0|0|0|100|NOK|38129|50211|lyfalmen|||00|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||38129|50211| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1008|2286|lyfalmen|||00|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1008||1008|2286| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|A|2|0|0|0|0|ACA|0|0|0|100|XEU|514|1610|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||514||514|1610| 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD|10640|15462|lyfalmen|V0464|15462|00|8|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||10640||10640|15462| 124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|1283|1852|lyfsjukr|||00|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1283||1283|1852| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|846|1557|lyfalmen|V0066|1557|00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||475||475|1557| 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|14650|20745|lyfalmen|V0264|20745|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14650||14650|20745| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||10|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|114225|145235|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||114225|145235| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|29314|38672|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||29314|38672| 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|25513|33901|lyfsjukr|||00|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||25513||25513|33901| 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|8504|12273|lyfsjukr|||00|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8504||8504|12273| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|47167|61077|lyfsjukr|||00|50|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||47167||47167|61077| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|94359|120303|lyfsjukr|||00|100|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||94359||94359|120303| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|188652|238641|lyfsjukr|||00|200|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||188652||188652|238641| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCS|0|0|0|100|SEK|1037|2326|lyfalmen|V0447|2029|10|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1037||1037|2326| 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|8769|6162|lyfalmen|V0279|3366|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3841||3841|6162| 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6417|12494|vetalmen|||0|30|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||6417||6417|12494| 128173|C08DA0108|Verapamil Mylan|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|883|2115|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Verapamíl||883||883|2115| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1242|2606|lyfalmen|||10|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1242||1242|2606| 128777|N02BA5102|Treo|freyđit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|3991|5760|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||3991||3991|5760| 129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31616|30047|lyfalmen|V0280|11323|00|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22062||22062|30047| 129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|34363|23121|lyfalmen|V0282|13278|00|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16543||16543|23121| 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|230|1222|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||230||230|1222| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0,0000|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3145| 129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4413|6944|lyfalmen|||00|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4413||4413|6944| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|18579|22704|lyfalmen|V0285|19809|00|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16211||16211|22704| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|29409|34568|lyfalmen|V0286|30725|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||25664||25664|34568| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2336|4103|lyfalmen|||63|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2336||2336|4103| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4028|6417|lyfalmen|||02|125|0|31,2500|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||4028||4028|6417| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|1826|3405|lyfalmen|||63|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1826||1826|3405| 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|11462|16587|lyfalmen|||0|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11462|16587| 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|64496|105225|veteldis|||0|500|0|0,0000|Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||64496|105225| 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3347|5486|lyfalmen|||00|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3347|5486| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|472|1553|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||472||472|1553| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|743|1924|lyfalmen|||00|100|0|15,0000|Vistor hf|Recip AB|||743||743|1924| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|991|2263|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|||991||991|2263| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1097|2408|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|||1097||1097|2408| 131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|A||0|0|E|0|LVR|0|0|0|100|XEU|2626|4413|lyfalmen|V0009|3163|00|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||2563||2563|4413| 131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5652|8639|lyfalmen|V0132|8639|23|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5652||5652|8639| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|9002|13222|lyfalmen|V0032|12083|0|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||9002|13222| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|27004|36249|lyfalmen|V0032|36249|0|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||27004|36249| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|90014|115327|lyfalmen|||0|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||90014|115327| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|ţpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|256|1178|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||198||198|1178| 132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|7990|11837|lyfalmen|V0348|11837|00|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7990||7990|11837| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9321|5245|lyfalmen|V0091|5245|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||3171||3171|5245| 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|7470|5207|lyfalmen|V0090|5207|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||3143||3143|5207| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1483|2936|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Kódein||1483||1483|2936| 132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7764|11528|lyfalmen|||0|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7764||7764|11528| 132761|D08AG0201|Betadine|áburđur|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||23|8|0|8,0000|Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|SAL|0|0|0|100|USD|1131|2455|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1131||1131|2455| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|ţpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1382|2798|lyfalmen|||23|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1382||1382|2798| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|28239|37322|lyfsjukr|||0|0|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||28239||28239|37322| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|37564|49025|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||37564||37564|49025| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|49082|63480|lyfsjukr|||0|2|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||49082|63480| 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|20|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|50|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|8303|12265|lyfalmen|||10|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8303||8303|12265| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|92894|118464|lyfsjukr|||00|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||92894||92894|118464| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|1524|2992|lyfalmen|||00|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1524||1524|2992| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|4019|6405|lyfalmen|V0378|5826|00|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||4019||4019|6405| 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|12047|17478|lyfalmen|V0378|17478|00|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||12047||12047|17478| 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|1584|2286|lyfsjukr|||0|5|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||1584||1584|2286| 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|3827|5523|lyfsjukr|||0|10|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||3827|5523| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4746|6850|lyfsjukr|||0|25|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||4746||4746|6850| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|A||0|1|0|1|BRS|0|0|0|100|DKK|70707|90620|lyfsjukr|||43|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70707||70707|90620| 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|131009|166299|lyfsjukr|||00|30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||131009||131009|166299| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|53255|68718|lyfsjukr|||00|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||53255||53255|68718| 135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|A||0|0|B|0|ADG|0|0|0|100|XEU|1857|3448|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1857||1857|3448| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|1009|2288|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1009||1009|2288| 135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|2261|4000|lyfalmen|||23|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2261||2261|4000| 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|ţpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1663|3182|lyfalmen|||23|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1663||1663|3182| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|6927|10383|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||6927||6927|10383| 136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|2266|3270|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||2266||2266|3270| 136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|7099|10246|lyfsjukr|||00|17|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||7099||7099|10246| 136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|5232|7551|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||5232||5232|7551| 136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|8156|11771|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||8156||8156|11771| 137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|5954|8593|lyfsjukr|||00|20|0||Icepharma hf|Hospira Nordic AB|Oxalíplatín||5954||5954|8593| 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og ađrar óvirkar samsetningar|||||1608| 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og ađrar óvirkar samsetningar|||||1989| 137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|20865|28068|lyfsjukr|||00|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||20865||20865|28068| 137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|XEU|6298|9090|lyfsjukr|||00|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6298||6298|9090| 137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|XEU|10573|15152|lyfsjukr|||00|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||10573||10573|15152| 137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|5988|8642|lyfsjukr|||00|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||5988||5988|8642| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|XEU|746|1077|lyfsjukr|||00|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||746||746|1077| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1519|2192|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1519||1519|2192| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1700|3233|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1700||1700|3233| 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|A||0|0|*|0|APC|0|0|0|100|XEU|4732|7381|lyfalmen|V0373|7290|06|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4732||4732|7381| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NEH|0|0|1|100|DKK|3001|5013|lyfalmen|||00|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín||3001||3001|5013| 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|137547|174504|lyfsjukr|||00|20|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||137547||137547|174504| 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|343757|433298|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||343757||343757|433298| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1457|2900|lyfalmen|V0266|1180|00|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1457||1457|2900| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|11784|16671|lyfsjukr|||02|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11784||11784|16671| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|DES|0|0|0|100|DKK|638|921|lyfsjukr|||02|5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||638||638|921| 140729|QN01AX|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|A||0|0|0|0|SRR|1|0|0|100|NOK|93430|179572|vetalmen|||00|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||93430||93430|179572| 140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1244|2609|lyfalmen|V0413|2327|03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1244||1244|2609| 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa||N01BB20|01.11.2008||R|A||0|0|0|0|DAC|0|0|1|100|SEK|3250|5353|lyfalmen|||00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Blöndur||3250||3250|5353|31.01.2012 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|4436|6229|lyfsjukr|||00|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4316||4316|6229| 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|21071|28327|lyfsjukr|||00|1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||21071||21071|28327| 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3863|5575|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3863||3863|5575| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|2753|4673|lyfalmen|||00|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2753||2753|4673| 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|K||0|1|E|0|MSE|0|0|0|100|SEK|20270|27798|lyfalmen|||00|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||20270||20270|27798| 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4727|7374|lyfalmen|||0|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||4727||4727|7374| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|8630|12713|lyfalmen|V0267|3502|00|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8630||8630|12713| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3274|4725|lyfsjukr|||02|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3274||3274|4725| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1073|2375|lyfalmen|||70|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1073||1073|2375| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2877|4843|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2877||2877|4843| 142928|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.09.2010||R|K||0|0|*|0|DAC|0|0|0|100|DKK|7391|7047|lyfalmen|||06|8|0|75,0000|D.A.C. ehf|D.A.C. ehf|Latanóprost||4488||4488|7047|31.01.2012 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1448|2888|lyfalmen|||03|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1448||1448|2888| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2274|3282|lyfsjukr|||03|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2274||2274|3282| 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972|31.12.2011|R|A|2|0|0|E|0|ANS|0|0|1|100|XEU|1247|2613|lyfalmen|||07|5|0|0,0000|Vistor hf|Anstalt zur gewerblichen Produktion|Prednisólón||1247||1247|2613| 143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3838|6158|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3838||3838|6158| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|SAL|0|0|0|100|USD|934|2185|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||934||934|2185| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1477|2928|lyfalmen|||00|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1477||1477|2928| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1331|2728|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1331||1331|2728| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|8448|12464|lyfalmen|V0386|9489|0|56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8448||8448|12464| 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|606|1736|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||606||606|1736| 143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1206|2557|lyfalmen|||10|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1206||1206|2557| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|2031|3686|lyfalmen|V0174|3686|00|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2031||2031|3686| 144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|DKK|2094|3772|lyfalmen|||10|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2094||2094|3772| 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|23024|31255|lyfalmen|||22|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23024||23024|31255| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|80856|103357|lyfsjukr|||AC|2|0|22,5000|Vistor hf|Novo-Nordisk|Sómatrópín||80856||80856|103357| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|60432|77725|lyfsjukr|||AC|2|0|15,0750|Vistor hf|Novo-Nordisk|Sómatrópín||60432||60432|77725| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|37549|49006|lyfsjukr|||AC|2|0|7,4250|Vistor hf|Novo-Nordisk|Sómatrópín||37549||37549|49006| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|654|1802|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||654||654|1802| 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|299|1316|lyfalmen|||00|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||299||299|1316| 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|460|1537|lyfalmen|||00|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||460||460|1537| 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK|85504|109190|lyfsjukr|||00|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||85504||85504|109190| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|2224|3950|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2224||2224|3950| 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972|31.12.2011|L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|ţpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|20570|19854|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13940||13940|19854| 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|K||0|1|0|1|GGL|0|0|0|100|GBP|30917|40683|lyfsjukr|||00|1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||30917||30917|40683| 146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|3041|4389|lyfsjukr|||0|2|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||3041||3041|4389| 146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|6178|8916|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||6178||6178|8916| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|A||0|1|0|0|ELI|0|0|0|100|XEU|18005|24956|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18005||18005|24956| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|873|2102|lyfalmen|V0351|1068|41|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||873||873|2102| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|2522|3640|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Cýtarabín||2522||2522|3640| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|1563|2256|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Cýtarabín||1563||1563|2256| 147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012||L|A||0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól|||||| 148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|113344|144606|lyfalmen|||00|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||113344||113344|144606| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|857|2080|lyfalmen|||00|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||857||857|2080| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|6319|9120|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||6319||6319|9120| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|13247|18507|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||13247||13247|18507| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HOS|0|0|0|100|SEK|28338|37447|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||28338||28338|37447| 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3650|7181|vetalmen|||27|25|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3650||3650|7181| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|SEK|2108|3791|lyfalmen|||00|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2108||2108|3791| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|2185|2522|lyfalmen|V0376|2160|06|2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1180||1180|2522| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|16199|22689|lyfalmen|||10|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16199||16199|22689| 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|52686|68003|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||52686|68003| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|3806|6114|lyfalmen|||00|28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||3806|6114| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|6313|9543|lyfalmen|V0120|7495|00|56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6313|9543| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3666|5922|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Meningókokka polysakkaríđ mótefnavakar||||3666|5922| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|6599|9934|lyfalmen|||02|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6599||6599|9934| 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1177|2517|lyfalmen|||05|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1177||1177|2517| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|16024|22470|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||16024|22470| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|49478|61495|lyfalmen|||00|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||47120||47120|61495| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|5368|4366|lyfalmen|V0148|4217|00|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2528||2528|4366| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|1583|3073|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1583||1583|3073| 151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|A||0|0|E|0|RAT|0|0|0|100|XEU|4502|5862|lyfalmen|V0006|5862|00|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||3622||3622|5862| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|2018|2912|lyfsjukr|||02|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2018||2018|2912| 152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|A||0|0|0|0|DAC|0|0|0|100|XEU|2596|4454|lyfalmen|V0123|4454|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2593||2593|4454| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|25|0|0,0000|Icepharma hf|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|3915|6263|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3915||3915|6263| 152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5722|8735|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5722||5722|8735| 152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|10498|15268|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10498||10498|15268| 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|18901|11980|lyfalmen|V0269|11980|00|100|0|28,0000|Lyfis ehf|Lyfis ehf|Pramipexól||8094||8094|11980| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1250|2617|lyfalmen|V0181|1447|10|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1250||1250|2617| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1791|3357|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||1791||1791|3357| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|40013|52099|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||40013|52099| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2262|4002|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2262||2262|4002| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1582|3071|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||1582||1582|3071| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2299|4052|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2299||2299|4052| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|230244|290839|lyfsjukr|||00|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||230244||230244|290839| 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|548|1657|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||548|1657| 153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|A||0|0|*|0|APC|0|0|0|100|XEU|35281|46637|lyfalmen|V0452|46637|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||35281||35281|46637| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|4318|6814|lyfalmen|V0181|5427|10|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4318||4318|6814| 153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|K|2|0|0|E|0|SAN|0|0|1|100|DKK|1580|3069|lyfalmen|||02|1|0|50,0000|Vistor hf|Sandoz A/S|Hýdroxókóbalamín||1580||1580|3069| 154464|D05AX5203|Xamiol|hlaup|||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|4566|7153|lyfalmen|||00|30|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4566||4566|7153| 154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|8147|12052|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8147||8147|12052| 154484|G04CA0102|Xatral Uno|forđatfl|10|mg|30|stk|1|ţpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3284|5400|lyfalmen|||00|30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||3284||3284|5400| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1063|2361|lyfalmen|||10|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1063||1063|2361| 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|29343|38708|lyfsjukr|||00|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||29343||29343|38708| 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|38443|50128|lyfsjukr|||00|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38443||38443|50128| 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|42238|54891|lyfsjukr|||00|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||42238||42238|54891| 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|31262|41116|lyfsjukr|||00|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||31262||31262|41116| 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|38456|50145|lyfsjukr|||00|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38456||38456|50145| 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|27550|36458|lyfsjukr|||00|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||27550||27550|36458| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|3815|6126|lyfalmen|||10|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3815||3815|6126| 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|35921|46963|lyfsjukr|||00|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||35921||35921|46963| 154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|1531|3002|lyfalmen|V0259|3002|00|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1531||1531|3002| 154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7368|10986|lyfalmen|V0550|7639|00|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7368||7368|10986| 154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|4353|6015|lyfalmen|V0334|5997|00|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3734||3734|6015| 154750|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2398|2397|lyfalmen|V0265|2397|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1089||1089|2397| 154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|6986|6015|lyfalmen|V0335|5997|00|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3734||3734|6015| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|AUG|0|0|0|100|XEU|1581|3070|lyfalmen|||00|25|0|0,0000|Aspen Europe GmbH|Aspen Europe GmbH|Chlorambucíl||1581||1581|3070| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|2225|3951|lyfalmen|V0247|3950|00|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2225||2225|3951| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3750|6037|lyfalmen|V0248|6037|00|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3750||3750|6037| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|6742|10130|lyfalmen|V0249|10130|00|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6742||6742|10130| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1532|3003|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1532||1532|3003| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|656|1805|lyfalmen|||00|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||656||656|1805| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|6743|10131|lyfalmen|V0181|10131|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6743||6743|10131| 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|ţpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6366|9616|lyfalmen|V0018|6970|00|42|0|14,0000|Icepharma hf|Roche|Orlístat||6366||6366|9616| 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|K||0|0|*|0|ELD|0|0|0|100|XEU|5892|8967|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5892||5892|8967| 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|K||0|0|*|0|ELD|0|0|0|100|XEU|5941|9034|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5941||5941|9034| 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|A||0|0|0|0|REP|0|0|1|100|SEK|434|1501|lyfalmen|||00|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||434||434|1501| 156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|XEU|2364|3412|lyfsjukr|||00|15|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||2364||2364|3412| 156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|XEU|1386|2000|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||1386||1386|2000| 156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|XEU|6474|9344|lyfsjukr|||00|45|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||6474||6474|9344| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9527|13940|lyfalmen|V0018|13940|00|84|0|28,0000|Icepharma hf|Roche|Orlístat||9527||9527|13940| 156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|HOP|0|0|0|100|XEU|8672|12516|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||8672||8672|12516| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|871|2099|lyfalmen|||00|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||871||871|2099| 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7340|12804|vetorma|||16|260|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7340||7340|12804| 157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|2730|3616|lyfalmen|V0279|3366|00|28|0|14,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||1980||1980|3616| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|DKK|500|1591|lyfalmen|||07|4|1|0,0000|Distica|Distica - óskráđ lyf|||500||500|1591| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|A||0|0|E|0|NOH|0|0|0|100|DKK|1535|3007|lyfalmen|V0239|3007|00|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1535||1535|3007| 158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|1579|3067|lyfalmen|||00|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1579|3067| 158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|29094|38872|lyfalmen|||00|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||29094|38872| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|957|2216|lyfalmen|V0239|1504|00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||957||957|2216| 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|104131|132567|lyfsjukr|||00|1|0|0,0200|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjađ)||||104131|132567| 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|208263|263253|lyfsjukr|||00|1|0|0,0400|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjađ)||||208263|263253| 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|590525|742991|lyfsjukr|||00|1|0|0,1000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjađ)||||590525|742991| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|53136|68568|lyfsjukr|||0|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||53136|68568| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|75801|97013|lyfsjukr|||0|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||75801||75801|97013| 158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|DES|0|0|0|100|DKK|825|2036|lyfalmen|||23|5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||825||825|2036| 158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|1032|2319|lyfalmen|V0469|2319|10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1032|2319| 159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3391|5546|lyfalmen|V0219|5546|00|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3391||3391|5546| 159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|5838|8893|lyfalmen|V0220|8893|00|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5838||5838|8893| 159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7573|11267|lyfalmen|V0221|11267|00|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7573||7573|11267| 159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|8824|12978|lyfalmen|V0223|12978|00|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||8824||8824|12978| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|5221|4624|lyfalmen|V0318|2466|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2717||2717|4624| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|20439|28010|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||20439||20439|28010| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|13389|12360|lyfalmen|V0320|4114|00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8372||8372|12360| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|1893|2584|lyfalmen|V0062|1969|00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1226||1226|2584| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|3277|3650|lyfalmen|V0067|1850|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2005||2005|3650| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|6754|4868|lyfalmen|V0071|2092|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2895||2895|4868| 159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|466|1545|lyfalmen|||72|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||466||466|1545| 159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1603|3100|lyfalmen|||72|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1603||1603|3100| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|APC|0|0|0|100|DKK|101505|129271|lyfsjukr|||00|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||101505||101505|129271| 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|4228|8291|vetalmen|||27|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4228||4228|8291| 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|2223|3948|lyfalmen|V0010|3915|00|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2223||2223|3948| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2289|3304|lyfsjukr|||02|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2289||2289|3304| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|36322|47467|lyfsjukr|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||36322||36322|47467| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|52886|68254|lyfsjukr|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||52886||52886|68254| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|997|2271|lyfalmen|||00|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||997||997|2271| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2384|4169|lyfalmen|||42|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2384||2384|4169| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|70553|90427|lyfsjukr|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||70553||70553|90427| 160739|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|30|stk|1|ţpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|380|1427|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||380|1427|31.12.2011 160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|A||0|0|E|0|BOI|0|0|1|100|DKK|1211|2564|lyfalmen|||24|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1211||1211|2564| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|75451|96574|lyfsjukr|||0|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||75451||75451|96574| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PER|0|0|1|100|DKK|599|1727|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||599||599|1727| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|929|1341|lyfsjukr|||03|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||929||929|1341| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|843|1217|lyfsjukr|||03|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||843||843|1217| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|612|1745|lyfalmen|||03|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||612||612|1745| 161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5022|7777|lyfalmen|V0131|7777|23|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5022||5022|7777| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|60787|78647|lyfalmen|V0452|46637|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||60787||60787|78647| 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|2890|4171|lyfsjukr|||00|2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2890||2890|4171| 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|A||1|1|0|1|RBP|0|0|0|100|DKK|14325|19747|lyfsjukr|||00|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14235||14235|19747| 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972|31.12.2011|L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120,0000|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd|||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|4996|7210|lyfsjukr|||00|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4996||4996|7210| 162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|A||0|0|B|0|LBK|0|1|0|100|DKK|785|1981|lyfalmen|V0512|1981|00|100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||785||785|1981| 162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|A||0|0|B|0|LBK|0|1|0|100|DKK|437|1505|lyfalmen|V0510|1505|00|100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||437||437|1505| 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|14658|20278|lyfsjukr|||00|18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14658||14658|20278| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|1935|3554|lyfalmen|||00|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1935||1935|3554| 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|A||0|0|0|0|LEV|1|0|0|100|XEU|5475|10685|vetalmen|||27|5|0||Le Vet B.V.|Le Vet B.V.|||||5475|10685| 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|A||0|0|*|0|APC|0|0|0|100|XEU|1650|3164|lyfalmen|V0373|2430|06|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1650||1650|3164| 162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|4784|4686|lyfalmen|V0148|4686|00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2762||2762|4686| 162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2261|4000|lyfalmen|||24|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2261||2261|4000| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1155|2487|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1155||1155|2487| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1679|3204|lyfalmen|V0351|3204|41|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1679||1679|3204| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|204|1186|lyfalmen|||0|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||204|1186| 163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3342|4836|lyfalmen|||24|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2872||2872|4836| 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|12042|lyfalmen|||00|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12042| 164119|J05AE0001|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE|01.02.2012||R|A||0|1|0|1|JCI|0|0|0|100|SEK|348749|439562|lyfsjukr|||00|42|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||348749||348749|439562| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|AUG|0|0|0|100|XEU|3482|5671|lyfalmen|||00|25|0|0,0000|Aspen Europe GmbH|Aspen Europe GmbH|Merkaptópúrín||3482||3482|5671| 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3917|5653|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3917||3917|5653| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1,5|0|0|E|0|MYL|0|0|0|100|SEK|3010|5025|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3010|5025| 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|9924|14483|lyfalmen|||00|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||9924||9924|14483| 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|1038|2327|lyfalmen|||00|100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1038||1038|2327| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|958|2218|lyfalmen|V0314|2218|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||958|2218| 164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|7353|10966|lyfalmen|V0014|10966|98|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7353||7353|10966| 165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eţ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|6966|13548|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||6966||6966|13548| 165431|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4510|7077|lyfalmen|||43|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4510||4510|7077| 165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5093|7874|lyfalmen|V0059|3893|43|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5093||5093|7874| 165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3287|5404|lyfalmen|V0058|2785|43|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3287||3287|5404| 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|267670|337808|lyfsjukr|||00|8|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||267670||267670|337808| 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|36322|47467|lyfsjukr|||00|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||36322||36322|47467| 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|52886|68254|lyfsjukr|||00|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||52886||52886|68254| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|705|1872|lyfalmen|||00|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||705||705|1872| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|204|1186|lyfalmen|||00|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||204||204|1186| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4139|5974|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4139||4139|5974| 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|70553|90427|lyfsjukr|||00|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||70553||70553|90427| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|239164|302033|lyfsjukr|||00|500|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||239164||239164|302033| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|0||3|g|20|spr||QJ51RC22|01.02.2010||R|A||0|0|0|0|INI|0|0|0|100|DKK|4724|9243|vetalmen|||16|60|0||Icepharma hf|Intervet International B.V.|||||4724|9243| 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007|31.01.2012|R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|1049|2342|lyfalmen|||00|10|0|1,0000|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||1049||1049|2342| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|1896|3501|lyfalmen|||00|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1896||1896|3501| 166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PER|0|0|0|100|DKK|15340|21611|lyfalmen|||23|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15340||15340|21611| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2231|3959|lyfalmen|||10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2231||2231|3959| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|4223|6684|lyfalmen|V0428|6684|10|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4223||4223|6684| 166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|4921|7639|lyfalmen|V0550|7639|00|90|0|120,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||4921||4921|7639| 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|A||0|1|0|0|IPI|0|0|0|100|DKK|134971|171748|lyfalmen|||02|1|0||Icepharma hf|Pfizer Limited|Clostridíum||||134971|171748| 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||| 167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|453|1527|lyfalmen|V0333|1527|00|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||453||453|1527| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|629|1768|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||629|1768| 168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|IKR|4762|6926|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||4400||4400|6926| 168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3081|5122|lyfalmen|V0433|5122|10|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3081||3081|5122| 168761|C07AB0209|Metoprolol Actavis|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2698|4263|lyfalmen|V0050|4263|00|98|0|62,0700|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2453||2453|4263| 168815|N03AF0105|Tegretol Retard|forđatfl|400|mg|30|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1210|2563|lyfalmen|||10|30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1210||1210|2563| 168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5687|8687|lyfalmen|V0240|8686|10|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5687||5687|8687| 168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|54228|69939|lyfsjukr|||00|10|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||54228||54228|69939| 169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|235775|297780|lyfsjukr|||00|50|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||235775||235775|297780| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|21908|29377|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||21908||21908|29377| 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5387|8277|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5387||5387|8277| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|1407|2755|lyfalmen|V0124|2755|67|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2755| 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|2450|4125|lyfalmen|V0125|4125|67|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4125| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2505|lyfalmen|V0411|2505|00|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2505| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1792|lyfalmen|V0177|1792|00|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1792| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1780|lyfalmen|V0418|1780|00|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1780| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1445|lyfalmen|V0176|1445|00|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1445| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2967|4966|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||2967||2967|4966| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3193|5275|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3193||3193|5275| 170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|24525|32661|lyfsjukr|||00|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||24525|32661| 170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|60869|78273|lyfsjukr|||00|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||60869|78273| 170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5791|8829|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5791||5791|8829| 170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|115055|146277|lyfsjukr|||00|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||115055||115055|146277| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|DKK|3938|6294|lyfalmen|||59|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3938||3938|6294| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|DKK|6893|10337|lyfalmen|||59|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6893||6893|10337| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2427|4227|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||2427||2427|4227| 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl|.|J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|11519|16339|lyfsjukr|||00|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11519||11519|16339| 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|27710|36659|lyfsjukr|||00|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||27710||27710|36659| 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|41565|54047|lyfsjukr|||00|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||41565||41565|54047| 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|3383|4260|lyfalmen|V0203|4260|00|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2451||2451|4260| 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|A||0|0|E|0|POF|0|0|0|100|IKR|12363|4326|lyfalmen|V0207|4326|00|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2499||2499|4326| 170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|A||0|1|0|1|CEE|0|0|0|100|XEU|58016|74693|lyfsjukr|||00|4|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|Azasitidín||58016||58016|74693| 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|A||0|0|0|0|DEC|1|0|0|100|DKK|2131|4239|vetalmen|||13|25|0||Vistor hf|Dechra Veterinary Products A/S|||2131||2131|4239| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3678|5939|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3678||3678|5939| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3962|6327|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3962||3962|6327| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|NOK|1558|3039|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|||1558||1558|3039| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4489|7048|lyfalmen|V0247|3950|00|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4489||4489|7048| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|7390|11017|lyfalmen|V0248|6037|00|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7390||7390|11017| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|42710|55484|lyfsjukr|||02|75|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||42710||42710|55484| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|28474|37617|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||28474||28474|37617| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|13346|19109|lyfalmen|V0249|10130|00|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13346||13346|19109| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|25047|33793|lyfalmen|||00|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||25047||25047|33793| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|65489|84071|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||65489||65489|84071| 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|30240|29885|lyfalmen|V0346|29885|00|112|0|74,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||21933||21933|29885| 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|1|*|0|AUG|0|0|0|100|XEU|3517|5718|lyfalmen|||00|100|0|0,0000|Aspen Europe GmbH|Aspen Europe GmbH|Búsúlfan||3517||3517|5718| 172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|11685|16892|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||11685||11685|16892| 172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|6424|9695|lyfalmen|||10|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6424||6424|9695| 172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|11934|17232|lyfalmen|||10|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11934||11934|17232| 172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|20705|28344|lyfalmen|||10|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||20705||20705|28344| 172767|J07AJ5204|DiTeKik|bóluefni|||0,5|ml|1|hgl||J07AJ52|01.11.1998|31.12.2011|R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2306|4062|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum međ öđrum toxóíđum||2306||2306|4062| 172775|J07AJ5204|DiTeKik|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998|31.12.2011|R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2306|4062|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum međ öđrum toxóíđum||2306||2306|4062| 172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|IKR|830|2043|lyfalmen|V0207|1442|00|4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2043| 172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|27001|36246|lyfalmen|||10|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||27001||27001|36246| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|433|1500|lyfalmen|||00|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||433||433|1500| 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2896|4869|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||2896||2896|4869| 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3527| 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|6182|9364|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6182||6182|9364| 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|ţpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1050|2344|lyfalmen|||00|10|0|10,0000|Vistor hf|Meda AS|Tenoxíkam||1050||1050|2344| 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|K||0|1|0|1|AMG|0|0|0|100|DKK|16776|22807|lyfsjukr|||00|2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16673||16673|22807| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|355|1393|lyfalmen|||00|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||355||355|1393| 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|2953|4947|lyfalmen|||00|250|1|13,8889|Distica|Distica - óskráđ lyf|Pyridostigmin||2953||2953|4947| 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|12932|18589|lyfalmen|||00|150|1|50,0000|Distica|Distica - óskráđ lyf|Pyridostigmin||12932||12932|18589| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1390|2006|lyfsjukr|||02|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1390||1390|2006| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|678|1835|lyfalmen|||00|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||678||678|1835| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|693|1855|lyfalmen|||00|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||693||693|1855| 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|1791|3357|lyfalmen|V0368|2697|00|5|0|25,0000|Vistor hf|Allergan|Brímónidín||1791||1791|3357| 174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|262|1266|lyfalmen|V0312|1260|00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||262|1266| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5251|8090|lyfalmen|V0368|8090|00|15|0|75,0000|Vistor hf|Allergan|Brímónidín||5251||5251|8090| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2562|2645|lyfalmen|V0033|2604|00|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||1270||1270|2645| 176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|6681|4920|lyfalmen|V0278|2595|00|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2933||2933|4920| 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|819|2028|lyfalmen|||43|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||819||819|2028| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|723|1896|lyfalmen|||03|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1896| 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK|168536|213395|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||168536||168536|213395| 179171|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.02.2012||R|A||1|0|0|1|AGP|0|0|0|100|XEU|5311|7665|lyfsjukr|||00|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5311||5311|7665| 179333|R02AA0304|Strepsils Menthol|sogtfl|||24|stk|1|ţpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|A||0|1|0|1|WIL|0|0|0|100|XEU|131150|166476|lyfsjukr|||00|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||131150||131150|166476| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|5658|8647|lyfalmen|||10|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5658||5658|8647| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|805|2009|lyfalmen|||30|5|0|0,0000|Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||805||805|2009| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||23|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|8126|15776|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer vet.|||8126||8126|15776| 181750|L01BA0105|Methotrexate Wyeth Lederle|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|9879|14258|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||9879||9879|14258| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|SEK|5901|11503|vetalmen|||16|100|0|0,0000|Vistor hf|Intervet International BV|||5901||5901|11503| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5448|10634|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||5448||5448|10634| 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|A||0|0|B|0|ALK|0|0|1|100|DKK|5849|8909|lyfalmen|||00|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5849|8909| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1201|2550|lyfalmen|||00|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1201||1201|2550| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|ţpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|833|2047|lyfalmen|||41|21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||833||833|2047| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|493|1582|lyfalmen|||08|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||493||493|1582| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1643|2050|lyfalmen|||08|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2050| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|625|1762|lyfalmen|||00|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||625||625|1762| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|4949|7677|lyfalmen|V0017|7322|98|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4949||4949|7677| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|21955|29913|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||21955||21955|29913| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|55797|72385|lyfalmen|V0185|58846|00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||55797||55797|72385| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|1190|2535|lyfalmen|||00|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1190||1190|2535| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|5352|8229|lyfalmen|V0235|7807|00|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5352||5352|8229| 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5338|8209|lyfalmen|||00|100|1|20,0000|Distica|Distica - óskráđ lyf|||5338||5338|8209| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2955|4950|lyfalmen|||00|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2955||2955|4950| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|USD|2033|3688|lyfalmen|||00|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíđ||2033||2033|3688| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7234|10440|lyfsjukr|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7234||7234|10440| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|2520|4355|lyfalmen|||03|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2520||2520|4355| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1038|2327|lyfalmen|V0413|2327|03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1038||1038|2327| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|502|1594|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||502||502|1594| 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|A||0|1|0|1|PER|0|0|0|100|DKK|465|671|lyfsjukr|||02|1|0||Icepharma hf|Pfizer ApS|Metótrexat||465||465|671| 190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|1008|2286|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1008||1008|2286| 191064|B05XC03|Vitalipid Infant|irţ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|3902|5632|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3902||3902|5632| 191247|B05XC02|Vitalipid Adult|irţ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|3718|5366|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3718||3718|5366| 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|3836|5536|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3836||3836|5536| 191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A||0|0|E|0|PER|0|0|1|100|DKK|527|1628|lyfalmen|||07|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||527||527|1628| 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|A||0|0|B|0|AGP|0|1|0|100|XEU|3862|6190|lyfalmen|||00|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3862||3862|6190| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1623|3128|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1623||1623|3128| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|452|1526|lyfalmen|||10|25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||452||452|1526| 193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2162| 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972|31.01.2012|R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|873|2102|lyfalmen|||02|50|0|2,5091|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||873||873|2102| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|1075|1551|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||1075||1075|1551| 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2077|3749|lyfalmen|||00|100|0|16,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2077||2077|3749| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1843|3428|lyfalmen|||00|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1843||1843|3428| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2496|4322|lyfalmen|V0390|4322|03|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2496||2496|4322| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|793|1992|lyfalmen|V0390|864|03|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||793||793|1992| 195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|13807|15943|lyfalmen|V0012|7489|00|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||10991||10991|15943| 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|89223|113857|lyfsjukr|||00|2|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||89223||89223|113857| 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK|168536|213395|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||168536||168536|213395| 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|759|1946|lyfalmen|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur||759||759|1946| 195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|389|1439|lyfalmen|||10|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||389||389|1439| 195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|824|2035|lyfalmen|||10|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||824||824|2035| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|2355|4129|lyfalmen|||00|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2355||2355|4129| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1467|2914|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1467||1467|2914| 196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26845|35573|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||26845|35573| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2582|5130|vetalmen|||27|10|0|0,0000|Icepharma hf|Intervet International B.V.|||2582||2582|5130| 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986|31.12.2011|R|A|5|0|0|0|0|INI|1|0|0|100|DKK|12251|23696|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||12251||12251|23696| 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|LTH|0|0|0|100|DKK|769|1959|lyfalmen|||06|10|0|0,0000|Vistor hf|Laboratoires THEA|Nafazólín í blöndum međ öđrum efnum||769||769|1959| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|860|2084|lyfalmen|||00|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||860||860|2084| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2815|4758|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2815||2815|4758| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2179|3888|lyfalmen|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2179||2179|3888| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|AUG|0|0|0|100|XEU|2125|3814|lyfalmen|||00|25|0|0,0000|Aspen Europe GmbH|Aspen Europe GmbH|Melphalan||2125||2125|3814| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|7205|10399|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Pfizer ApS|Flúóróúracíl||7205||7205|10399| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|409|590|lyfsjukr|||02|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||409||409|590| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|36206|47798|lyfalmen|||00|100|0|0,0000|Icepharma hf|Pfizer ApS|Estramústín||36206||36206|47798| 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|IKR|9134|12653|lyfalmen|V0515|12275|00|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||8586||8586|12653| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PER|0|0|1|100|DKK|635|1776|lyfalmen|||00|30|0|7,5000|Icepharma hf|Pfizer ApS|Tríazólam||635||635|1776| 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|94553|120547|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||94553|120547| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|4688|7320|lyfalmen|V0126|7320|44|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4688||4688|7320| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|JAB|0|0|0|100|XEU|56407|72673|lyfsjukr|||00|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||56407||56407|72673| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5405|8127|lyfalmen|||00|60|1|12,0000|Distica|Distica - óskráđ lyf|||5278||5278|8127| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|677|977|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||677||677|977| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|589|850|lyfsjukr|||03|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||589||589|850| 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||9907| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|ţpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|1776|3337|lyfalmen|||00|30|0|3,7500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||1776||1776|3337| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|6350|9594|lyfalmen|V0288|9592|00|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||6350||6350|9594| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3673|5932|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3673||3673|5932| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2519|4353|lyfalmen|||23|66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2519||2519|4353| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|19103|26334|lyfalmen|V0289|26332|00|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||19103||19103|26334| 373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4140|6571|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4140||4140|6571| 373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|6839|10263|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6839||6839|10263| 373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|9440|13821|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9440||9440|13821| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|1587|3078|lyfalmen|V0126|1830|44|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1587||1587|3078| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|SEK|686|1846|lyfalmen|V0500|1590|00|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||686||686|1846| 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|5757|8309|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5757||5757|8309| 374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|4612|7216|lyfalmen|||00|30|0|30,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4612||4612|7216| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|11548|16704|lyfalmen|||00|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11548||11548|16704| 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|9008|13230|lyfalmen|||00|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9008||9008|13230| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|10691|15532|lyfalmen|||00|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10691||10691|15532| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|12491|18036|lyfalmen|||00|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12491||12491|18036| 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|31131|41429|lyfalmen|V0459|41429|00|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||31131||31131|41429| 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|20381|27938|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||20381||20381|27938| 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|93388|119561|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||93388||93388|119561| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4306|6798|lyfalmen|||63|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4306||4306|6798| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|11185|10434|lyfalmen|V0182|10234|00|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6964||6964|10434| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|115485|146816|lyfsjukr|||00|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||115485||115485|146816| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|162712|206086|lyfsjukr|||00|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||162712||162712|206086| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|206012|260428|lyfsjukr|||00|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||206012||206012|260428| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1516|2981|lyfalmen|||00|12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1516||1516|2981| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1874|3471|lyfalmen|||00|12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1874||1874|3471| 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5614|8587|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5614||5614|8587| 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|7638|7735|lyfalmen|V0143|7735|00|12|0|12,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||4991||4991|7735| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7009|10495|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7009||7009|10495| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1292|2254|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1292|2254| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|7783|13577|vetorma|||00|20|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||7783||7783|13577| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 383990|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.11.2011|31.01.2012|R|A||0|0|0|0|NOB|1|0|0|100|XEU|3735|7344|vetalmen|||16|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3735||3735|7344| 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6182|7052|lyfalmen|||00|8|0|16,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||4492||4492|7052|31.01.2012 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|57873|74990|lyfalmen|V0184|38270|00|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||57873||57873|74990| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|734|1460|vetalmen|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||734||734|1460| 387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|CEP|0|0|0|100|DKK|201935|255311|lyfsjukr|||00|200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||201935||201935|255311| 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3332|5465|lyfalmen|||00|25|0|5,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||3332||3332|5465| 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|4200|6653|lyfalmen|||00|30|0|30,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||4200||4200|6653| 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|8149|12055|lyfalmen|||23|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||8149||8149|12055| 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|A|2|0|0|E|0|APC|0|0|0|100|IKR|805|1887|lyfalmen|V0466|1887|00|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||716||716|1887| 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2391|4178|lyfalmen|V0410|4178|23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2391||2391|4178| 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2184|3895|lyfalmen|||23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2184||2184|3895| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|693|1855|lyfalmen|V0128|1855|00|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||693||693|1855| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|641|1784|lyfalmen|||00|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||641||641|1784| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|977|2244|lyfalmen|V0367|1318|00|3|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||977||977|2244| 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|2702|3791|lyfalmen|V0143|2578|00|4|0|4,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2108||2108|3791| 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|5241|3502|lyfalmen|V0267|3502|00|100|0|7,2000|Lyfis ehf|Lyfis ehf|Pramipexól||1897||1897|3502| 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|K||0|1|E|0|MSE|0|0|0|100|SEK|58415|75670|lyfalmen|||00|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||58415||58415|75670| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|2945|4936|lyfalmen|||01|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2945||2945|4936| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|7058|10562|lyfalmen|V0429|10561|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7058||7058|10562| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|2788|4721|lyfalmen|V0037|4721|00|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2788||2788|4721| 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|K||0|1|E|0|MSE|0|0|0|100|SEK|30376|40481|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||30376||30376|40481| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|13601|19429|lyfalmen|V0196|19427|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13601||13601|19429| 391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2683|4578|lyfalmen|||00|50|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2683||2683|4578| 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|239164|302033|lyfsjukr|||00|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||239164||239164|302033| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|fl||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17419|lyfalmen|||00|50|1|2,5000|Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17419| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|DKK|5668|11056|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5668||5668|11056| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|A||0|0|B|0|LYF|0|1|0|100|XEU|4763|6326|lyfalmen|V0327|6326|00|100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3961||3961|6326| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|K||0|1|0|1|AMG|0|0|0|100|DKK|149955|188903|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||149020||149020|188903| 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|SEK|28075|37095|lyfalmen|V0356|37095|00|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27678||27678|37095| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|170841|216288|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||170841||170841|216288| 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|K||0|1|0|1|MKA|0|0|0|100|SEK|36447|47623|lyfsjukr|||00|20|0||Icepharma hf|Merck KgaA|Cetúxímab||36447||36447|47623| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|9984|14409|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche|Capecitabín||9984||9984|14409| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|57245|73725|lyfsjukr|||00|120|0|0,0000|Icepharma hf|Roche|Capecitabín||57245||57245|73725| 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|A||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||00|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||| 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|7675|9534|lyfalmen|V0012|4280|00|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||6306||6306|9534| 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|3544|3163|lyfalmen|V0009|3163|00|28|0|28,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||1649||1649|3163| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3253|lyfalmen|V0244|3253|00|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1715||1715|3253| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|9101|13357|lyfalmen|||02|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9101||9101|13357| 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|40698|52958|lyfsjukr|||00|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||40698||40698|52958| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1495|2952|lyfalmen|||06|8|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1495||1495|2952| 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5197|8017|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5197||5197|8017| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|225|1215|lyfalmen|||00|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||225||225|1215| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|409|1467|lyfalmen|||00|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||409||409|1467| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|195|1174|lyfalmen|||00|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||195||195|1174| 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|10756|15621|lyfalmen|V0459|13810|00|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||10756||10756|15621| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|765|1954|lyfalmen|||00|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||765||765|1954| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1224|2582|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1224||1224|2582| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|1200|2549|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1200||1200|2549| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|1927|3543|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1927||1927|3543| 402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|AHP|0|0|0|100|XEU|657|1806|lyfalmen|||51|0|0|0,0000|Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||657||657|1806| 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1685|3352|vetalmen|||58|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1685||1685|3352| 403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|20745|23674|lyfalmen|V0470|23674|00|100|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||16984||16984|23674| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5183|10125|vetalmen|||27|20|0|0,0000|Vistor hf|Intervet International BV|||5183||5183|10125| 403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5919|9004|lyfalmen|||10|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||5919||5919|9004| 403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|A||0|1|0|1|PER|0|0|0|100|DKK|37290|48681|lyfsjukr|||00|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||37290|48681| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1427|2859|lyfalmen|||06|14|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1427||1427|2859| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0,0000|Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1791| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|65680|84311|lyfsjukr|||02|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||65680||65680|84311| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|690|996|lyfsjukr|||02|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||690||690|996| 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|K||0|0|0|0|AEL|1|0|0|100|XEU|8180|15879|vetalmen|||00|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8180||8180|15879| 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1798|3367|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1798||1798|3367| 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|19165|26411|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||19165||19165|26411| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|18280|25301|lyfalmen|||00|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18280||18280|25301| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20855|28532|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20855||20855|28532| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|22858|31046|lyfalmen|||00|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22858||22858|31046| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20619|28236|lyfalmen|||00|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20619||20619|28236| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|62169|80381|lyfalmen|||00|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||62169||62169|80381| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|72980|93949|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||72980||72980|93949| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|82744|106203|lyfalmen|||00|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||82744||82744|106203| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|6310|9539|lyfalmen|||00|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6310||6310|9539| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2195|3910|lyfalmen|||00|100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2195||2195|3910| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|1|100|DKK|169|1139|lyfalmen|||00|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||169||169|1139| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|0|100|DKK|367|1409|lyfalmen|||00|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||367||367|1409| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2896|4869|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2896||2896|4869| 408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2270|4013|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2270||2270|4013| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|4308|6800|lyfalmen|||08|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4308||4308|6800| 409326|N05CD0307|Flunipam|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.2011|31.01.2012|R|A||1|0|0|0|MYL|0|0|0|100|NOK|522|1621|lyfalmen|||00|30|1|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||522||522|1621| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3747|6033|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3747||3747|6033| 409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4255|6728|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4255||4255|6728| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|12547|18106|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12547||12547|18106| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|2992|5000|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2992||2992|5000| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PAB|1|0|0|100|DKK|10678|20676|vetalmen|||27|120|0|0,0000|Vistor hf|Pharmaxim AB|||10678||10678|20676| 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|10167|14815|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10167||10167|14815| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1141|2468|lyfalmen|||00|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1141||1141|2468| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|779|1973|lyfalmen|||23|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Tretínóín||779||779|1973| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|682|1840|lyfalmen|||00|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||682||682|1840| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|4915|7094|lyfsjukr|||02|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4915||4915|7094| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|25473|33851|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||25473||25473|33851| 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|ţpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1560|3041|lyfalmen|||67|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1560||1560|3041| 411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7452|11101|lyfalmen|||98|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7452||7452|11101| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.01.1990||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|22800|30973|lyfalmen|V0183|30972|00|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||22800||22800|30973| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3751|5414|lyfsjukr|||00|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3751||3751|5414| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|8594|16674|vetalmen|||02|100|0|0,0000|Vistor hf|Merial|||8594||8594|16674| 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|K||0|1|0|1|BIB|0|0|0|100|XEU|128744|163456|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||128744||128744|163456| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|3427|5595|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3427||3427|5595| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|A||0|0|*|0|MYL|0|0|0|100|SEK|4209|6665|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4209||4209|6665| 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|A||0|0|E|0|WIH|0|0|0|100|XEU|28638|34305|lyfalmen|V0342|34258|00|98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||25455||25455|34305| 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|DKK|2160|3862|lyfalmen|||00|2|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|||2160||2160|3862| 414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|3839|6159|lyfalmen|||00|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||3839||3839|6159| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1332|2729|lyfalmen|||00|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1332||1332|2729| 415556|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|14998|21119|lyfalmen|V0034|18454|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||14948||14948|21119| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1914|3526|lyfalmen|||05|15|0|15,0000|Vistor hf|Novo-Nordisk|Estradíól||1914||1914|3526| 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|A||0|0|0|0|PSA|0|0|0|100|DKK|14301|20307|lyfalmen|V0253|20307|00|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||14301||14301|20307| 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|9573|9545|lyfalmen|V0088|4254|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6314||6314|9545| 416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|4202|6101|lyfalmen|V0005|2130|00|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||3797||3797|6101| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5104|7889|lyfalmen|||00|300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||5104||5104|7889| 416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|4943|7134|lyfsjukr|||00|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4943||4943|7134| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|2910|4888|lyfalmen|||23|10|0|205,4500|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2910||2910|4888| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|DKK|26207|35249|lyfalmen|||23|150|0|3081,8200|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||26207||26207|35249| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1235|2597|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1235||1235|2597| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|41694|54208|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||41694||41694|54208| 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|A||0|0|E|0|BII|0|0|0|100|DKK|34539|45706|lyfalmen|V0460|45706|00|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||34539|45706| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4851|7543|lyfalmen|||10|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4851||4851|7543| 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1614|3115|lyfalmen|||20|50|0|50,0000|Vistor hf|Schering-Plough|Betametasón||1614||1614|3115| 418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|7390|11017|lyfalmen|V0014|10966|00|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7390||7390|11017| 418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|23751|27463|lyfalmen|V0475|27463|00|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||20003||20003|27463| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2063|4104|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2063||2063|4104| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2677|5313|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2677||2677|5313| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3355|5497|lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3355||3355|5497| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7173|10720|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7173||7173|10720| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|DKK|52668|67981|lyfsjukr|||00|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||52668||52668|67981| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|39966|52040|lyfsjukr|||00|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||39966||39966|52040| 419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|842|2059|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||842||842|2059| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|12160|17620|lyfalmen|||02|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12160||12160|17620| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1525|2993|lyfalmen|V0036|2992|70|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1525||1525|2993| 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1520|2987|lyfalmen|V0051|2273|00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1520||1520|2987| 422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3473|5333|lyfalmen|V0050|4263|43|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3235||3235|5333| 422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5985|9095|lyfalmen|||43|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||5985||5985|9095| 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|A|2|0|1|0|1|CSB|0|0|0|100|SEK|73652|94316|lyfsjukr|||63|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||73652||73652|94316| 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979|31.12.2011|R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|4685|7316|lyfalmen|||49|100|0|50,0000|Vistor hf|Meda AS|Brómókriptín||4685||4685|7316| 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6828|5000|lyfalmen|V0011|3936|0|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2992||2992|5000| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|1635|2852|vetorma|||16|24|0|0,0000|Icepharma hf|Intervet International B.V.|||||1635|2852| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|810|2015|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||810||810|2015| 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|ţpakki||N04BC01|01.11.1979|31.12.2011|R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|18420|25477|lyfalmen|||52|100|0|25,0000|Vistor hf|Meda AS|Brómókriptín||18420||18420|25477| 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|A||1|1|0|1|RBP|0|0|0|100|DKK|4813|6902|lyfsjukr|||00|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4782||4782|6902| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|678|1835|lyfalmen|||00|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||678||678|1835| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|885|2118|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||885||885|2118| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2667| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|867|2093|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||867||867|2093| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1018|2300|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1018||1018|2300| 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|49689|64242|lyfsjukr|||00|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||49689||49689|64242| 428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|6185|3174|lyfalmen|V0113|3174|00|100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1657||1657|3174| 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|27811|27818|lyfalmen|V0344|27818|00|112|0|37,3300|Lyfis ehf|Lyfis ehf|Rívastigmín||20286||20286|27818| 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4252|6724|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4252||4252|6724| 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|41831|54857|lyfalmen|||AC|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||41831||41831|54857| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|4120|6543|lyfalmen|||00|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4120||4120|6543| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1709|2467|lyfsjukr|||02|50|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||1709||1709|2467| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1454|2098|lyfsjukr|||02|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1454||1454|2098| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|4512|8836|vetalmen|||27|100|0|0,0000|Vistor hf|Intervet International BV|||4512||4512|8836| 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|A||0|0|*|0|WIH|0|0|0|100|XEU|29480|38270|lyfalmen|V0184|38270|00|98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||28614||28614|38270| 430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|33862|44856|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||33862||33862|44856| 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|2983|4138|lyfalmen|V0144|4016|00|4|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2362||2362|4138| 430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2467|4282|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2467||2467|4282| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|768|1958|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||768||768|1958| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1169|2506|lyfalmen|||00|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1169||1169|2506| 431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|A||0|1|0|1|AVS|0|0|0|100|NOK|234365|296011|lyfsjukr|||00|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||234365||234365|296011| 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|1426|2858|lyfalmen|||00|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1426|2858| 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|4833|7519|lyfalmen|||00|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4833||4833|7519| 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|A||0|0|E|0|NDR|0|0|0|100|SEK|37768|49758|lyfalmen|||02|12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||37768|49758| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|1156|2489|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1156||1156|2489| 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|A||0|0|0|0|NOB|1|0|0|100|XEU|3732|7339|vetalmen|||16|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3732||3732|7339| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11151|16161|lyfalmen|||0|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11151||11151|16161| 433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2608|4475|lyfalmen|||00|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2608||2608|4475| 433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|5709|8717|lyfalmen|||00|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5709||5709|8717| 433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|8714|12828|lyfalmen|||00|28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8714||8714|12828| 433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|621|1757|lyfalmen|||00|7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||621||621|1757|31.01.2012 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|1145|1997|vetorma|||99|10|0|0,0000|Icepharma hf|Intervet International B.V.|||||1145|1997| 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|MCS|0|0|1|100|SEK|901|2140|lyfalmen|||20|50|0|50,0000|Vistor hf|McNeil Sweden AB|Blöndur||901||901|2140| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|MEB|0|0|1|100|DKK|5849|8909|lyfalmen|||00|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5849||5849|8909| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|MEB|0|0|1|100|DKK|5849|8909|lyfalmen|||00|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5849||5849|8909| 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|XEU|10343|15056|lyfalmen|V0315|5683|00|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10343||10343|15056| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6743|10131|lyfalmen|||00|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6743||6743|10131| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4679|7308|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4679||4679|7308| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|8321|10837|lyfalmen|V0284|9238|00|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7259||7259|10837| 435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|3404|5564|lyfalmen|V0284|5543|00|60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||3404||3404|5564| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2815|4758|lyfalmen|||00|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2815||2815|4758| 436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|238086|300680|lyfsjukr|||02|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||238086||238086|300680| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3567|5787|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3567||3567|5787| 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9897|14446|lyfalmen|V0090|5207|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||9897||9897|14446| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|747|1929|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||747||747|1929| 436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|244164|308308|lyfsjukr|||02|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||244164||244164|308308| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|961|2222|lyfalmen|||00|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||961||961|2222| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3517|5718|lyfalmen|||00|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3517||3517|5718| 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|10138|11131|lyfalmen|V0029|10885|00|100|0|100,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||7474||7474|11131| 437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|68436|87770|lyfsjukr|||02|125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||68436||68436|87770| 438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|A||0|1|0|1|BIB|0|0|0|100|XEU|32854|43114|lyfsjukr|||00|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||32854||32854|43114| 438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|6216|9411|lyfalmen|V0265|2397|00|28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6216||6216|9411| 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|742|1922|lyfalmen|||00|20|1|4,0000|Parlogis hf|Parlogis - óskráđ lyf|||742||742|1922| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|1250|2617|lyfalmen|||00|10|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1250||1250|2617| 438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|3256|5361|lyfalmen|V0259|3002|00|28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3256||3256|5361| 438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|11197|16224|lyfalmen|V0334|5997|00|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11197||11197|16224| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|A|4|0|0|0|0|SCP|0|0|1|100|DKK|1897|3502|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1897||1897|3502| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|5972|9077|lyfalmen|V0362|3158|00|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||5972||5972|9077| 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|165934|210130|lyfsjukr|||00|3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||165934||165934|210130| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2765|4690|lyfalmen|||66|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2765||2765|4690| 439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8597|12668|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8597||8597|12668| 439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2366|lyfalmen|||00|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2366| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1493|2155|lyfsjukr|||00|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1493||1493|2155| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2357|3402|lyfsjukr|||00|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2357||2357|3402| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|933|2184|lyfalmen|V0046|2184|00|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||933||933|2184| 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1263|2635|lyfalmen|||20|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Blöndur||1263||1263|2635| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0,0000|Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1002|2278|lyfalmen|||00|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1002||1002|2278| 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|A||0|0|E|0|BII|0|0|0|100|DKK|11513|16657|lyfalmen|V0460|15235|00|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11513|16657| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3477|5664|lyfalmen|||02|1|0|1,0000|Vistor hf|Novo-Nordisk|Glúkagon||3477||3477|5664| 443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|26506|35624|lyfalmen|||10|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||26506||26506|35624| 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|7675|11406|lyfalmen|||22|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7675||7675|11406| 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|DKK|3151|5218|lyfalmen|V0061|3267|00|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3151||3151|5218| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2294|4045|lyfalmen|||00|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2294||2294|4045| 444927|M05BA0601|Bondronat|irţ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006|31.12.2011|R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|15118|20856|lyfsjukr|||00|2|0|0,3300|Icepharma hf|Roche|Íbandrónsýra||15118||15118|20856| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1600|3096|lyfalmen|||00|30|0|30,0000|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1600||1600|3096| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1458|2900|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||1458||1458|2900| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|10674|15509|lyfalmen|||00|4|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10674||10674|15509| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|6083|9229|lyfalmen|||00|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6083||6083|9229| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|7529|11207|lyfalmen|||00|2|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7529||7529|11207| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|8960|13164|lyfalmen|||00|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8960||8960|13164| 448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|0|0|IGB|0|0|0|100|SEK|635|1776|lyfalmen|||04|10|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||635||635|1776| 448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1240|2604|lyfalmen|||00|30|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1240||1240|2604| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2134|3827|lyfalmen|V0202|3506|00|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2134||2134|3827| 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|A||0|0|0|1|Bru|0|0|0|100|XEU|1154|1666|lyfsjukr|||00|0|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1154||1154|1666| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1401|2824|lyfalmen|||00|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1401||1401|2824| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5590|8068|lyfsjukr|||00|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5590||5590|8068| 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|K||0|0|*|0|ELI|0|0|0|100|XEU|5418|8319|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5418||5418|8319| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2311|lyfalmen|V0169|2296|00|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2311| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|ţpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|879|1682|lyfalmen|V0060|1682|00|20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||566||566|1682| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3052|4026|lyfalmen|V0313|4026|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2280||2280|4026| 450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|7498|13080|vetorma|||16|2|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||7498||7498|13080| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|55008|71394|lyfalmen|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||55008||55008|71394| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|82513|105913|lyfalmen|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||82513||82513|105913| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|110016|140429|lyfalmen|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||110016||110016|140429| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5771|8012|lyfalmen|||00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5194||5194|8012| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|15241|21487|lyfalmen|||00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15241||15241|21487| 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|A||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1171|2509|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1171||1171|2509| 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|K||0|0|0|0|LHS|0|0|0|100|XEU|11234|19597|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11234||11234|19597| 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|11958|17265|lyfalmen|||00|3000|0|3,0000|Vistor hf|Laboratories 3M Santé|Imikvímóđ||11958||11958|17265| 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCC|0|0|0|100|DKK|2363|4140|lyfalmen|||00|90|0|0,0000|Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2363||2363|4140| 452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2396|4185|lyfalmen|||10|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2396||2396|4185| 452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7042|10540|lyfalmen|||10|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7042||7042|10540| 452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|4625|7234|lyfalmen|||10|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4625||4625|7234| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|1484|2589|vetorma|||16|6|0|0,0000|Vistor hf|Merial (MSD)|||||1484|2589| 453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13638|19475|lyfalmen|||10|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||13638||13638|19475| 453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|8852|13016|lyfalmen|||10|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||8852||8852|13016| 453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|24857|33555|lyfalmen|||10|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||24857||24857|33555| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PER|0|1|0|100|DKK|2776|4006|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2776||2776|4006| 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dćla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2314|4073|lyfalmen|||00|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2314||2314|4073| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|15469|21773|lyfalmen|||00|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15469||15469|21773| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|43887|39100|lyfalmen|V0341|31876|00|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||29275||29275|39100| 454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|2433|3948|lyfalmen|||00|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||2223||2223|3948|31.01.2012 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|17365|24152|lyfalmen|||00|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||17365||17365|24152| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|48352|43596|lyfalmen|V0342|34258|00|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||32858||32858|43596| 454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|A||0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||04|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|SKB|0|0|0|100|GBP|53722|69304|lyfsjukr|||00|1|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||53722||53722|69304| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1158|2303|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1158||1158|2303| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|1022|2305|lyfalmen|||00|30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1022||1022|2305| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|3673|5932|lyfalmen|||00|120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3673||3673|5932| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|22116|30115|lyfalmen|||00|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||22116||22116|30115| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|927|2175|lyfalmen|||00|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||927||927|2175| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1049|2342|lyfalmen|||0|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1049||1049|2342| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|2175|3883|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2175||2175|3883| 457119|B05DA0002|Dianeal PD1 Glucose Duo|kviđ.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10052|14498|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||10052||10052|14498| 457242|B05DB0002|Dianeal PD1 Glucose Duo|kviđ.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9799|14142|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||9799||9799|14142| 457291|B05DB0002|Dianeal PD1 Glucose Duo|kviđ.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12395|17438|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12395||12395|17438| 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|805|2009|lyfalmen|V0003|2009|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||805||805|2009| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|CHE|0|0|1|100|SEK|1180|2522|lyfalmen|||00|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1180||1180|2522| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1454|2896|lyfalmen|||43|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1454||1454|2896| 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|ţpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2114|3799|lyfalmen|||43|30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2114||2114|3799| 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|ţpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8743|12867|lyfalmen|V0161|12867|00|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||8743||8743|12867| 458737|B05DA0003|Dianeal PD4 Glucose Duo|kviđ.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12395|17438|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12395||12395|17438| 458778|B05DB0003|Dianeal PD4 Glucose Duo|kviđ.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12395|17438|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12395||12395|17438| 458794|B05DB0003|Dianeal PD4 Glucose Duo|kviđ.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12395|17438|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12395||12395|17438| 458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|24425|33013|lyfalmen|||00|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||24425||24425|33013| 459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|2501|2595|lyfalmen|V0278|2595|00|28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1234||1234|2595| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|864|1247|lyfsjukr|||02|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||864||864|1247| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|1582|2283|lyfsjukr|||02|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1582||1582|2283| 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1449|2890|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||1449||1449|2890|31.01.2012 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1353|2758|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||1353||1353|2758|31.01.2012 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|7675|11406|lyfalmen|||22|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7675||7675|11406| 459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2203|3921|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2203||2203|3921| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4472|7025|lyfalmen|||00|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4472||4472|7025| 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4047|6443|lyfalmen|||51|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4047||4047|6443| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|ţpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|567|1683|lyfalmen|||23|20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||567||567|1683| 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|7172|13944|vetalmen|||16|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7172||7172|13944| 460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|AHP|0|0|0|100|XEU|5637|8618|lyfalmen|||51|5|0|0,0000|Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||5637||5637|8618| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|189|1166|lyfalmen|||00|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||189||189|1166| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|673|1828|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||673||673|1828| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|673|1828|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||673||673|1828| 462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7651|11374|lyfalmen|V0385|11374|56|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7651||7651|11374| 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|12196|17665|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12196||12196|17665| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|6763|13159|vetalmen|||02|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||6763|13159| 463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|9046|13282|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||9046||9046|13282| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5395|10532|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5395||5395|10532| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|LPL|0|1|0|100|DKK|1785|3349|lyfalmen|||00|100|0|8,3333|Swedish Orphan Biovitrum A/S|Lundbeck Pharmaceuticals|Melperón||1785||1785|3349| 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|K||0|0|*|0|APC|0|0|0|100|DKK|4114|6480|lyfalmen|V0376|6480|06|8|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||4074||4074|6480| 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1198|2383|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1198||1198|2383| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1132|2252|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1132||1132|2252| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1213|2413|vetalmen|||27|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1213||1213|2413| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|638|1269|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||638||638|1269| 466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|673|1828|lyfalmen|||10|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||673||673|1828| 466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2083|3757|lyfalmen|||10|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2083||2083|3757| 466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1491|2947|lyfalmen|||10|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1491||1491|2947| 466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|5827|8878|lyfalmen|||10|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5827||5827|8878| 466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2772|4699|lyfalmen|||10|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2772||2772|4699| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|7985|11830|lyfalmen|||10|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7985||7985|11830| 466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|4561|7147|lyfalmen|||10|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4561||4561|7147| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4565|7152|lyfalmen|||64|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4565||4565|7152| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|15403|21213|lyfsjukr|||00|0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||15403||15403|21213| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|23605|31507|lyfsjukr|||00|0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||23605||23605|31507| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|18644|25281|lyfsjukr|||00|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18644||18644|25281| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|30071|39622|lyfsjukr|||00|1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||30071||30071|39622| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|DKK|34168|45240|lyfalmen|||00|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||34168||34168|45240| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|15578|21910|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||15578||15578|21910| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|55927|72071|lyfsjukr|||00|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||55927||55927|72071| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|29661|39584|lyfalmen|||10|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||29661||29661|39584| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|508|733|lyfsjukr|||00|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||508||508|733| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6464|6638|lyfalmen|V0317|4605|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4189||4189|6638| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|386|557|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||386||386|557| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|9412|6320|lyfalmen|V0318|4404|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3957||3957|6320| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|23782|12809|lyfalmen|V0320|7346|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8700||8700|12809| 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|4530|4326|lyfalmen|V0207|4326|00|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2499||2499|4326| 468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|A||0|0|E|0|APC|0|0|0|100|SEK|4463|7013|lyfalmen|V0467|6741|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||4463||4463|7013| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5683|8681|lyfalmen|||00|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5683||5683|8681| 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|7653|11045|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7653||7653|11045| 469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6365|9614|lyfalmen|V0228|9591|00|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6365||6365|9614| 469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|5175|7987|lyfalmen|V0227|7430|00|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5175||5175|7987| 469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3378|5528|lyfalmen|V0226|4843|00|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3378||3378|5528| 470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5925|9012|lyfalmen|||24|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5925||5925|9012| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|7169|10347|lyfsjukr|||02|150|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||7169||7169|10347| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|9569|13810|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||9569||9569|13810| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr|||02|100|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|9560|13797|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||9560||9560|13797| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|13729|19112|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||13729||13729|19112| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|1229|2589|lyfalmen|||68|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1229||1229|2589| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|2143|3738|vetorma|||99|20|0|0,0000|Icepharma hf|Intervet International B.V.|||||2143|3738| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|3346|5485|lyfalmen|||00|100|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3346||3346|5485| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|4802|9393|vetalmen|||27|10|0|0,0000|Vistor hf|Orion Corporation|||4802||4802|9393| 472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2134|3723|lyfalmen|||43|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2058||2058|3723| 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3161|5231|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3161||3161|5231| 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|13916|15520|lyfalmen|V0012|7489|00|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||10682||10682|15520| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|15572|21425|lyfsjukr|||00|400|0|0,4000|Vistor hf|Meda AB|Dextran||15572||15572|21425| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1027|2312|lyfalmen|||00|30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1027||1027|2312| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|36849|48128|lyfsjukr|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||36849||36849|48128| 474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|14522|17447|lyfalmen|V0456|17447|00|28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||12022||12022|17447| 474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1867|3461|lyfalmen|||00|140|0|35,0000|Vistor hf|Schering-Plough|Mómetasón||1867||1867|3461| 474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|S||0|0|0|0|PHM|0|0|0|100|DKK|27878|53703|vetalmen|||02|1200|0|0,0000|Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||27878|53703| 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|805|1180|lyfalmen|V0266|1180|00|30|0|1,0600|Lyfis ehf|Lyfis ehf|Pramipexól||199||199|1180| 475327|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|pakki||N02BE01|01.07.2008|30.11.2011|L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|930|2180|lyfalmen|||00|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||930||930|2180| 475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3203|5289|lyfalmen|V0130|5289|23|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3203||3203|5289| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|286|1299|lyfalmen|||00|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||286||286|1299| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|350|1386|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||350||350|1386| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|977|2244|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||977||977|2244| 475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|3690|5955|lyfalmen|||00|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3690||3690|5955| 475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|4860|7556|lyfalmen|||00|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4860||4860|7556| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5615|8588|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5615||5615|8588| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|6067|9207|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6067||6067|9207| 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|78143|99952|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||78143|99952| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1161|2496|lyfalmen|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1161||1161|2496| 476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|11945|13886|lyfalmen|V0282|13278|00|56|0|56,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||9488||9488|13886| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|5206|8029|lyfalmen|||00|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5206||5206|8029| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|A||0|0|*|0|APC|0|0|0|100|XEU|499|1590|lyfalmen|V0500|1590|00|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||499||499|1590| 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|A||0|1|*|0|WIL|0|0|0|100|XEU|29554|39450|lyfalmen|V0454|39450|00|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||29554||29554|39450| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|ţpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|9916|14472|lyfalmen|||00|98|0|130,6667|Vistor hf|Meda AS|Benazepríl||9916||9916|14472| 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|ţpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|20722|28366|lyfalmen|||00|98|0|261,3333|Vistor hf|Meda AS|Benazepríl||20722||20722|28366| 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|ţpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4204|6658|lyfalmen|||00|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4204||4204|6658| 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|A||0|0|E|0|WIH|0|0|0|100|XEU|26363|31876|lyfalmen|V0341|31876|00|98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||23519||23519|31876| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|12731|18337|lyfalmen|||00|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||12731||12731|18337| 481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|14033|19971|lyfalmen|||00|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14033||14033|19971| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2796|4035|lyfsjukr|||00|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2796||2796|4035| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|4826|6965|lyfsjukr|||00|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4826||4826|6965| 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|K||0|0|*|0|POF|0|0|0|100|DKK|2445|4252|lyfalmen|V0374|4252|06|2|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2445||2445|4252| 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|A||0|0|E|0|AGP|0|0|1|100|XEU|293|1200|lyfalmen|V0055|1200|00|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||214||214|1200| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|57677|74267|lyfsjukr|||00|3|0|83,9552|Vistor hf|Ferring|Triptórelín||57677||57677|74267| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|5993|9105|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5993||5993|9105| 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|K||0|1|0|1|AEU|0|0|0|100|DKK|154369|195616|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||154369||154369|195616| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1384|2801|lyfalmen|||00|300|0|0,0000|Vistor hf|Meda AB (V)|Benzýdamín||1384||1384|2801| 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|A||0|0|E|0|ANS|0|0|1|100|XEU|1251|2619|lyfalmen|||07|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1251||1251|2619| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|SAL|0|0|1|100|USD|477|1560|lyfalmen|||29|5|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||477||477|1560| 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|681|1839|lyfalmen|||29|5|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||681||681|1839| 487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|A||0|0|B|0|LYF|0|1|0|100|XEU|4763|6326|lyfalmen|V0326|6326|00|100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3961||3961|6326| 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|A||0|1|*|0|WIL|0|0|0|100|XEU|33005|43781|lyfalmen|V0453|43781|00|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||33005||33005|43781| 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|ţpakki||J01XE01|01.03.2004|31.12.2011|R|A|3|0|0|0|0|REP|0|0|1|100|SEK|597|1724|lyfalmen|||00|25|0|6,2500|Vistor hf|Recip AB|Nítrófúrantóín||597||597|1724| 487959|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.07.2008|30.11.2011|L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|957|2216|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||957||957|2216| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2659|4545|lyfalmen|V0198|3760|00|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2659||2659|4545| 488114|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.07.2008|31.12.2011|L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1345| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|6336|9575|lyfalmen|||67|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6336||6336|9575| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|11395|16495|lyfalmen|||67|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11395||11395|16495| 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|104163|132607|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||104163|132607| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1170|lyfalmen|V0188|439|67|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1170| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|E|0|NOH|0|0|1|100|IKR|882|1546|lyfalmen|V0188|1318|67|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1546| 490417|G03FB0504|Evorel Sequi|forđapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2393|4181|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2393||2393|4181| 490425|G03FA0104|Evorel Conti|forđapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2522|4357|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2522||2522|4357| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3990|6365|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3990||3990|6365| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10919|10592|lyfalmen|V0112|2456|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7080||7080|10592| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5304|8163|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5304||5304|8163| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|15496|14387|lyfalmen|V0113|3174|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9854||9854|14387| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|19709|17965|lyfalmen|V0114|5976|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12435||12435|17965| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|49794|64374|lyfsjukr|||00|3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||49794||49794|64374| 492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3311|5437|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3311||3311|5437| 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12646|18230|lyfalmen|V0002|7629|00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12646||12646|18230| 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|IKR|31723|40579|lyfalmen|V0516|37405|00|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||30454||30454|40579| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1408|2833|lyfalmen|||00|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1408||1408|2833| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|2488|4311|lyfalmen|||00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2488||2488|4311| 494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|81517|104186|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||81517||81517|104186| 494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|203793|257643|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||203793||203793|257643| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2031|3686|lyfalmen|||00|60|0|60,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2031||2031|3686| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2278|4024|lyfalmen|V0128|1855|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Estradíól||2278||2278|4024| 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3311|5437|lyfalmen|V0410|4178|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3311||3311|5437| 494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1882|3482|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1882||1882|3482| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|18708|25838|lyfalmen|||00|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||18708||18708|25838| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7276|8409|lyfalmen|V0382|6350|02|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5484||5484|8409| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10396|12922|lyfalmen|V0383|9973|02|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8783||8783|12922| 495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2855|4813|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2855||2855|4813| 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|30240|29885|lyfalmen|V0345|29885|00|112|0|56,0000|Lyfis ehf|Lyfis ehf|Rívastigmín||21933||21933|29885| 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4261|8354|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||4261|8354| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|AUG|0|0|0|100|GBP|5937|9029|lyfalmen|||02|100|0|0,8333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||5937||5937|9029| 496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|AUG|0|0|0|100|GBP|1041|2331|lyfalmen|||00|50|0|8,3333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||1041||1041|2331| 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|K||0|1|0|1|SOI|0|0|0|100|DKK|86686|110673|lyfsjukr|||00|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||86686||86686|110673| 496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|AUG|0|0|0|100|GBP|3267|5376|lyfalmen|||00|100|0|33,3333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||3267||3267|5376| 496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|473|1554|lyfalmen|||04|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||473||473|1554| 496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|853|2074|lyfalmen|||00|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||853||853|2074| 497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|3255|5360|lyfalmen|||00|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3255||3255|5360| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|0|0|ACA|0|0|0|100|XEU|342|1375|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||342||342|1375| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|507|1359|lyfalmen|V0448|1359|00|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||330||330|1359| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1054|1846|lyfalmen|V0449|1846|00|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||686||686|1846| 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|1515|2918|lyfalmen|V0369|2918|06|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1470||1470|2918| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1372|2784|lyfalmen|||03|2|0|9,3300|Vistor hf|Schering-Plough|Betametasón||1372||1372|2784| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|17099|23819|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17099||17099|23819| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|18240|25251|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18240||18240|25251| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|22721|30874|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||22721||22721|30874| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|27449|36808|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||27449||27449|36808| 501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2803|4742|lyfalmen|||67|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2803||2803|4742| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3086|5129|lyfalmen|V0434|4404|10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3086||3086|5129| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3009|5024|lyfalmen|||00|100|0|25,0000|Vistor hf|Amdipharm Ltd|Maprótilín||3009||3009|5024| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|30350|39972|lyfsjukr|||00|1|0|27,9851|Vistor hf|Ferring|Triptórelín||30350||30350|39972| 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|6668|7069|lyfalmen|||00|28|0|4,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||4504||4504|7069| 503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|A|3|0|0|0|0|NOH|0|0|1|100|IKR|||lyflausa|||00|20|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak|||||| 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|1665|3185|lyfalmen|V0494|3185|00|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1665||1665|3185| 504191|N02BA5102|Treo|freyđit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2059|3724|lyfalmen|||00|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2059||2059|3724| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1170|2508|lyfalmen|||00|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1170||1170|2508| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8279|12233|lyfalmen|||00|100|0|75,0000|Vistor hf|Amdipharm Ltd|Maprótilín||8279||8279|12233| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|1820|2627|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||1820||1820|2627| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|3634|5245|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||3634||3634|5245| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|8293|11969|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||8293||8293|11969| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2485|4307|lyfalmen|||10|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2485||2485|4307| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|403|1459|lyfalmen|||10|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||403||403|1459| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|664|1158|vetorma|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||664|1158| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2824|4926|vetorma|||16|120|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2824|4926| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|16214|28285|vetorma|||13|1000|0|0,0000|Icepharma hf|Intervet International B.V.|||16214||16214|28285| 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2535|5040|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||2535||2535|5040| 508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2578|4434|lyfalmen|||10|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2578||2578|4434| 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5152|10065|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||5152|10065| 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4132|8107|vetalmen|||0|50|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4132||4132|8107| 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|12784|24720|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||12784||12784|24720| 508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|A||0|1|0|1|SAA|0|0|0|100|NOK|720341|905910|lyfsjukr|||00|15|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||720341||720341|905910| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|9170|13451|lyfalmen|||02|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9170||9170|13451| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2764| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|48387|62608|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||48387||48387|62608| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|16778|22939|lyfsjukr|||00|2|0|12,0000|Icepharma hf|Roche|Epóetín||16778||16778|22939| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|25114|33401|lyfsjukr|||00|2|0|18,0000|Icepharma hf|Roche|Epóetín||25114||25114|33401| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|41195|53582|lyfsjukr|||00|2|0|30,0000|Icepharma hf|Roche|Epóetín||41195||41195|53582| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|81466|104122|lyfsjukr|||00|4|0|60,0000|Icepharma hf|Roche|Epóetín||81466||81466|104122| 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|189154|239271|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||189154|239271| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4194|5486|lyfalmen|V0445|5486|00|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||3347||3347|5486| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|2732|4645|lyfalmen|||00|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2732||2732|4645| 511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|36617|42150|lyfalmen|V0540|42150|00|28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||31706||31706|42150| 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2714|4620|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2714||2714|4620| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|23425|31281|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||23425||23425|31281| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14654|20273|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14654||14654|20273| 512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|A||0|0|B|0|LYF|0|1|0|100|XEU|4763|6326|lyfalmen|V0325|6326|00|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3961||3961|6326| 512608|B05XA3101|Peditrace|irţ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5298|7646|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5298||5298|7646| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|23024|31255|lyfalmen|||22|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23024||23024|31255| 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|2133|4243|vetalmen|||27|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2133||2133|4243| 514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2053|3716|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2053||2053|3716| 514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|A||0|0|B|0|ADG|0|0|0|100|XEU|2106|3788|lyfalmen|||00|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2106||2106|3788| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PER|0|1|0|100|DKK|4452|4264|lyfalmen|||00|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2454||2454|4264| 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|100|0|10,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2511| 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|100|0|20,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2523| 517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|5469|8389|lyfalmen|V0010|8389|00|120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||5469||5469|8389| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|2978|4981|lyfalmen|V0462|3545|00|90|0|11,2500|Vistor hf|Novo-Nordisk|Repaglíníđ||2978||2978|4981| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3243|5344|lyfalmen|V0471|3709|00|90|0|22,5000|Vistor hf|Novo-Nordisk|Repaglíníđ||3243||3243|5344| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3487|5677|lyfalmen|V0472|3983|00|90|0|45,0000|Vistor hf|Novo-Nordisk|Repaglíníđ||3487||3487|5677| 518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|925|2173|lyfalmen|||00|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||925||925|2173| 518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3409|5571|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3409||3409|5571| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2102|3783|lyfalmen|||23|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2102||2102|3783| 518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|12809|18435|lyfalmen|V0286|18435|00|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||12809||12809|18435| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1110|2426|lyfalmen|||08|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1110||1110|2426| 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|A||0|0|0|0|AEG|0|0|1|100|SEK|1662|3181|lyfalmen|||01|100|0|2,5000|GlaxoSmithKline ehf|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1662||1662|3181| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|7320|10921|lyfalmen|V0431|9502|02|2|0|5,7222|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||7320||7320|10921| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|4853|7546|lyfalmen|V0142|7413|00|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4853||4853|7546| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5480|8404|lyfalmen|V0143|2578|00|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5480||5480|8404| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|15442|21739|lyfalmen|V0143|7735|00|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15442||15442|21739| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5878|8948|lyfalmen|V0144|4016|00|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5878||5878|8948| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|16263|22769|lyfalmen|V0144|12047|00|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16263||16263|22769| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1355|2532|lyfalmen|V0056|2532|00|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||1188||1188|2532| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2163|3480|lyfalmen|V0057|3480|00|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||1881||1881|3480| 520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|358|1397|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||358||358|1397| 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|25|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1649| 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|25|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1658| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|32325|42927|lyfalmen|V0269|11980|00|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||32325||32325|42927| 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|11102|15816|lyfsjukr|||00|100|1|0,0000|Distica|Distica - óskráđ lyf|Hýdroxýkarbamíđ||11102||11102|15816| 521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|17667|24531|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||17667||17667|24531| 521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|3038|3709|lyfalmen|V0471|3709|00|90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||2048||2048|3709| 522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8457|16411|vetalmen|||16|320|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||8457||8457|16411| 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2299|4052|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2299||2299|4052| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|187499|237194|lyfsjukr|||00|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||187499||187499|237194| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|SEK|334|1364|lyfalmen|V0055|1200|00|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||334||334|1364| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|SEK|396|1449|lyfalmen|V0225|1437|00|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||396||396|1449| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|DKK|2791|4725|lyfalmen|||00|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2791||2791|4725| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|DKK|398|1452|lyfalmen|||02|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||398||398|1452| 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörđ|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7241|10813|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||7241||7241|10813| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|446|1517|lyfalmen|||00|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||446||446|1517| 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1323| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1263|2635|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1263||1263|2635| 524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|447|1519|lyfalmen|||43|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||447||447|1519| 524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2816|4760|lyfalmen|||43|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2816||2816|4760| 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|0|0|EIS|0|0|0|100|IKR|8619|7381|lyfalmen|V0010|6851|00|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||4732||4732|7381| 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1197| 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1915|3809|vetalmen|||00|1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1915||1915|3809| 525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|878|2108|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||878||878|2108| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|779|1973|lyfalmen|||00|15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||779||779|1973| 525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|A||0|0|0|0|LVR|0|0|0|100|IKR|4621|7229|lyfalmen|V0006|5862|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||4621||4621|7229| 525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1501|2961|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1501||1501|2961| 525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|5003|7751|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5003||5003|7751| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|10921|15847|lyfalmen|||00|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10921||10921|15847| 525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5456|7874|lyfsjukr|||00|1000|0|1,0000|Actavis Group hf|Braun|Kalíumklóríđ||5456||5456|7874| 525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|4967|7169|lyfsjukr|||00|1000|0|1,0000|Actavis Group hf|Braun|Natríumklóríđ||4967||4967|7169| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|4492|7052|lyfalmen|V0435|7052|00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4492||4492|7052| 526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4177|6621|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4177||4177|6621| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|6718|13072|vetalmen|||16|188|0|0,0000|Vistor hf|Intervet International BV|||6718||6718|13072| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3573|5795|lyfalmen|||10|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3573||3573|5795| 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|A||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||00|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|15269|21045|lyfsjukr|||00|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15269||15269|21045| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1262|2634|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Emedastín||1262||1262|2634| 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|SEK|9853|13529|lyfalmen|V0356|12365|00|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9227||9227|13529| 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|A|1,5|0|0|0|0|PAL|0|0|0|100|DKK|4526|8863|vetalmen|||16|72|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4526||4526|8863| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4812|9412|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4812||4812|9412| 529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|69091|88592|lyfsjukr|||00|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||69091||69091|88592| 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|A||0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||00|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6810| 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3125|5182|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3125||3125|5182| 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|6006|8668|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6006||6006|8668| 531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2983|4988|lyfalmen|||43|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2983||2983|4988| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|8259|11920|lyfsjukr|||00|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8259||8259|11920| 532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|20345|17723|lyfalmen|V0187|17723|00|50|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||12242||12242|17723| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|660|1810|lyfalmen|||01|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||660||660|1810| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|349|1385|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||349||349|1385| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1012|2292|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1012||1012|2292| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|280|1290|lyfalmen|||00|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||280||280|1290| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1783|3346|lyfalmen|||00|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1783||1783|3346| 533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|14539|12431|lyfalmen|V0283|12431|00|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||8424||8424|12431| 533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2022|3673|lyfalmen|||43|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2022||2022|3673| 535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||| 535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|3271|3366|lyfalmen|V0279|3366|00|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1797||1797|3366| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6536|9848|lyfalmen|||00|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6536||6536|9848| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|445|1516|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||445||445|1516| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|567|1683|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||567||567|1683| 536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|IKR|12900|18549|lyfalmen|V0115|18549|00|100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||12900||12900|18549| 536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|A||0|1|0|1|BIB|0|0|0|100|XEU|65709|84347|lyfsjukr|||00|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||65709||65709|84347| 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|ţpakki||N04BC01|01.05.1983|31.12.2011|R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|9409|13778|lyfalmen|||52|100|0|12,5000|Vistor hf|Meda AS|Brómókriptín||9409||9409|13778| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|594|1036|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||594|1036| 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|6362|9182|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6362||6362|9182| 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2349| 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|135430|171847|lyfsjukr|||00|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||135430||135430|171847| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10478|15241|lyfalmen|||00|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10478||10478|15241| 539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|8042|11908|lyfalmen|V0285|11885|00|60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||8042||8042|11908| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|222|1211|lyfalmen|||00|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||222||222|1211| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|552|1662|lyfalmen|||00|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||552||552|1662| 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|McNeil Sweden AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|1809|3382|lyfalmen|||23|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1809||1809|3382| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2809|4750|lyfalmen|||00|250|0|250,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2809||2809|4750| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|5927|9015|lyfalmen|V0373|7290|06|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5927||5927|9015| 541060|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2013|3661|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2013||2013|3661| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|9583|14016|lyfalmen|V0199|14016|10|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9583||9583|14016| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|15522|21840|lyfalmen|V0200|21840|10|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15522||15522|21840| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl|.|J01GB03|01.08.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5909|8528|lyfsjukr|||00|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5909||5909|8528| 542803|C08DA0103|Isoptin retard|forđatfl|240|mg|28|stk|1|ţpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1508|2970|lyfalmen|||10|28|0|28,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1508||1508|2970| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4756|7413|lyfalmen|||00|100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7413| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|2929|4914|lyfalmen|||00|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||2929||2929|4914| 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|2227|3095|lyfalmen|V0373|2430|06|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1599||1599|3095| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|A||0|0|*|0|LYF|0|1|0|100|XEU|7416|9274|lyfalmen|V0457|9274|00|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||6116||6116|9274| 543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|A||0|1|0|1|MLD|0|0|0|100|DKK|517607|651479|lyfsjukr|||00|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||517607||517607|651479| 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A|3|0|1|*|0|ASP|0|0|0|100|XEU|13079|18774|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13079||13079|18774| 544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|983|2178|lyfalmen|V0005|532|00|7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||929||929|2178| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|985|2255|lyfalmen|||00|15|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||985||985|2255| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|912|2155|lyfalmen|||00|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||912||912|2155| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|2250|3985|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2250||2250|3985| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|30459|40585|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||30459||30459|40585| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|24557|33178|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||24557||24557|33178| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|30638|40810|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||30638||30638|40810| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|26029|35026|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||26029||26029|35026| 546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|902|2050|lyfalmen|||10|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||835||835|2050| 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|8323|12293|lyfalmen|||00|56|1|37,3333|Parlogis hf|Parlogis - óskráđ lyf|||8323||8323|12293| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4720| 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|3439|2954|lyfalmen|V0004|2130|00|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1496||1496|2954| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10333|14850|lyfsjukr|||00|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10333||10333|14850| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3405|4914|lyfsjukr|||00|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3405||3405|4914| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|7859|11658|lyfalmen|||63|0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||7859||7859|11658| 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|ţpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|5341|8214|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5341||5341|8214| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|ţpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|15372|21651|lyfalmen|||00|84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||15372||15372|21651| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|95278|121456|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||95278||95278|121456| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9528|13941|lyfalmen|||02|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9528||9528|13941| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|141088|178948|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||141088||141088|178948| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2157|3858|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir mótefnavakar||2157||2157|3858| 550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1520| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|11352|11323|lyfalmen|V0280|11323|00|56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||7614||7614|11323| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|10751|15614|lyfalmen|V0235|15614|00|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10751||10751|15614| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1836|3419|lyfalmen|||03|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1836||1836|3419| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3918|6267|lyfalmen|V0198|6267|00|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||3918||3918|6267| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|738|1917|lyfalmen|||00|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1917| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|IKR|2157|2130|lyfalmen|V0466|1887|00|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||894||894|2130| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|IKR|3931|4230|lyfalmen|V0467|3775|00|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||2429||2429|4230| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|1450|2891|lyfalmen|V0003|1005|00|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1450||1450|2891| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3631|2009|lyfalmen|V0003|2009|00|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||805||805|2009| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7648|3948|lyfalmen|V0010|3915|00|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||2223||2223|3948| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BAP|0|0|0|100|SEK|3581|5806|lyfalmen|||63|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3581||3581|5806| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|5053|7820|lyfalmen|||00|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5053||5053|7820| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3316|5443|lyfalmen|||00|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3316||3316|5443| 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3124|5181|lyfalmen|V0241|3814|00|50|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3124||3124|5181| 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PER|0|0|0|100|DKK|12095|17539|lyfalmen|V0237|17539|00|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12095|17539| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|4137|6567|lyfalmen|V0237|5846|00|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4137||4137|6567| 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7667|14894|vetalmen|||27|500|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||7667||7667|14894| 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|26789|35503|lyfsjukr|||00|1|0|9,0070|Icepharma hf|E. Merck AB|Sómatrópín||26789||26789|35503| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|4913|7628|lyfalmen|V0241|7628|00|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4913||4913|7628| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6682|10048|lyfalmen|V0242|7005|00|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6682||6682|10048| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|9578|14010|lyfalmen|V0242|14010|00|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9578||9578|14010| 557546|D10AF0202|Zineryt|áburđur|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1606|3104|lyfalmen|||38|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1606||1606|3104| 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|282812|356812|lyfsjukr|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||282812|356812| 559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|853|2074|lyfalmen|||10|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||853||853|2074| 559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1958|3586|lyfalmen|||10|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1958||1958|3586| 559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|665|1817|lyfalmen|||04|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||665||665|1817| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1572|3058|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1572||1572|3058| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5769|8799|lyfalmen|||23|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5769||5769|8799| 559963|C01DA0201|Discotrine|forđapl|5|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994|31.12.2011|R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2722|4631|lyfalmen|||23|30|0|30,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2722||2722|4631| 559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3508|5706|lyfalmen|||23|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3508||3508|5706| 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|SEK|13291|18563|lyfsjukr|||00|240|0|0,0000|Icepharma hf|Baxter|Desflúran||13291||13291|18563| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1353| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3078|5118|lyfalmen|||00|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3078||3078|5118| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||20|2|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1532|3003|lyfalmen|||07|4|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1532||1532|3003| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5867|8933|lyfalmen|||00|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5867||5867|8933| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6362|9610|lyfalmen|||00|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6362||6362|9610| 560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|100999|128636|lyfsjukr|||00|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||100999||100999|128636| 560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|467090|544419|lyfsjukr|||00|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||432300||432300|544419| 561145|N03AX2101|Trobalt|filmhtfl|150|mg|63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|5685|8684|lyfalmen|||00|63|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5685||5685|8684| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1726|3268|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1726||1726|3268| 562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|A||0|0|B|0|APC|0|0|0|100|XEU|2512|4344|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2512||2512|4344| 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|K||0|1|0|1|GGL|0|0|0|100|GBP|103059|131222|lyfsjukr|||00|1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||103059||103059|131222| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|21324|29121|lyfalmen|V0431|28505|02|6|0|17,1667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||21324||21324|29121| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|35976|47509|lyfalmen|V0431|47509|02|10|0|28,6111|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||35976||35976|47509| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|758|1944|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||758||758|1944| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A||0|0|B|0|GSK|0|0|1|100|GBP|685|1844|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||685||685|1844| 563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1392|2812|lyfalmen|||10|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1392||1392|2812| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|207417|262668|lyfalmen|||02|60|0|171,6667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||207417||207417|262668| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3601|5833|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3601||3601|5833| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3733|6014|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3733||3733|6014| 563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|11431|19941|vetorma|||00|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||11431||11431|19941| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|82502|105423|lyfsjukr|||00|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||82502||82502|105423| 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||01|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|11638|16828|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11638||11638|16828| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1409|2835|lyfalmen|V0444|2198|06|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1409||1409|2835| 566661|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|74379|95228|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||74379||74379|95228| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|2248|3983|lyfalmen|||00|100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2248||2248|3983| 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|A||0|1|0|1|GGL|0|0|0|100|GBP|207989|262909|lyfsjukr|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||207989||207989|262909| 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|A||0|0|B|0|ALK|0|0|1|100|DKK|5849|8909|lyfalmen|||00|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5849|8909| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|3369|5516|lyfalmen|V0291|3301|00|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3369||3369|5516| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6820|10237|lyfalmen|V0292|5494|00|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6820||6820|10237| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9968|14543|lyfalmen|V0293|8107|00|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||9968||9968|14543| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13090|18787|lyfalmen|V0294|10395|00|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13090||13090|18787| 567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||24|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1101|2413|lyfalmen|||00|3|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1101||1101|2413| 568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|XEU|1414|2842|lyfalmen|V0058|2842|10|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1414||1414|2842| 568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|XEU|2240|3972|lyfalmen|V0059|3972|10|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2240||2240|3972| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|17321|23620|lyfsjukr|||02|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||17321||17321|23620| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|19916|26877|lyfsjukr|||02|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||19916||19916|26877| 569897|J07AJ5204|DiTeKik|bóluefni|||0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998|31.12.2011|R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2306|4062|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum međ öđrum toxóíđum||2306||2306|4062| 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|IKR|16141|21402|lyfalmen|V0253|20307|00|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||15173||15173|21402| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|160433|203226|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||160433||160433|203226| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|190365|240791|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||190365||190365|240791| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|400875|504981|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||400875||400875|504981| 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|10465|6888|lyfalmen|V0011|6888|00|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||4372||4372|6888| 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|5300|8158|lyfalmen|V0245|8158|00|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||5300||5300|8158| 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD|3615|5853|lyfalmen|V0464|5154|00|2|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3615||3615|5853| 573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3250|5353|lyfalmen|V0129|5353|23|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3250||3250|5353| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|97368|124079|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Roche|Trastuzumab||97368||97368|124079| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|24023|32031|lyfsjukr|||00|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||24023||24023|32031| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|40675|52930|lyfsjukr|||00|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||40675||40675|52930| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|E|0|NOH|0|0|1|100|IKR|2756|2587|lyfalmen|V0189|2044|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2587| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2493|2043|lyfalmen|V0151|1977|00|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||830||830|2043| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|7766|6913|lyfalmen|V0322|4175|00|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4390||4390|6913| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|4597|2043|lyfalmen|V0152|1977|00|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||830||830|2043| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|13763|6913|lyfalmen|V0323|6605|00|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4390||4390|6913| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|6890|9944|lyfsjukr|||00|12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||6890||6890|9944| 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|1150|2481|lyfalmen|V0243|2481|00|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||1150||1150|2481| 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|A||0|0|0|0|ICE|0|0|0|100|USD|5793|10106|vetorma|||00|20|0||Icepharma hf|Icepharma hf|||5793||5793|10106| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1294|2677|lyfalmen|||02|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1294||1294|2677| 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|4812|6315|lyfalmen|V0005|2130|00|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3953||3953|6315| 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|711|1880|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||711||711|1880| 580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|A||0|0|B|0|LYF|0|1|0|100|XEU|2792|3895|lyfalmen|V0324|3895|00|100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2184||2184|3895| 580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|2930|3545|lyfalmen|V0462|3545|00|90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1928||1928|3545| 581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|3381|3983|lyfalmen|V0472|3983|00|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||2248||2248|3983| 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|A||0|0|0|0|ANI|1|0|0|100|XEU|14475|27967|vetalmen|||27|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14475||14475|27967| 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD|2352|4125|lyfalmen|||00|2|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2352||2352|4125| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|28282|37376|lyfsjukr|||02|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||28282||28282|37376| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|54579|70379|lyfsjukr|||02|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||54579||54579|70379| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|109158|138876|lyfsjukr|||02|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||109158||109158|138876| 582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|A||0|0|0|1|GEH|0|0|0|100|NOK|65989|84699|lyfsjukr|||02|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||65989||65989|84699| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5005|8731|vetorma|||16|50|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5005||5005|8731| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|18858|32897|vetorma|||16|200|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||18858||18858|32897| 582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|4746|7070|lyfalmen|||00|56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||4505||4505|7070|31.01.2012 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|44372|57569|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||44372||44372|57569| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|100949|128573|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||100949||100949|128573| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|ţpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|819|2028|lyfalmen|||00|28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||819||819|2028| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|48915|63271|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||48915||48915|63271| 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|53534|69068|lyfsjukr|||00|2|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||53534||53534|69068| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|97272|123959|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||97272||97272|123959| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1103|2416|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1103||1103|2416| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|116102|147591|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||116102||116102|147591| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|53015|68416|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||53015||53015|68416| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|109208|138939|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||109208||109208|138939| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|119378|151702|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||119378||119378|151702| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3831|5529|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3831||3831|5529| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2320|3348|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2320||2320|3348| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|1856|3446|lyfalmen|||64|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1856||1856|3446| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10017|14454|lyfsjukr|||02|20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10017||10017|14454| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3649|5266|lyfsjukr|||02|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3649||3649|5266| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4460|7008|lyfalmen|||02|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4460||4460|7008| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|32737|43444|lyfalmen|||00|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32737||32737|43444| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1743|3292|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1743||1743|3292| 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|14216|19724|lyfsjukr|||00|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||14216||14216|19724| 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|A||0|0|0|0|AGP|0|0|0|100|XEU|10146|14787|lyfalmen|V0095|14787|00|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||10146||10146|14787| 588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|4642|7257|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4642||4642|7257| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2198|3914|lyfalmen|V0461|3913|43|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2198||2198|3914| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|9574|14004|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||9574||9574|14004| 588772|H05BA0103|Miacalcic Nasal|nefúđi|200|ae/sk|2|ml|1|úđagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|8818|12970|lyfalmen|||23|2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8818||8818|12970| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6104|10648|vetorma|||16|3|0|0,0000|Icepharma hf|Pfizer Animal Health|||6104||6104|10648| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2366|4127|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||2366||2366|4127| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|5889|10273|vetorma|||16|6|0|0,0000|Icepharma hf|Pfizer Animal Health|||5889||5889|10273| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3181|5549|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||3181||3181|5549| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3304|5764|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||3304||3304|5764| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|DKK|3191|5567|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||3191||3191|5567| 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|USD|6239|9442|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráđ lyf|Lyf viđ vörtum og líkţornum||6239||6239|9442| 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|USD|7925|11748|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráđ lyf|Lyf viđ vörtum og líkţornum||7925||7925|11748| 590244|N03AF0202|Trileptal (D.A.C.)|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.07.2011||R|A||0|0|E|0|DAC|0|0|0|100|DKK|3124|4270|lyfalmen|||00|50|0|15,0000|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||2458||2458|4270|31.01.2012 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|2036|3693|lyfalmen|V0041|3693|10|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||2036||2036|3693| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|23034|31267|lyfalmen|||02|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||23034||23034|31267| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|180885|228893|lyfsjukr|||00|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||180885||180885|228893| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|ţpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|1,6000|Actavis Group hf|Actavis hf|Paracetamól|||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|520|1619|lyfalmen|V0238|722|00|50|0|3,1250|Icepharma hf|Roche|Klónazepam||520||520|1619| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|920|2166|lyfalmen|V0238|2166|00|150|0|9,3750|Icepharma hf|Roche|Klónazepam||920||920|2166| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1357|2764|lyfalmen|||00|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1357||1357|2764| 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|20844|28519|lyfalmen|||03|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||20844||20844|28519| 594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|7867|5976|lyfalmen|V0114|5976|00|100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||3705||3705|5976| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|340|593|vetorma|||16|10|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||340|593| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2824|4926|vetorma|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2824|4926| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|5995|8652|lyfsjukr|||02|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||5995||5995|8652| 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|623|1760|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||623||623|1760| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|65210|83721|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||65210|83721| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2349|4121|lyfalmen|||43|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2349||2349|4121| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|453|1527|lyfalmen|||00|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||453||453|1527| 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|A||1|0|0|0|PCO|0|0|0|100|DKK|4136|6565|lyfalmen|||00|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4136|6565| 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|LDR|0|0|0|100|DKK|1337|2736|lyfalmen|||00|20|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|||1337||1337|2736| 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|SEK|5086|7865|lyfalmen|||00|50|1|25,0000|Distica|Distica - óskráđ lyf|Flunarizín||5086||5086|7865| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|SEK|2772|4699|lyfalmen|||00|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2772||2772|4699| 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1564|lyfalmen|||00|4|1|0,0000|Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1564| 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|12095|17539|lyfalmen|||00|20|1|200,0000|Distica|Distica - óskráđ lyf|||12095||12095|17539| 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|11317|16388|lyfalmen|||00|100|1|160,0000|Parlogis hf|Parlogis - óskráđ lyf|||11317||11317|16388| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|6207|9398|lyfalmen|||00|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6207||6207|9398| 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|50663|65941|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Pentósan pólýsúlfat natríum||50663||50663|65941| 938665|A12CX0001|K-Phos Neutral|töflur|||100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6476|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Málmlyf ýmisleg||4071||4071|6476| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|GBP|17832|24739|lyfalmen|||00|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||17832||17832|24739| 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|GBP|10727|15581|lyfalmen|||00|10|1|100,0000|Distica|Distica - óskráđ lyf|||10727||10727|15581| 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|2731|4643|lyfalmen|||00|1|1|83,3300|Distica|Distica - óskráđ lyf|Estradíól||2731||2731|4643| 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998|31.01.2012|R|A||0|0|E|0|PCO|0|0|0|100|DKK|5450|8363|lyfalmen|||00|1|1|166,6700|Distica|Distica - óskráđ lyf|Estradíól||5450||5450|8363| 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998|30.11.2011|R|A||0|0|E|0|PCO|0|0|0|100|DKK|9430|13807|lyfalmen|||00|1|1|333,3300|Distica|Distica - óskráđ lyf|Estradíól||9430||9430|13807| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|2910|4888|lyfalmen|||00|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||2910||2910|4888| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5435|8342|lyfalmen|||00|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5435||5435|8342| 944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1375|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|||342||342|1375| 944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|664|1816|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1816| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|4044|lyfalmen|||00|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4044| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5033|7792|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|||5033||5033|7792| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1990|3630|lyfalmen|||00|100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3630| 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1335|1927|lyfsjukr|||55|10|1|26,6700|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1335||1335|1927| 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|838|2054|lyfalmen|||00|21|1|21,0000|Parlogis hf|Parlogis - óskráđ lyf|||838||838|2054| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5435|8342|lyfalmen|||00|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5435||5435|8342| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3465|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3465| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8691|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8691| 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|DKK|17262|23546|lyfsjukr|||00|30|1|30,0000|Distica|Distica - óskráđ lyf|Megestról||17262||17262|23546| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1960|3589|lyfalmen|||00|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3589| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1850|3438|lyfalmen|||00|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3438| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4320|6817|lyfalmen|||00|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||4320||4320|6817| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5628|lyfalmen|||00|100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|||||3451|5628| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2360|4136|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4136| 963802|M01AB0107|Indometacin|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.10.2010|31.12.2011|R|A||0|0|E|0|PCO|0|0|1|100|GBP|406|1463|lyfalmen|||04|10|1|10,0000|Distica|Distica - óskráđ lyf|Indómetacín||406||406|1463| 965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|A||0|1|E|0|LDR|0|0|0|100|IKR|8480|12508|lyfalmen|||00|120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12508|